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Abstract 
 
 
Helicobacter pylori is associated with gastric diseases, such as gastritis, peptic and 
duodenal ulcers, mucosa associated lymphoid tissue lymphoma and gastric 
adenocarcinomas. Despite more than half of the global population being infected with this 
bacterium, not all individuals will develop clinical symptoms. Nevertheless, its association 
with gastric cancer, the high infection rate, as well as the failures on eradication efforts 
and vaccine development lead to an important health concern. In order to better 
understand the mechanisms leading to disease and also to develop effective ways to fight 
H. pylori infection, it is important to understand its physiological and metabolic behavior.  
H. pylori is a microaerophilic, gram negative, fastidious organism, for which no 
effective defined medium has been developed. Furthermore, current cultivation procedures 
use media that, even when semi-defined, have a variety of nutrients that can be used as 
carbon and energy sources. Under those conditions, the metabolic and physiological 
characterization of H. pylori is very difficult.  
The aim of this work was thus to study the physiology and metabolism of H. pylori 
to allow a better understanding of the behavior and pathogenicity of this organism. For that 
aim, a systems biology approach was used where Gas Chromatography-Mass 
Spectrometry (GC-MS) based metabolomics and genomics data were used to characterize 
the nutritional requirements and the preferred carbon sources and to build a reliable 
metabolic model.  
Data on H. pylori’s exometabolome was for the first time collected from 
experiments performed with semi-defined media and allowed to establish the essentiality 
of several amino acids: L-histidine, L-leucine, L-methionine, L-valine, L-isoleucine and L-
phenylalanine. Moreover, this analysis indicated that L-aspartate, L-glutamate, L-proline 
and L-alanine could be potential carbon sources for H. pylori. Thus, a comparative analysis 
of different amino and organic acids as carbon sources was performed and glutamine / 
glutamate emerged as the most effective compounds. However, since glutamine is 
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unstable under the conditions used, glutamate was selected the most adequate carbon 
source for growing H. pylori.  
Then, a simplified medium containing only the essential amino acids and L-
glutamate, besides vitamins and salts, as well as 5% of fetal bovine serum (FBS) was used 
to perform physiological studies. Under those conditions, the specific growth rate was 
determined to be 0.126 h-1, while the use of uniformly labeled 13C L-glutamate together with 
GC-MS measurements of proteinogenic amino acids allowed to confirm the essential 
amino acids and raise some clues about L-proline and L-alanine which, given their 
presence in FBS, had still unclear roles. L-proline, although not labeled, is probably not 
essential and could be obtained from arginine, while L-alanine showed very low labeling 
patterns and is hypothesized to originate from pyruvate. Finally, labeling experiments 
allowed to confirm the presence of a complete tricarboxylic acid cycle. 
These collected data, together with genomics and other information available, 
were used to build and validate the first genome-scale metabolic model of H. pylori that is 
able to make quantitative predictions, covering roughly 23% of the genome. This model 
can be used, in the future, to investigate novel drug targets and elucidate the metabolic 
basis of infection.  
Furthermore, a comparative study was performed that analyzed different methods 
for assessing growth, viability, culturability and morphology, as these are important 
physiological parameters. 
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Resumo 
 
A caracterização fenotípica é de extrema importância para entender o 
metabolismo celular, especialmente em organismos patogénicos, para os quais, na sua 
maioria, a informação disponível é limitada. Compreender o metabolismo de um 
organismo patogénico é fundamental para desvendar os mecanismos de interação 
patogénio-hospedeiro, com vista à identificação de alvos para desenvolvimento de 
fármacos. 
Neste trabalho estudou-se o metabolismo da bactéria Helicobacter pylori, um 
micro-organismo patogénico associado a doenças gástricas, usando uma estratégia de 
Biologia de Sistemas. 
As experiências realizadas usando um meio liquido semi-definido para crescer H. 
pylori provaram a existência de um fator de stress associado a uma paragem do seu 
crescimento, acompanhada de uma mudança de morfologia. Sendo conhecido o caracter 
pleiomórfico da H. pylori quando sujeita a determinadas condições de stress, e dado que 
os requisitos nutricionais não se encontravam completamente definidos, foi levantada a 
hipótese deste fator de stress estar associado à falta de um nutriente essencial. Assim, foi 
efetuada uma análise de exometaboloma com vista a determinar os seus requisitos 
nutricionais e preferências. Verificou-se a existência de aminoácidos essenciais ao 
crescimento, e comprovou-se a preferência dos aminoácidos como fonte de carbono 
(glutamato, prolina, alanina e aspartato). No entanto, algumas dúvidas persistiram 
relativamente à essencialidade de prolina e alanina.  
Para identificar a fonte de carbono preferencial foram testados diversos 
aminoácidos. Identificou-se que o aminoácido L-glutamato é o mais indicado ao 
crescimento de H. pylori, tendo-se efetuado a caracterização do seu crescimento com o 
referido aminoácido como fonte de carbono. 
Como forma de comprovar a efetiva utilização de L-glutamato como fonte de 
carbono, foram efetuadas experiências com 13C L-glutamato, tendo-se utilizado 
cromatografia gasosa com espectroscopia de massas para a análise das amostras. A 
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análise dos aminoácidos do hidrolisado de biomassa de H. pylori permitiu comprovar a 
utilização de L-glutamato como fonte de carbono. Comprovou-se ainda a essencialidade 
dos aminoácidos isoleucina, histidina, leucina, metionina, fenilalanina e valina. Foi possível 
também identificar algumas vias metabólicas ativas para as quais residiam dúvidas, como 
o caso da existência do ciclo de Krebs completo. As experiências realizadas permitiram 
ainda levantar hipóteses acerca da biossíntese de L-prolina e L-alanina em H. pylori a 
partir de L-arginina e piruvato, respetivamente.  
Com a informação recolhida, associada à anotação do genoma recentemente 
efetuada foi possível reconstruir um modelo metabólico à escala genómica para H. pylori 
26695. As previsões obtidas com o referido modelo estão de acordo com os dados 
experimentais. Este modelo contém informação biológica relevante para este organismo, 
com possível aplicação na identificação de potenciais alvos metabólicos, para a obtenção 
de fármacos mais efetivos na erradicação de H. pylori.  
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1.1 Thesis motivation and objectives 
Helicobacter pylori is one of the most thriving human pathogens, being 
disseminated all over the world1. Unless treated, H. pylori can persist in the human 
stomach for life, although not all individuals will develop disease. The disease outcome can 
vary from gastritis, peptic ulcer, gastric cancer to mucosal-associated lymphoid tissue 
lymphoma.  
To fully understand the mechanisms associated with host colonization and host-
pathogen interaction, it is indispensable to understand the pathogen’s metabolism inside 
the host, where it must extract nutrients to fulfill its metabolic requirements2. In the 
particular case of H. pylori, its metabolism and physiology are not well studied, owing, in 
part, to the difficulties found until now in growing this pathogen in vitro under defined 
conditions.  
Using Systems Biology approaches, different tools can be applied to understand 
the system as a whole. The use of “omics” data has made possible the reconstruction of 
genome-scale metabolic models for a large number of organisms. This type of in silico 
models allows to predict cellular behavior, bridging the gap between genotypes and 
phenotypes, aiding efforts to diverse areas, including drug discovery3,4. The availability of 
the genome sequence of H. pylori 26695 and its annotation have allowed the construction 
of metabolic models for this organism5,6. However, the accuracy of model predictions is 
associated with the data used to build and validate the model, which is limited for H. 
pylori. 
 
This work aimed at studying H. pylori’s metabolism using a Systems Biology 
approach. The specific goals included: 
- Contribute to understand the nutritional requirements and preferences of H. 
pylori; 
- Collect physiological and metabolomics data that can help to understand more 
of H. pylori’s metabolism; 
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- Reconstruct a new genome-scale metabolic model based on novel results on 
genome (re-)annotation; 
- Use the physiological data collected to validate the genome-scale metabolic 
model. 
 
 
1.2 Structure of the thesis 
This thesis is composed of eight chapters. Chapter 2 is a general introduction to 
the topics, and can be divided into two main subjects: H. pylori and Systems Biology. The 
part devoted to H. pylori addresses mainly topics related with H. pylori’s microbiological 
characteristics, growth, physiology and metabolism. In the Systems Biology part, emphasis 
on “omics”  technologies is given, with an overview on omics studies reported for H. pylori. 
The Metabolomics approach, which is the “omics” technology used in this thesis, is further 
explored. Finally, the process of genome-scale metabolic model reconstruction is 
described.  
Considering the well-known H. pylori’s pleiomorphic nature, in Chapter 3 a study 
of growth and morphology assessment methods for H. pylori growing in liquid medium is 
presented. This study allowed concluding about the suitable methods to monitor H. pylori’s 
growth.  
Chapter 4 presents a reconciliation of H. pylori’s nutritional requirements, 
gathering experimental results and in silico predictions. A metabolic footprinting approach 
was applied to understand which are the components being used when H. pylori was 
growing using a “complete” liquid medium (containing all 20 amino acids) and thus, infer 
about amino acids requirements. 
Chapter 5 and 6 are devoted to the study of H. pylori’s preferred carbon sources. 
In Chapter 5, different compounds (mainly amino acids) were tested and compared as 
carbon sources for H. pylori’s growth. Based on the results obtained in Chapter 5, 
glutamate was selected as the preferred carbon source, and the growth using this 
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substrate was further characterized in Chapter 6. A strategy of using an isotopically 
labelled substrate (13C glutamate) was performed in order to determine the labelling profile 
in several biomass constituents. 
The reconstruction of an updated genome-scale metabolic model for H. pylori 
26695 is presented in Chapter 7. This chapter includes several steps: genome re-
annotation, reconstruction using a semi-automated method, manual curation, definition of 
biomass composition (determined experimentally) and model validation with the 
experimental data obtained in previous chapters.  
To conclude, in Chapter 8 the main conclusions and considerations about future 
work are presented.  
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2.1 Helicobacter pylori – General Aspects 
In 1982, Barry J. Marshall and J. Robin Warren identified a bacillary organism in 
the gastric epithelium1, and, at that time, they could not imagine that their discovery would 
result in the awarding of the Nobel Prize in Physiology and Medicine in 20052. With their 
discovery, they changed the assumption that peptic ulcer was caused by stress and 
lifestyle1,2. In fact, the association of Helicobacter pylori with gastritis and peptic ulcer 
disease was proved later through studies with human volunteers1–4.  
Due to its relation with gastric diseases, in the last 20 years intense research has 
been performed around H. pylori, proved by the number of publications that increased 
from around 500 in 1992 to around 1500 in 2012, totalizing more than 32 000 
publications in international peer-reviewed journals (searched with “Helicobacter pylori” 
terms in the PUBMED database)5.  
 
2.1.1 Taxonomy 
H. pylori is a member of the Proteobacteria phylum, belonging to the class 
Epsilonproteobacteria, Campylobacterales order, Helicobacteraceae family6. Despite the 
differences found in flagella, in 1984 H. pylori was included in the Campylobacter genus 
and was named Campylobacter pyloridis 7. In 1987, the nomenclature was revised and the 
species name was corrected to Campylobacter pylori 8. In the following years, several 
studies revealed significant differences between this organism and Campylobacter species, 
being more closely related with Wolinella succinogenes 9,10. In 1989, C. pylori was included 
in a new genus - Helicobacter. The name refers to its helical morphology, and this species 
was designated Helicobacter pylori 11. In the Helicobacter genus there are more than 20 
species, including human and animal pathogens, with new Helicobacter species being 
regularly discovered6,12–14. The features that can be used to differentiate Helicobacter 
species are: host, location, morphological characteristics (cell size, flagella), growth 
conditions, antibiotics susceptibility, biochemical characteristics (such as catalase, oxidase 
and urease activity, nitrate reduction, among others), or G+C content6,13,14. There are two 
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major groups of Helicobacter species: the gastric Helicobacter species (such as H. felis, H. 
mustelae, H. acinonychis, H. pylori, among others) and non-gastric (enterohepatic) 
Helicobacter species (such as H. hepaticus, H. pullorum, H. cinaedi, H. canis, among 
others)13–15. These groups present a high level of specificity relatively to the organ they 
colonize15.  
 
2.1.2 Microbiological characteristics 
H. pylori is a gram-negative bacterium, measuring 2.0-5.0 µm in length and 0.5-
1.0 µm in width15–17. Although it usually exhibits a spiral or curved rod shape15,16, coccoid 
shapes can appear when the organism is subjected to certain adverse conditions, such as 
prolonged in vitro culture, increased temperature, alkaline pH, increased oxygen tension, 
or antibiotic treatment18. There is some controversy about the nature of these coccoidal 
forms, with some authors reporting that they represent a morphological manifestation of 
cell death19, and others a viable but non culturable state (VBNC)20,21. It is thought that these 
forms cannot be cultured in vitro, although they are metabolically active. Despite evidences 
that these forms can induce infection, this is another controversial topic. The recovery of 
coccoid to spiral forms in H. pylori was reported, and notwithstanding this fact was proven 
in other species such as E. coli or S. tiphymurum, this result is still not universally 
accepted by the scientific community, since other authors were not able to prove these 
findings in H. pylori. During the conversion of H. pylori spiral to coccoid forms, 
intermediate U forms can also be observed22.  
H. pylori is motile, with 2-6 sheathed unipolar flagella of approximately 3 µm long 
and 2.5 nm thick. Each flagellum frequently carries a distinctive terminal bulb, which is an 
expansion of the flagellar sheath16,23–25. The sheath is an extension of the outer membrane 
and its role can be to protect the flagellar structure from the acidic environment of the 
stomach16,17,24. The flagella, in association with the spiral shape, are essential for host 
colonization, allowing the movement in viscous solutions such as the mucus layer of the 
gastric epithelium25–27. When cultured in plates with solid medium, H. pylori colonies appear 
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translucent, not clearly haemolytic and with 1-2 mm in diameter23. H. pylori is a 
microaerophilic and non-sporulating organism28. 
 
 
2.2 Epidemiology of Helicobacter pylori infection 
2.2.1 Prevalence of infection 
H. pylori is the agent of one of the most disseminated infections in the world29. 
There are many studies reporting the prevalence of H. pylori infection in different countries 
along time, with review articles being published every year within the last years30–35. The 
prevalence of H. pylori infection varies with geographical areas, age, race and 
socioeconomic status30. The global prevalence of H. pylori is depicted in Figure 2.1. 
In general, more than 50% of the global population is infected with H. pylori 29, 
ranging from 25-50% of infection in developed countries to 70-90% in developing 
countries12. The infection rate observed in developing countries might be related with 
factors such as unsanitary conditions and contaminated water12. It is important to highlight 
that a high H. pylori prevalence does not mean a high rate of disease. For instance, in 
developed countries there is a low infection rate and a relatively high prevalence of gastric 
cancer and the opposite is also true for some countries36.  
H. pylori is mostly acquired in childhood, probably from close family members12,15 
and, if not treated, may become a lifelong infection15,29. It is clear that the infection rates 
have been decreasing in the last years, with emphasis in developed and developing 
countries35, although this fact is more noticeable in developed countries and can be linked 
to improvements in hygiene practices30 and with the decrease of family sizes37.  
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Figure 2.1. Worldwide prevalence of H. pylori. N.D. means that no consistent data were found. Adapted 
from Azevedo et al. ( 2007)38. 
 
2.2.2 Pathologies associated with H. pylori infection 
Despite the fact that more than half of the global population is infected with H. 
pylori, the infection is frequently asymptomatic and only a small proportion of the 
individuals will develop clinical signs of its colonization15,39.  
H. pylori’s association with gastric diseases is well known, and includes conditions 
such as gastritis, peptic ulcer, adenocarcinome and mucosa associated lymphoid tissue 
(MALT) lymphoma12. Gastric cancer is the second most prevalent cancer in the world39. In 
the last years, aspects related with H. pylori associated diseases have been systematically 
updated in the “Helicobacter” Journal. Those reviews are divided in non-malignant 
diseases40–46 and gastric malignancies (cancer and lymphoma)47–53  
It is estimated that patients who carry H. pylori have a 10-20% risk of developing a 
ulcer disease in their lifetime and a 1-2% risk of developing distal gastric cancer15. The 
particular risk of developing a disease in the presence of H. pylori infection has been 
associated with bacterial, host and environmental factors15. 
The possible association of H. pylori infection with other diseases, besides gastric 
diseases, has now been intensively investigated. Studied conditions include cardiovascular, 
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respiratory and ear, nose and throat diseases, hematologic, ophthalmology, oral mucosa 
and skin diseases, hepatobiliary diseases, diabetes mellitus and metabolic disorders, 
immunologic diseases, and neurological disorders. For some disorders, for instance 
Idiopathic Thrombocytopenic Purpura (ITP) there are strong evidences that there is a link 
between the disease and H. pylori infection54,55, whilst for other diseases more studies are 
needed in order to prove H. pylori association. The studies published on extra gastric 
manifestations of H. pylori infection have been systematically reviewed in the last years in 
the “Helicobacter” Journal54–63.  
 
 
2.3 In vitro growth of Helicobacter pylori 
2.3.1 In vitro growth media 
Since its first culture in 1984, a considerable number of studies describing media 
have been published, either to transport, isolate, preserve or cultivate H. pylori in vitro. The 
use of both solid and liquid media has been reported, although the best results were 
obtained using solid media, frequently supplemented with sheep or horse blood (Table 
2.1). 
Growth in liquid media is not straightforward to achieve, as H. pylori grows very 
slowly even in rich media, and contamination with other organisms is a concern. Thus, 
antibiotics (vancomycin, polymyxin, trimethoprim, amphotericin, polymyxin, among others) 
are often added. Complex liquid media are mostly used (Table  2.2), although a few semi-
defined media have also been developed, where defined medium are used but 
supplemented with undefined components (Table 2.3). The use of some defined 
supplements (cyclodextrins or cholesterol) has also been described as an adequate 
replacement for the complex supplements (Table 2.4). However, the cell densities 
obtained are quite low and the supplementation with undefined components drastically 
improves growth. The use of undefined components such as fetal bovine serum (FBS), 
horse serum (HS) or bovine serum albumin (BSA) is a setback when cultures with defined 
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media are required, such as in proteomics or metabolomics studies. The exact function of 
the supplements added to the culture medium is unknown, and it is not yet clear whether 
supplements have a nutritional function. Animal serum, for example, is a very rich mixture 
of components, considered undefined and variable, although some compounds have been 
identified such as protein components, hormones, fatty acids, vitamins and growth factors, 
among others64. It is hypothesized that serum may act as a growth-stimulating factor65,66, 
but it can also be speculated that it acts as an attachment and/or detoxifying factor by 
binding to and inactivating toxic compounds, like in cell culture media64.  
Cyclodextrin, another frequently used supplement, was described to increase 
medium viscosity and osmolarity67 and/or to act by chelating toxic molecules present in the 
culture medium or produced by microbial metabolism65,67,68. Cholesterol is considered a 
growth-enhancing compound67,69, and it is present in serum and blood. It was found that H. 
pylori can incorporate cholesterol and it comprises around 25% of the lipid membrane 
content of H. pylori 70–73, although it seems that H. pylori cannot synthesize it, neither it is 
an absolute requirement for growth67.  
In fact, the use of defined liquid media for H. pylori was reported74–76. All of the 
described media have similar basis, with differences, in some cases, only in one amino 
acid74. Inorganic salts and vitamins are also present, although some media have only 
thiamine75. Other components are present, such as glucose74–76, pyruvate67, lipoic acid67,77 
among others. Ham’s F-12 is the most complete medium in terms of compounds, but with 
lower concentrations of amino acids. In addition, it was described to support robust 
growth, even using small inocula67,78. 
However, in none of the reported studies has H. pylori survived in the defined 
medium without adaptation. This adaptation to completely defined media, without 
supplements, was achieved by either replacing complex by defined medium in continuous 
cultures75 or by diluting semi-defined medium with fresh medium without supplements with 
subsequent passages to defined medium79. In other cases, H. pylori only survives in 
defined media if it is directly inoculated from plates for each liquid experiment. 
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Table 2.1. Complex solid media described for H. pylori growth.  
Different media described for H. pylori growth. When the medium is a derivation from another medium this is indicated in the components column. When the purpose of the 
medium was other than cultivation, it is indicated in the notes column. Supplements: w/o – without; YE – yeast extract; Serum-based – with one of the following serum-based 
supplements, horse serum, fetal calf serum, calf serum, iron-supplemented calf serum, heat-treated fetal bovine serum; heat-treated adult bovine serum; Blood-based – with one of 
the following blood-based supplements, human blood, rabbit blood, horse blood, heated horse blood; lysed horse blood, defibrinated horse blood, sheep blood, defibrinated sheep 
blood; HM – hemin; EYE – egg yolk emulsion, CL – cholesterol; BSA – bovine serum albumin or lipid-rich bovine serum albumin; CD – β-cyclodextrin or 2,6-di-O-methyl-β-
cyclodextrin; ST – starch or cornstarch; CC – charcoal or activated charcoal. TTC - Triphenyl tetrazolium chloride; IsoVitaleX – enrichment with glucose, amino acids, vitamins, 
nucleotides and iron.  
Medium 
Components 
added 
Supplements 
Notes Reference 
w/o YE 
Serum-
based 
Blood-
based 
HM EYE CL BSA CD ST CC 
Belo Horizonte 
Medium 
BHIA 
TTC 
           - Queiroz et al. (1987)80 
Blood Agar 
Base 
-            
Isolation and 
subcultivation 
Ansorg et al. (1991)81 
-            - 
Hutton et al. (2012)82 
-            - 
-            -- 
-            - 
Brain Heart Infusion 
Agar (BHIA) 
-            - Kehler et al. (1994)83 
IsoVitaleX 
Antibiotics 
           - Goodwin et al. (1985)84 
-            Isolation Hachem et al. (1995)85 
IsoVitaleX            - Westblom et al. (1991)86 
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Table 2.1. Complex solid media described for H. pylori growth. (Continued).  
Medium Components added 
Supplements 
Notes Reference 
w/o YE 
Serum-
based 
Blood-
based 
HM EYE CL BSA CD ST CC 
Brain Heart Infusion Agar 
(BHIA) 
-            - 
Ohno and Murano 
(2007)87 
-            - 
Shibayama et al. 
(2006)88 
Brucella Agar (BA) 
-            - 
Buck and Smith 
(1987)89 
-            - 
-            - 
Brussels Campylobacter 
Charcoal Agar 
TTC 
Antibiotics 
           
Isolation and 
subcultivation Ansorg et al. (1991)
81 
Brugmann agar (Horse 
blood based) 
Agar 
TTC 
Antibiotics 
           
Selective 
medium 
for isolation from 
biopsies 
Deyi et al. (2010)90 
Campylobacter pylori 
selective (CPS) 
CBA 
Skirrow’s medium with 
modifications 
           
Selective 
medium 
for isolation 
Dent and McNulty 
(1988)91 
Columbia base agar (CBA) 
-            - Secker et al. (1991)92 
IsoVitaleX 
Urea 
Phenol red 
Granulated agar 
           
Detection of 
urease activity Cellini, et al. (1992)
93 
-            - Olivieri et al. (1993)94 
IsoVitaleX            - Albertson et al.(1998)69 
-            - 
Stevenson et al. 
(2000)95 
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Table 2.1. Complex solid media described for H. pylori growth. (Continued).  
Medium 
base 
Components 
added 
Supplements 
Notes Reference 
w/o YE 
Serum-
based 
Blood-
based 
HM EYE CL BSA CD ST CC 
Chocolate agar (CBA 
based) 
CBA 
            
Buck and Smith 
(1987)89 
           - 
           - 
CBA            Transport medium Xia et al.(1993)96 
Egg Yolk Enulsion (EYE) 
Agar 
CBA based 
IsoVitaleX 
TTC 
           - 
Westblom et al. 
(1991)86 
GAB-CAMP medium 
modified 
GC agar base 
IsoVitaleX 
Antibiotics 
           - 
Soltesz et al. 
(1992)97 
GC agar base            - 
Taneera et al. 
(2002)98 
Gonococci (GC) Agar 
Base 
-            - 
Buck and Smith 
(1987)89 
-            - 
-            - 
-            - 
GCHI chocolate agar Antibiotics            - 
Morgan et al. 
(1987)99 
H. pylori special 
peptone agar (HPSPA) 
Special peptone 
Yeast extract 
Beef extract 
Sodium chloride 
Pyruvic acid 
Sodium Salt 
Granulated agar 
           
Selective medium for 
isolation from cattle and 
beef samples Stevenson et al. 
(2000)95 
           - 
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Table 2.1. Complex solid media described for H. pylori growth. (Continued).  
Medium 
base 
Components 
added 
Supplements 
Notes Reference 
w/o YE 
Serum-
based 
Blood-
based 
HM EYE CL BSA CD ST CC 
HP agar (HPSPA 
based) 
Yeast extract 
Beef extract 
Special peptone 
Sodium chloride 
Hydrochloric acid 
Urea 
Phenol red 
Antibiotics 
           
Selective medium for 
water samples 
Degnam et al. 
(2003)100 
Iso-sensitest agar 
(Oxoid) 
-            
Antimicrobial 
susceptibility test 
Hartzen et al. 
(1997)101 
Johnson Murano 
Agar 
-            - 
Stevenson et al. 
(2000)95 
Modified Glupczynski 
medium 
BHIB Based 
Legionella CYE 
agar 
TTC 
Antibiotics 
           
Selective 
medium 
Tee et al. 
(1991)102 
BHIB Based 
Legionella CYE 
agar 
           - 
Stevenson et al. 
(2000)95 
Mueller-Hinton 
Agar (MHA) 
-            - 
Buck and Smith 
(1987)89 
-            - 
Olivieri et al. 
(1993)94 
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Table 2.1. Complex solid media described for H. pylori growth. (Continued).  
Medium 
base 
Components 
added 
Supplements 
Notes Reference 
w/o YE 
Serum-
based 
Blood-
based 
HM EYE CL BSA CD ST CC 
Mueller-Hinton 
Agar (MHA) 
-            - 
Walsh and Moran (1997)103 
Stevenson et al. (2000)95 
Vega et al.(2003)104 
Skirrow Agar 
Antibiotics            
Isolation from  
biopsies 
Krajden et al. (1987)105 
Antibiotics 
 
           
Isolation from  
biopsies 
 
Coudron and Kirby (1989)106            
           
Tryptic Soy Agar (TSA) 
-            
Isolation from  
biopsies 
Coudron and Kirby (1989)106 
Hachem et al. (1995)85 
Walsh and Moran (1997)103 
-            
Isolation from  
biopsies 
Coudron and Kirby (1989)106 
Vestfold Charcoal 
(Charcoal agar based) 
IsoVitaleX 
TTC 
           - Henriksen et al. (2000)107 
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Table 2.2. Complex liquid media described for H. pylori growth.  
Different media described for H. pylori growth. When the objective of the medium was other than cultivation, this is indicated in the notes column. w/o – without; YE – yeast extract; 
Serum-based – with one of the following serum-based supplements, horse serum, fetal calf serum, new-born calf serum, iron-supplemented calf serum, heat-inactivated horse 
serum, heat-treated fetal bovine serum, heat-treated adult bovine serum, human serum; Blood-based – with one of the following blood-based supplements, human blood serum, 
human blood lysed, human erythrocyte lysate, lamb blood; PGM – porcine gastric mucin; BSA – bovine serum albumin or lipid-rich bovine serum albumin; HM – hemin;  CL – 
cholesterol; CD – α-cyclodextrin, β-cyclodextrin or 2,6-di-O-methyl-β-cyclodextrin; CE – cyanobacterial extract; ST – starch or cornstarch; MC – methyl cellulose; AC – activated 
charcoal; IsoVitaleX – enrichment with glucose, amino acids, vitamins, nucleotides and iron; Vitox - enrichment with glucose, amino acids, vitamins, nucleotides and iron. 
Medium 
base 
Components 
added 
Supplements 
Notes Reference 
w/o YE 
Serum-
based 
Blood-
based 
PGM BSA HM CL CD CE ST MC AC 
Brain Heart 
Infusion Broth 
(BHIB) 
-              - 
Shahamat et al. 
(1991)108 
Kehler et al. (1994)83 
-              - 
Shahamat et al. 
(1991)108 
-              
Cultivation 
from 
biopsies 
Shahamat et al. 
(1991)108 
Xia et al.(1993)96 
Jiang and Doyle 
(2000)109 
Sainsus et al. 
(2008)78 
-              
Transport 
medium 
Shahamat et al. 
(1991)108 
Xia et al.(1993)96 
-              - 
Stevenson et al. 
(2000)95 
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Table 2.2. Complex liquid media described for H. pylori growth. (Continued). 
Medium 
base 
Components 
added 
Supplements 
Notes Reference 
w/o YE 
Serum-
based 
Blood-
based 
PGM BSA HM CL CD CE ST MC AC 
Brain Heart Infusion 
Broth (BHIB) 
Antibiotics              - Jiang and Doyle (2000)109 
-              
Enzyme 
expression 
Hutton et al. (2012)82 
Lin et al. (1996)110 
Ferrous sulphate 
Sodium pyruvate 
With or without 
antibiotics 
             - Jiang and Doyle (2000)109 
-              - Shibayama et al. (2006)88 
-              - 
Ohno and Murano (2007)87 
Hutton et al. (2012)82 
Blood agarose 
Vitox 
Antibiotics (DENT) 
             - Duque-Jamaica et al. (2010)111 
-              - 
Hutton et al. (2012)82 
-              - 
Brucella Broth (BB) 
-              
Cultivation 
from 
biopsies 
Buck and Smith (1987)89 
Shahamat et al. (1991)108 
Sainsus et al. (2008)78 
-              - Shahamat et al. (1991)108 
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Table 2.2. Complex liquid media described for H. pylori growth. (Continued). 
Medium 
base 
Components added 
Supplements 
Notes Reference 
w/o YE 
Serum-
based 
Blood-
based 
PGM BSA HM CL CD CE ST MC AC 
Brucella 
Broth (BB) 
-              - 
Morgan et al. (1987)99 
Secker et al. (1991)92 
Olivieri et al. (1993)94 
Albertson et al. (1998)69 
Douraghi et al. (2010)65 
-              - 
Buck and Smith 
(1987)89 
-              - 
-              - 
-              -- 
Olivieri et al. (1993)94 
Albertson et al.(1998)69 
Sodium 
polyanetholsulfonate 
             - Kehler et al. (1994)83 
Antibiotics              - Marchini et al. (1995)68 
IsoVitaleX              -- Westblom et al. (1991)86 
IsoVitaleX              - 
Kitsos and Stadtlander 
(1998)112 
Glucose              - Sato et al. (2003)113 
-              - Douraghi et al. (2010)65 
-              - Park et al. (2011)114 
Hepes 
Trace metals 
Sodium pyruvate 
             
Regrowth 
medium 
Richards et al. (2011)115 
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Table 2.2. Complex liquid media described for H. pylori growth. (Continued). 
Medium 
base 
Components 
added 
Supplements 
Notes Reference 
w/o YE 
Serum-
based 
Blood-
based 
PGM BSA HM CL CD CE ST MC AC 
Buffered yeast extract-α-
ketoglutarate (BYEα) 
-              - Shahamat et al. 
(1991)108 -              - 
Customized 
Tryptone 
Yeast extract 
Trace metals 
Tris Magnesium 
chloride 
             - 
Andersen et al. 
(1997)116 
Columbia Broth (CB) 
-              - 
Shahamat et al. 
(1991)108 
-              - 
-              - 
Gonoccocal broth (GB) -              - 
Taneera et al. 
(2002)98 
H. pylori special peptone 
broth (HPSPB) 
Special peptone 
Yeast extract 
Beef extract 
Sodium chloride 
Pyruvic acid 
Sodium salt 
             - 
Stevenson et al. 
(2000)95 
Modified Brucella Broth 
Tryptone 
Peptamine 
Glucose 
Yeast extract 
Sodium chloride 
             - 
Lin et al. 
(1996)110 
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Table 2.2. Complex liquid media described for H. pylori growth. (Continued). 
Medium 
base 
Components 
added 
Supplements 
Notes Reference 
w/o YE 
Serum-
based 
Blood-
based 
PGM BSA HM CL CD CE ST MC AC 
Mueller-Hinton 
Broth (MHB) 
-              - Shahamat et al. 
(1991)108 -              - 
-              
Cultivation 
from 
biopsies 
Shahamat et al. 
(1991)108 
Sainsus et al. (2008)78 
-              - 
Shahamat et al. 
(1991)108 
Walsh and Moran 
(1997)103 
Cation-adjusted              - Coudron and Stratton 
(1995)117 Cation-adjusted              - 
Proteose peptone 
nº3 
             - 
Walsh and Moran 
(1997)103 
-              - 
Stevenson et al. 
(2000)95 
Vega et al. (2003)104 
-              - 
Vega et al.(2003)104 0.3% agar              
Transport 
medium 
Porcine stomach mucin  
(10% in water) 
-              
Preservation 
medium Ansorg et al. (1991)
81 
Stuart transport 
medium 
-              
Transport 
medium Soltesz et al. (1992)
97 
Supplemented peptone -              - Kehler et al. (1994)83 
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Table 2.2. Complex liquid media described for H. pylori growth. (Continued). 
Medium 
base 
Components 
added 
Supplements 
Notes Reference 
w/o YE 
Serum-
based 
Blood-
based 
PGM BSA HM CL CD CE ST MC AC 
Tryptic Soy 
Broth (TSB) 
-              - Shahamat et al. 
(1991)108 -              - 
-              
Cultivation from 
biopsies 
Shahamat et al. 
(1991)108 
Sainsus et al. 
(2008)78 
-              - 
Shahamat et al. 
(1991)108 
Walsh and Moran 
(1997)103 
Proteose peptone 
nº3 
             - 
Walsh and Moran 
(1997)103 
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Table 2.3. Semi-defined liquid media (defined media supplemented with undefined components) described for H. pylori growth.  
Different media used for H. pylori growth. When the objective of the medium was other than cultivation, this is indicated in the notes column. w/o – without; YE – yeast extract; 
Serum-based – with horse serum or fetal calf; HG – haemoglobin; BSA – bovine serum albumin or lipid-rich bovine serum albumin; CD –2,6-di-O-methyl-β-cyclodextrin. 
Medium base Components added 
Supplements 
Notes Reference 
YE 
Serum-
based 
HG BSA CD 
Customized 
Salts 
Trace metals (iron sulphate) 
Glucose 
Phenol red 
Adenine 
Lipoid acid 
Vitamins 
Amino acids (all 20, except tyr) 
     - Reynolds and Penn (1994)77 
Customized 
Reynolds and Penn medium      - Albertson et al. (1998)69 
Glucose      - Albertson et al. (1998)69 
Customized Agarose      - Vartanova et al. (2005)118 
Culture Indication medium 
(CIM) – Modified Ham’s F-12 
-      - Sainsus et al. (2008)78 
Dubelcco’s Modified Eagle 
Medium (DMEM) 
      
Thin-layer liquid culture 
technique 
Joo et al. (2010)119 
Ham’s F-12 
-      
Growth, storage and 
recovery 
BSA (98% purity) 
Testerman et al. (2001)67 
-      
Growth, storage and 
recovery 
Testerman et al. (2001)67 
-      Cultivation from biopsies Sainsus et al. (2008)78 
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Table 2.3. Semi-defined liquid media (defined media supplemented with undefined components) described for H. pylori growth. (Continued). 
Medium base Components added 
Supplements 
Notes Reference 
YE 
Serum-
based 
HG BSA CD 
Modified Isosensitest broth 
Amino acids (all, except his and trp, with 
ornithine) 
     
Without saccharides, 
hydrolyzed casein and 
peptones 
Mendz and Hazell (1995)120 
Roswell Park Memorial Institute 
(RPMI).1640 
-      
Thin-layer liquid culture 
technique 
Joo et al. (2010)119 
-      
Thin-layer liquid culture 
technique 
Joo et al. (2010)119 
 
 
Table 2.4. Defined media described for H. pylori growth. 
Different defined media described for H. pylori growth. When the objective of the medium was other than cultivation, this is indicated in notes column. w/o – without; CL – 
cholesterol; BCD - β-cyclodextrin; 2,6DMBCD - 2,6-di-O-methyl-β-cyclodextrin. 
Medium base Components added 
Supplements 
Notes Reference 
w/o CL BCD 2,6DMBCD 
Customized 
ACES buffer 
Salts 
Trace metals 
Thiamine 
Hypoxanthine 
Amino acids (all 20, except asn, cys, gln, 
gly, lys and thr) 
    - Nedenskov (1994)74 
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Table 2.4. Defined media described for H. pylori growth. (Continued). 
Medium base Components added 
Supplements 
Notes Reference 
w/o CL BCD 2,6DMBCD 
Customized 
Salts 
Trace metals 
Thiamine 
Hypoxanthine 
Nytropyrin 
Adenine 
Uracil 
Guanine 
Xanthine 
Glucose 
Amino acids (all 20, with cystine) 
    Continuous culture Stark et al. (1997)121 
Customized by Reynolds and Penn Glucose     - Albertson et al. (1998)69 
Ham’s F-12 
-     
Growth, storage and recovery Testerman et al. (2001)67 
-     
F-12m: Ham’s F-12 based 
Salts 
Trace metals 
Phenol red 
Thiamine 
Hypoxanthine 
Sodium pyruvate 
Amino acids (all 20, except gly and lys) 
    - Testerman et al. (2001)67 
Ham’s F-12 based 
Salts 
Trace metals 
Phenol red 
Thiamine 
Hypoxanthine 
Sodium pyruvate 
Amino acids (ala, arg, cys, his, leu, met, phe, val) 
    - Testerman et al. (2006)79 
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2.3.2 Environmental conditions 
H. pylori has been considered a microaerophilic bacterium, growing at low 
percentages of oxygen. However, in the last years, some studies proved that percentages 
of oxygen between 5 and 21% are tolerated by H. pylori. In fact, H. pylori can grow in 
aerobic conditions at high cell concentrations, although at low cell densities H. pylori 
behaves more like an oxygen-sensitive microarophile114,122. An absolute requirement of 
carbon dioxide in the growth atmosphere has been reported, showing that H. pylori is a 
capnophilic organism114,122. Whereas some anaerobic features were identified in H. pylori’s 
metabolism, its growth under strictly anaerobic conditions has not been successfully 
reported122–124, being oxygen an absolute requirement for growth. In fact, several 
experiments have been performed under the absence of oxygen with evidence for some 
metabolic activity such as substrates consumption and by-products formation and those 
will be mentioned along this text. Nevertheless, none of those authors has reported any 
growth in the absence of oxygen.  
Despite the fact that H. pylori can grow in vitro under aerobic conditions, 
microaerobiosis seems to mimic better the physiology of the organisms grown in their 
natural habitat122,125. Thus, usually H. pylori is grown in vitro using an atmosphere with a 
mixture of 5% O2, 10% CO2 and 85% N2, generated by microaerophilic gas-generating 
systems in jars, or in incubators where the gas mixture is continuously flushed, under high 
humidity content and at 37ºC. 
Usually, the pH is not adjusted during H. pylori cultures in vitro, and the media 
used are frequently buffered. Some studies in fermenters with pH control were also 
performed121,126. It is assumed that the optimal pH for H. pylori growth is around 7, although 
H. pylori can support a wide range of pH values (2-8.6)127. H. pylori has mechanisms to 
survive under acidic conditions, such as the urease enzyme, which decompose urea, 
generating bicarbonate and ammonia, thus, increasing pH. The adjustment of the pH by 
H. pylori during cultures was reported by Andersen et al. (1997), concluding that optimal 
growth occurs until the pH reaches 8.5128. 
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Cultures with and without shaking have been described, although agitation is used 
the majority of times, since generally higher cell densities are obtained, unless small 
volumes of liquid and high interface areas are used95. 
A few studies111,129 attempted to improve liquid cultivation based rational 
optimization strategies like statistical experimental design of culture conditions 
(atmosphere, pH, shaking speed, inoculum concentration, volume of culture). 
 
 
2.4 Helicobacter pylori’s Metabolism  
H. pylori is very well adapted to its specific niche and able to persist in the human 
stomach lifelong. This ability is conferred by unique metabolic and physiological features130. 
However, the knowledge acquired about the metabolism of H. pylori is still very limited, 
needing further exploration. In this section, the current information on the most important 
metabolic pathways of this bacterium is summarized.  
 
2.4.1 Carbohydrates utilization 
The capability of H. pylori to acquire and metabolize carbohydrates is very limited. 
The capacity of consuming glucose was initially denied but the first genome sequencing131 
disproved this assumption, corroborating experimental data obtained by Mendz et al. 
(1993)132. Further enzymatic experiments proved that, notwithstanding glucose is minimally 
utilized by H. pylori, this organism presents a complex glucose metabolism133. 
A D-glucose sodium-dependent transport system was experimentally identified for 
H. pylori 134 and was also verified by genome analysis with the identification of a 
glucose/galactose transporter (gluP, HP1174)131,135. Psakis et al. (2009) showed that D-
mannose can also be transported by the HP1174 transporter136. Further genome analyses 
indicate that this gene is possibly the only gene encoding a transport protein for sugars in 
H. pylori 136,137. Glucose phosphorylation was proved to be associated with a glucokinase 
activity, that was both detected in vitro 138 and identified in the genomic sequence 
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(HP1103)131. Glucose catabolism via the pentose phosphate pathway was proved by Mendz 
et al. (1991)139, who also suggested there is another pathway involved in glucose 
metabolism140, with the main metabolic product detected from glucose being lactate. In 
contrast, Chalk et al. (1994) reported glucose oxidation via the Entner-Doudoroff (ED) 
pathway with mainly acetate as a product (aerobically). Sorbitol and gluconate were also 
identified as glucose products when dense cell suspensions were incubated with 13C 
labeled glucose under anaerobic conditions141. In spite of the existing enzymatic capabilities 
for the utilization of glucose as the main source of carbon and energy, there are evidences 
that amino or organic acids are effectively the preferred carbon and energy sources for H. 
pylori growth120. This topic will be further explored in the next chapters. 
 
2.4.2 Central carbon metabolism 
2.4.2.1 Glycolysis and gluconeogenesis 
In the glycolysis pathway, glucose is converted into pyruvate with ATP generation, 
providing part of the energy utilized by most organisms. Gluconeogenesis, the formation of 
glucose from non-carbohydrate sources, such as pyruvate, shares the enzymes with 
glycolysis with the exception of irreversible reactions that are only glycolytic or 
gluconeogenic. The presence of glycolysis in H. pylori is doubtful. Hoffman et al. (1996) 
reported enzymatic activities for all glycolytic enzymes, as well as gluconeogenic enzymatic 
activities. However, he found less enzymatic activity in exclusive glycolytic enzymes when 
compared with exclusive gluconegenic enzymes133. In contrast, Mendz et al. (1994) and 
Chalk et al. (1994) were not able to detect the presence of the glycolytic pathway141,142. 
Homologues to enzymes involved in glycolysis and gluconeogenesis are present in H. 
pylori with the exception of the glycolytic enzymes catalyzing irreversible reactions, the 
phosphofructose kinase and pyruvate kinase, which were not identified in the 
genome130,131,135. The absence of these two enzymes, and the presence of the irreversible 
gluconeogenic enzymes (fructose-1,6-biphosphatase and pyruvate dikinase) indicates that 
the gluconeogenesis pathway is active, but glycolysis is not 130,135. 
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2.4.2.2 Entner-Doudoroff and Pentose Phosphate pathways  
In alternative to glycolysis, glucose can be catabolized by the Entner-Doudoroff 
(ED) or the Pentose Phosphate (PP) pathways. In agreement with the genomic sequence131, 
there is experimental evidence for the presence of the ED pathway in H. pylori, proved with 
NMR141,143, and enzymatic experiments133. Although the ED pathway can be viewed as an 
option for H. pylori to utilize glucose as an energy source, experiments with H. pylori in 
mice proved that this metabolic pathway is not essential for colonization of the mouse 
gastric mucosa144, being a non-inducible pathway. It has been suggested that this pathway 
can also be used to consume gluconate or other aldonic acids, but without experimental 
evidence144. 
Evidences for the existence of the PP pathway (both oxidative and reductive 
branches) have been reported for H. pylori 133,139. The PP pathway can provide NADPH for 
reductive biosynthesis and ribose-5-phosphate for nucleotides synthesis139. Chalk et al. 
(1994), in their experiments using 13C NMR spectroscopy were not able to detect glucose 
oxidation by the PP pathway, suggesting that in H. pylori it may be mainly a biosynthetic 
route141. Regarding sequence similarity, all encoding enzymes of the PP pathway were 
identified in the genome, with the exception of the 6-phosphogluconate dehydrogenase, 
which is responsible for the oxidative decarboxylation of 6-phosphogluconate to ribulose-5-
phosphate, leading to conclude that H. pylori may have another protein with a similar 
function135 or that indeed only the reductive branch is active in this organism. 
 
2.4.2.3 Pyruvate metabolism 
Pyruvate is a key metabolite, being an important intermediary in H. pylori’s 
metabolism both for anabolic pathways or an intermediary for cofactors oxidation. The 
main sources for pyruvate in H. pylori were found to be lactate, L-alanine, L-serine and D-
amino acids130,142.  
It has been described that H. pylori converts pyruvate to acetyl coenzyme A only 
by pyruvate:flavodoxin oxidoreductase (PFOR)145,146. The presence of this enzyme 
contributes to H. pylori’s microaerophilic phenotype, since PFOR is oxygen labile146. St 
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Maurice et al. (2007) identified activity of NADPH flavodoxin and quinone reductase (FqrB) 
(HP1164). FqrB is coupled by flavodoxin to the PFOR system and catalyzes a pyruvate-
dependent production of NADPH147. The reverse reaction produces pyruvate via CO2 
fixation, which is consistent with H. pylori’s capnophilic nature147. 
According to experimental results, pyruvate is not a principal nutrient but it is 
quickly metabolized by cells, often with production of acetate, formate, lactate, succinate 
and alanine microaerobically120,142. However, homologues for pyruvate formate-lyase and 
pyruvate oxidase were not detected in H. pylori’s genome130, and thus the enzyme 
associated with formate production is not known. In acetate formation from pyruvate, 
pyruvate is first converted to acetyl-CoA by PFOR, then to acetyl-phosphate by a 
phosphotransacetylase, (HP905) and finally to acetate by acetate kinase (HP903). Also, 
acetyl-CoA synthetase, that converts acetyl-CoA to acetate in a single step was identified 
(acoE, HP1045)130. D-Lactate dehydrogenase, responsible for D-lactate production was also 
identified by sequence homology (dld, HP1222)148. As shown experimentally, H. pylori 
exhibit some metabolic features characteristic of anaerobic organisms, such as the 
production of acetate and formate in mixed-acid fermentation. The presence of mixed-acid 
fermentation can be interpreted as a metabolic adaptation of its specific niche, as stressed 
by Mendz et al. (1995)142. The formation of succinate suggests that part of the TCA cycle is 
active and operating in the reductive direction, also characteristic of anaerobiosis142. 
Although, as referred previously, H. pylori fails to grow under strict anaerobic conditions in 
the laboratory, the mentioned anaerobic features may be important in vivo for survival 
under determined conditions, and may play an important role in transmission. 
 
2.4.2.4 Tricarboxylic acid cycle 
The existence of a complete oxidative tricarboxylic acid (TCA) cycle has been a 
controversial point about H. pylori’s metabolism. Genomic evidences had previously 
indicated that H. pylori does not have a complete TCA cycle, lacking genes codifying 
enzymes for three usual TCA cycle enzymes (alpha-ketoglutarate dehydrogenase, succinyl-
CoA synthetase and malate dehydrogenase)131,135. The presence of the TCA cycle in H. pylori 
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was studied by Pitson et al. (1999) by enzyme activities measurements, proposing that H. 
pylori has a branched TCA cycle, typical of anaerobic metabolism149. According to this point 
of view, the operation of the cycle in H. pylori occurs in the oxidative direction from 
oxaloacetate to alpha-ketoglutarate and in the reductive direction from oxaloacetate to 
succinate, with an alpha-ketoglutarate oxidase linking the branches149. However, alternative 
enzymes for the missing TCA cycle steps were discovered, completing the TCA cycle146,150.  
The consensus enzymes and discrepancies detected in the TCA cycle are shown 
in Figure 2.2. There is a consensus about the presence of the following enzymes: citrate 
synthase, aconitase, isocitrate dehydrogenase, fumarate reductase and fumarase149. For 
the conversion of alpha-ketoglutarate to succinate, an alpha-ketoglutarate oxidase activity 
was detected149. The absence of the alpha-ketoglutarate dehydrogenase was proved by 
Corthezy-Theulaz et al. (1997)151. Hughes et al. (1995) and Hughes et al. (1998) also 
identified the presence of an alpha-ketoglutarate:ferredoxin oxidoreductase (also called 
alpha-ketoglutarate oxidoreductase - KOR), an oxygen sensitive enzyme that contributes to 
H. pylori’s microaerophilic requirements145,146. In addition, KOR was proved to be essential 
for the energy metabolism of H. pylori’s coccoid forms, and when this enzyme was 
inactivated there was no spiral to coccoid morphological conversion152. The conversion from 
succinyl-CoA to succinate was proved to be associated with succinyl-CoA: acetoacetate 
CoA-transferase, that catalyzes the transference of CoA from succinyl-coA to acetoacetate 
with formation of acetoacetyl-coA151. The existence of a succinate conversion to fumarate is 
not unanimous, with authors agreeing with the presence of a fumarate reductase activity, 
but disagreeing in the possible opposite succinate dehydrogenase activity. Pitson et al. 
(1999)149 did not detect it, in contrast with Kather et al. (2000)150 that reported this activity. 
Evidences of the presence of both fumarate reductase and fumarase were obtained by 
Mendz et al. (1993) by the detection of malate and succinate from fumarate153. Fumarate 
transport has also been characterized154. The fumarate reductase properties in H. pylori 
were studied, supporting the existence of an anaerobic metabolism, fumarate acting as a 
terminal acceptor in anaerobic respiration155–157. However, H. pylori is not able to grow 
under anaerobic conditions, being thought that anaerobic respiration and fermentation are 
not sufficient to support H. pylori growth122. In addition, several studies have arisen in order 
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to investigate fumarate reductase as a potential therapeutic target156–158. The role of 
fumarate reductase in host colonization was studied by Ge et al. (2000), concluding that, 
although it is not essential for H. pylori’s survival in vitro, it is very important for survival in 
gastric mice mucosa158. 
For the conversion of malate to oxaloacetate, the activity of a malate 
dehydrogenase was detected149,159, whereas Kather et al. (2000) proved the presence of a 
malate:quinone oxidoreductase for the same conversion, without evidence of the 
reversibility of this step (reduction of oxaloacetate), showing that, in some situations, the 
TCA cycle of H. pylori can operate in the oxidizing direction150. In the genome, however, the 
gene codifying for malate dehydrogenase was not identified131, but a malate:quinone 
oxidoreductase was identified (HP0086)150. The activity of the anaplerotic enzymes pyruvate 
carboxylase, phosphoenolpyruvate carboxylase and phosphoenolpyruvate carboxykinase 
was not detected146 or was very low159. Anaplerotic reactions would nevertheless be very 
important to replenish oxaloacetate159. Additionally, the glyoxylate bypass was not identified, 
being only detected the activity of malate synthase and missing isocitrate lyase to 
complete the pathway149. The presence of malate synthase can be viewed as a direct entry 
for glyoxylate into the TCA cycle or into a glyoxylate oxidizing cycle149. However, malate 
synthase was not identified in the genomic sequence131. 
The gamma-aminobutyrate shunt, an alternative to convert alpha-ketoglutarate to 
succinate, was not detected in H. pylori 149 although it was detected in H. bizzozeronii, a 
canine-adapted organism cultivated from human gastric biopsies160. 
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Figure 2.2. TCA cycle in H. pylori with possible enzymes involved in each reaction. When more than one 
possibility was described in the literature, both options are showed with dashed arrows. (Adapted from Pitson 
et al. (1999)149 and Kather et al. (2000)150). 
 
 
2.5 Systems Biology  
The Systems Biology approach has been replacing the reductionist view of 
classical biology, which relies on the study of individual cellular components and their 
functions, and dominated research in the last decades161. Systems biology integrates 
different levels of information in order to understand biological systems (such as cells or 
organisms)162–164. By studying biological systems as a whole, systems biology bridges the 
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gap between molecules and physiology165. In the last years, with the advances in molecular 
biosciences, genome-sequencing and the development of high-throughput molecular 
methods that allow to characterize cellular components at a given time, the notion of 
cellular networks has arisen and turned into the research focus161,165. 
The systems biology approach is only possible by the integration of experimental 
and computational knowledge with the use of a range of analytical techniques, 
measurement technologies, experimental methods and software tools162,163. It is accepted 
that Systems Biology is inter-disciplinary, applying the knowledge of disciplines such as 
biology, physics, chemistry, engineering and computer science166. 
Depending on the goal to achieve, there are two different systems biology 
approaches that can be applied. One approach starts from the bottom (constitutive parts) 
and applies detailed knowledge about the system to construct mathematical models that 
can be used to simulate the system’s behavior (bottom-up systems biology). In the other 
approach, biological information is extracted from “omics” data with the goal to disclose 
and characterize molecular mechanisms (top-down systems biology)165,167–169. 
 
2.5.1 “Omics” Technologies 
The “omics” era started with the use of the word “genomics” by Thomas H. 
Roderick in 1986, to name a journal, which included sequencing data, discovery of new 
genes, gene mapping and new genetic technologies170. Nowadays, the term “omics” is 
largely applied to refer the study of a variety of “omes”, encompassing the study of a 
complete set of a given type of system components. As such, genomics, transcriptomics, 
proteomics and metabolomics refer to the analysis of the genome (complete set of genes); 
transcriptome (complete set of transcripts), proteome (complete set of proteins) and 
metabolome (complete set of metabolites), respectively. The evolution in analytical 
methods and technologies and the introduction of high-throughput methods has supported 
the “omics” concept, allowing the analysis of cellular functions. The “omics” technologies 
rely on the generation of large-scale datasets, being a systems biology challenge to deal 
with all of these data, to extract the biological meaning and to integrate the different levels 
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of information with the final goal of understanding the system as a whole and characterize 
phenotypes. 
In Figure 2.3 the various “omics” technologies are outlined, targeting different 
levels of cellular information, with indication of the most applied technologies in each 
“omic”. 
 
 
Figure 2.3 “Omes” and respective “omics” technologies. Examples of methods that allow their analysis. 
 
According to the work developed under this dissertation, metabolomics is further 
explored in the next few pages. 
 
2.5.1.1 Metabolomics 
Metabolomics is the “omics” technology that aims to identify and quantify the 
complete set of small molecules (metabolites or metabolic intermediates) associated with 
an organism, tissue, cell or biological sample. In the last years, this approach has been 
largely applied to understand biological systems, having some definitions emerged in this 
field (Table 2.5).  
The level and type of metabolites can be associated with the physiological, 
pathological or developmental status of a biological system, representing the closest 
indicator of a cell’s phenotype171.  
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In metabolism, an assortment of metabolite classes is included, such as amino 
acids, organic acids, sugars, lipids and coenzymes. Moreover, the number of metabolites 
that constitutes the metabolome is variable among different organisms, varying from 
hundreds in bacteria to thousands in plants172. As such, metabolomics has to deal with a 
large number of chemical entities with a huge chemical diversity in composition and 
structure171,172. Thereby, the main limitation in metabolomics is technical, being impossible 
with the current technologies to analyze the whole metabolome at a time. Besides that, the 
complexity and difficulties in metabolomics analysis is exacerbated by the dynamic nature 
of metabolites in the cell, which have a rapid turnover, varying their concentration and 
composition quickly in response to environmental stimuli171,172. 
 
Table 2.5 Terms and respective definitions applied in metabolomic analysis. (Adapted from Fiehn (2002)173 
Nielsen and Oliver (2005)174, and  Nielsen (2007)175). 
Term Definition 
Metabolomics Approaches use to analyze the metabolome or a fraction of it. 
Metabolome 
Complete set of metabolites synthesized by a cell associated with its 
metabolism. 
Endometabolome Total of intracellular metabolites 
Exometabolome Total of extracellular metabolites (excreted) 
Metabolic profiling 
Analysis of a specific group of compounds (for instance, lipids, 
carbohydrates). Frequently semi quantitative. 
Metabolic footprinting 
Exometabolome analysis. Applied to the analysis of specific metabolites or to 
spectra without information of particular metabolites. 
Metabolic fingerprinting 
Fingerprint of the metabolites that are produced by the cell. Usually, does not 
provide information about specific metabolites. Can be used to classify 
samples. 
Metabolic target 
analysis 
Analysis of metabolites that participate in a specific part of the metabolism. 
Quantitative. Mainly used for screening purposes. 
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The application of a metabolomics approach involves several steps from sampling 
to interpretation of biological meaning (
Figure 2.4. Workflow in a metabolomics approach with examples in each step.
 
i. Sample preparation
The chosen sample preparation procedure is associated with the specific 
objective. In microbial metabolome analysis, different sample 
be considered, depending on whether a target class of metabolites or an untargeted 
analysis is sought, as well as the “localization” of the metabolites in the cell. These 
objectives determine the necessity of a specific extracti
for extracellular microbial metabolites sample preparation is not critical, with few steps 
performed, in intracellular metabolite analysis the sample preparation protocols have to be 
carefully chosen in order to obtain an a
exometabolome analysis is the separation of the extracellular medium from the cells, 
usually performed by centrifugation or filtration
directly analyzed from the culture supernatant. The preparation of samples for extracellular 
and intracellular analysis can be performed together or separately. Since intracellular 
metabolites have a high turnover rate, the metabolic enzymatic
Statistical analysis
Cleaning
LC-MS
Endometabolome (Quenching, extraction,...)
Figure 2.4) that are briefly described below.
 
 
preparation methods have to 
on and quenching protocol. While 
ccurate analysis176. The first step on microbial 
176,177. The extracellular metabolites are 
 activity should be rapidly 
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stopped (quenching) after cells harvesting for intracellular metabolite analysis178. The 
quenching and extraction steps can be done simultaneously with solvents or separately178. 
The quenching/extraction protocols applied are variable and can include for instance rapid 
changes of temperature (low : < -40°C or high : > 80°C), pH (high alcali: KOH or NaOH or 
high acid: perchloric or trichloroacetic acid), the use of cold methanol, cold glycerol-saline 
solution, liquid nitrogen or fast filtration176,177,179. For further details, the methods applied for 
sample preparation have been thoroughly revised175,180. It should however be emphasized 
that different quenching/extraction protocols are being developed and applied for several 
organisms, for instance E. coli 181–183, C. glutamicum 182, B. subtilis 184, L. bulgaricus 185, S. 
aureus 186, or S. cerevisiae 182,187–189. 
In terms of statistical analysis, it is important that a sufficient number of replicates 
is performed. Smart et al. (2010) recommend five technical replicates from three 
biological replicates for intracellular analysis and three technical replicates from each 
biological replicate for extracellular metabolite analysis177. 
Since the level of extracellular metabolites sometimes is very low and intracellular 
metabolites are often diluted during extraction procedures, a step of sample concentration 
is frequently needed, which can be achieved by freeze-drying at low temperatures to avoid 
metabolite degradation177.  
 
ii. Analytical Methods 
There are various analytical platforms suitable to be applied to metabolomics 
analysis, such as Nuclear Magnetic Resonance (NMR) spectroscopy, several separation 
methods coupled with Mass Spectrometry (MS) or Fourier Transform Infrared 
Spectroscopy (FTIR). Nevertheless, NMR spectroscopy and MS are the mostly used 
analytical platforms in metabolomics. Both techniques exhibit advantages and limitations, 
and the choice depends on the sample characteristics and the purposes of the study 190. 
NMR detects the specific resonance of absorption profiles of metabolites in a 
magnetic field. The most important advantages of NMR spectroscopy are that, besides the 
simple and easy sample preparation, it is a non-destructive technique that does not need 
further sample separation, and has high reproducibility190,191. The low sensitivity of this 
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platform compared with MS, and the requirement of large sample volumes are its major 
limitations190,191. 
Gas Chromatography (GC) or Liquid Chromatography (LC), where the compounds 
are separated, coupled with MS, which is based on ion molecular mass-to-charge ratio 
(m/z) determination is often used179. In the last years, a new evolution of LC, Ultra High 
Performance Liquid Chromatography (UHPLC), has been applied, increasing the sensitivity 
in comparison with LC190. UHPLC-MS has some advantages compared to the other 
platforms used, such as short separation time, analysis of a larger range of metabolites 
than GC-MS, high mass accuracy and resolution, and simple sample preparation190,191. 
However, unlike GC-MS, it presents a low reproducibility of retention times between 
different systems190. The high reproducibility of retention times and fragmentation patterns, 
allowing the construction of libraries and enabling compound identification without 
standards, makes the GC-MS the most popular platform in metabolomics studies. The 
consistent mass spectrum obtained for each compound in GC-MS is achieved by the use 
of electron ionization (EI), which is the most frequently used ionization method191. A very 
complete collection of studies published using GC-MS as the analytical platform in 
metabolomics was published by Koek et al. (2011)192.  
Besides the presented advantages, GC-MS exhibits some limitations related with 
the requirement for volatile samples, increasing the steps and difficulty on sample 
preparation due to the derivatization procedure, which can also lead to the introduction of 
additional sample to sample variation. The derivatization is a chemical modification of 
molecules that yields compounds with a similar chemical structure (derivative) but with 
specific characteristics, which in the case of GC-MS are volatility, less-polarity and thermal 
stability. In chemical derivatization, active hydrogens in functional groups, such as –COOH, 
–OH, –NH, and –SH are replaced by other chemical groups. The most applied 
derivatization method for analysis by GC-MS is using silylation reagents (reviewed by Koek 
et al. (2011).192). Alternative reagents, such as chloroformates are also used193. For 
instance, a propylchloroformate derivatization was applied in short-chain fatty acids and 
branched-chain amino acids analysis194,195, an ethylclhoroformate derivatization was applied 
for analysis of amino and organic acids, fatty acids, phenolic compounds and amines196,197, 
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and a methylchloroformate derivatization was applied in amino, organic and fatty acids 
analysis198–200.  
 
iii. Data Processing and Analysis 
After performing the analyses in MS or NMR, in order to prepare the data for 
statistical analysis, a data processing step is needed. This stage can encompass some 
steps such as data cleaning, normalization and transformation. In MS data, an overlapping 
of the signal compounds is frequently observed. The deconvolution is thus a frequent 
treatment of data used to extract the individual metabolite signals from the raw signal201. 
The Automated Mass Spectral Deconvolution and Identification System (AMDIS)202 from the 
National Institute of Standards and Technology (NIST) is one of most used software 
packages to perform the deconvolution and to match unknown spectra with libraries to 
identify detected compounds203. The next steps that could be necessary to perform are the 
baseline correction, normalization and sculling (data transformation included) (detailed in 
Liland, (2011)204). 
The data analysis is the subsequent step, where statistical methods are applied 
with the final goal of extracting the biological meaning of the generated data. Here, 
supervised or unsupervised methods are applied.  
 
2.5.1.2 H. pylori “Omics” data 
H. pylori 26695 was one of the first bacteria to have its genome completely 
sequenced in 1997131. Since then, “omics” high-throughput methods have been applied to 
study the genome, proteome and transcriptome of H. pylori. The advances in omics 
technologies have allowed to make progress in targeting H. pylori and its association with 
disease, giving important clues about its inactivation, although it is not yet possible to 
uncover all mechanisms involved in H. pylori pathogenesis and host-pathogen 
interaction205.  
Recent advances in genomics made accessible next-generation sequencing 
(NGS) methods, which enabled the sequencing of a large variety of H. pylori strains, with 
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54 H. pylori strains fully sequenced and 329 strains with ongoing sequencing projects 
(Genebank database in March 2014)206. Due to the extensive list of sequenced genomes 
and the data availability on the NCBI genome online database 
(http://www.ncbi.nlm.nih.gov/genome) the referred data are not presented or analyzed 
here in detail. The sequenced genomes include strains isolated from patients with different 
pathologies (gastritis, duodenal ulcer, gastric cancer, MALT-lymphoma) and/or from 
different parts of the world (North and South America, Far East Asia, Europe, Malaysia, 
Africa, India and Australia), contributing to discover new disease-specific biomarkers and 
uncover new virulence mechanisms207. H. pylori’s genomic features are presented in Table 
2.6.  It is important to highlight that H. pylori has a high genomic plasticity that allows for 
host adaptation208,209. The comparison of genomic sequences of two H. pylori strains 
(26695 and J99), isolated from patients with different pathologies, showed that 6-7% of 
the genes are strain-specific210. Analysis by whole genome DNA microarray of 15 clinical 
isolates from different geographical origins, showed that a minimal H. pylori genome 
consists of 1281 genes, encoding mainly metabolic and cellular processes211. The genetic 
variability, high mutation and homologous recombination rates, led to a high diversity of H. 
pylori strains208,212,213. 
 
Table 2.6. H. pylori genomic features, obtained from the average of 54 fully-sequenced strains (data 
available in the NCBI genome database in March, 2014)206.  
Genomic features 
Genome size (Mb) 1.63 (1.51 – 1.71) 
GC content (%) 38.9 (38.4 - 39.3) 
Predicted genes 1601 (1429 - 1749) 
Proteins 1540 (1382 - 1707) 
 
Transcriptomics are applied in order to understand what are the genes actively 
expressed at a given time under a defined condition, typically involving measuring the 
complete set of RNA transcripts by the use of microarrays technology or by RNA 
sequencing. Gene expression omnibus (GEO)214 (available online at 
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http://www.ncbi.nlm.nih.gov/geo/) is a public repository for functional genomics data that 
gathers high-throughput gene expression data for a large variety of organisms. The studies 
present in this database on H. pylori are gathered in Table 2.7. Owing to the scope of the 
present work, transcriptomics studies were filtered to “genome expression profiling”, being 
excluded other types of studies such as “genome variation profiling by array” The 
published transcriptomics studies address topics such as gene expression under different 
conditions and stimuli in order to uncover regulatory mechanisms. 
Chapter 2 
46 
Table 2.7. Transcriptomics studies with H. pylori. (Extracted and adapted from GEO214 (available online at http://www.ncbi.nlm.nih.gov/geo/). 
Objectives 
Technology used 
(Manufacturer) 
H. pylori 
Strains 
Experimental conditions Experimental design Reference 
Study of the modH gene, a 
phase-variable DNA 
methytransferase of H. 
pylori 
in situ 
oligonucleotide 
(Custom, Agilent) 
P12 
Culture on brain heart infusion 
broth, supplemented with 10% (v/v) 
fetal bovine serum, vitamin mix and 
vancomycin 
Comparison of wild type and mutant strains 
(Wild Type P12 and P12 ∆ modH5 ) (3 replicates each) 
Srikhanta et 
al. (2000)215 
Study of the effect of 
hpyAVIBM (a C5 cytosine 
methyltransferase) deletion 
on H. pylori’s transcriptome 
in situ 
oligonucleotide 
(Custom, Agilent) 
26695 
AM5 
SS1 
Cells grown to 0.6 of optical density 
Wild Type strains (26695, AM5 and SS1) vs. Mutant 
strains (26695 ∆ hpyAVIBM, AM5 ∆ hpyAVIBM, SS1 ∆ 
hpyAVIBM) 
(2 replicates each) 
Without 
publication1 
Study of the biological cost 
of rifampicin resistance in 
H. pylori. 
Spotted DNA/cDNA 
(Postgenome Lab 
(RIPCM)) 
26695 
Culture on Brain heart infusion 
broth (3.7% brain heart infusion 
with 10% inactivated fetal bovine 
serum and 5% yeast extract). 
Wild Type strain vs. 26695 Mutant 1 (phenotype: 
Rifampicin resistant; rpob mutation 1: G1588A; rpob 
mutation 2: D530N) vs. 26695 Mutant 2 (phenotype: 
Rifampicin resistant; rpob mutation 1: C1618T; rpob 
mutation 2: H540Y) 
(4 replicates each) 
Momynaliev, 
2009 
(Publication in 
Russian2) 
Elucidation of factors 
required to sustain the 
transcription response to 
DNA damage. 
Spotted DNA/cDNA 
(Stanford 
Functional 
Genomics Facility, 
Stanford School of 
Medicine) 
Isogenic 
mutants 
of NSH57 
Culture on Brucella broth with 10% 
fetal bovine serum. For antibiotic 
resistance marker selection, media 
were supplemented with antibiotics. 
Wild Type ciprofloxacin-treated vs Wild Type untreated 
comB4 merodiploid (MSD89) vs Wild type 
addA vs Wilde Type; comB10 addA vs Wild Type 
recA untreated vs recA ciprofloxacin treated 
comB4 merodiploid recA vs Wild Type 
Wilde Type untreated vs gentamycin-treated 
recR - mutant (MSD49) vs Wild Type 
(3-4 replicates each) 
Dorer et al. 
(2010)216 
1 Ritesh Kumar (Indian Institute of Science), 2011; 2Kuvat Momynaliev (Research Institute for Phys-Chim Medicine, Russia), 2010. 
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Table 2.7. Transcriptomics studies with H. pylori. (Continued). 
Objectives 
Technology used 
(Manufacturer) 
H. pylori 
Strains 
Experimental conditions Experimental design Reference 
Identification of the HP0244 regulon at different 
pH conditions 
Spotted DNA/cDNA 
(TeleCom 
International, Inc. 
ArrayIt Division) 
26695 
Culture on agar plates. For exposure to experimental 
low-pH conditions, the brain heart infusion (BHI) 
medium was used 
Wild-type vs HP0244-KO-pH7.4 
Wild-type vs HP0244-KO-pH4.5 
Wild-type vs HP0244-KO-pH2.5 
(3 replicates each) 
Wen et al. 
(2009)217 
Characterization of H. pylori adaptations to the 
transition from chronic atrophic gastritis (ChAG) 
to gastric adenocarcinome and impact of these 
adaptations on gastric epithelial stem cells 
In situ oligonucleotide 
(Custom, Affymetrix) 
Clinical 
isolates 
Kx1 and 
Kx2 
Culture on Brucella broth medium and addition to 
mouse gastric epithelial progenitor (mGEPs) cells in 
RPMI 1640 medium supplemented with 10% FBS at 
37ºC or just RPMI 1640 medium supplemented with 
10% FBS (without mGEP cells) 
H.pylori isolates associated with 
chronic atrophic gastritis (chAG) 
(Kx1) 
H.pylori isolates associated with 
gastric adenocarcinoma (Kx2) 
Kx1 infecting mGEP 
Kx2 infecting mGEP 
(2-3 replicates each) 
Giannakis et 
al. (2008)218 
Characterization of H. pylori adaptations to 
chronic atrophic gastritis (ChAG). Response of 
gastric epithelial progenitors (GEPs) to H. pylori 
isolates from Swedish patients with chronic 
atrophic gastritis (ChAG) 
in situ oligonucleotide 
(Custom, Affymetrix) 
HPAG1 
Clinical 
isolates 
Liquid culture on Brucella or Brain Heart Infusion 
(BHI) broth supplemented with 10% fetal calf serum 
and 1% IsoVitaleX. (enrichment) 
Wild-type ChAG associated 
Wild-type HoZ-KO 
488_Kx1 (ChAG associated) 
488_Kx2 (gastric cancer 
associated) 
HPAG (ChAG associated) 1hr in 
rich media, pH7 
HPAG (HopZ) 0hr in rich media, 
pH 7 
HPAG (HopZ) 1hr in rich media, 
pH 7 
HPAG (HopZ) 1hr in rich media, 
pH 5 
Giannakis et 
al. (2009)219 
Characterization of ArsRS regulon, associated 
with acid adaptation 
Spotted DNA/cDNA 
(Max-Planck-Institute 
for Infection Biology – 
MPIIB) 
G27 
26695 
G27 
mutants 
Brain heart infusion (BHI) broth with fetal calf serum 
and antibiotics 
Global transcriptional profiling of 
an ArsS-deficient H. pylori 
mutant grown at pH 5.0 (ArsRS 
Regulon) (4 replicates) 
Pflock et al. 
(2006)220 
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Table 2.7. Transcriptomics studies with H. pylori. (Continued). 
Objectives 
Technology used 
(Manufacturer) 
H. pylori 
Strains 
Experimental conditions Experimental design Reference 
Characterization of the 
HP1021-dependent regulon 
Spotted DNA/cDNA 
(Max-Planck-
Institute for 
Infection Biology – 
MPIIB) 
26695 
Brain heart infusion (BHI) broth 
with fetal calf serum and antibiotics 
Determination of differentially expressed genes in the 
HP1021-deficient mutant 26695/HP1021::km vs 
26695 wild-type (4 replicates) 
Pflock et al. 
(2007)221 
Study of H. pylori G27 
HP0518 mutant motility 
Spotted DNA/cDNA 
(Max-Planck-
Institute for 
Infection Biology – 
MPIIB) 
G27 
G27 mutant 
RPMI1640 with fetal bovine serum 
 
G27 wild-type vs H. pylori G27 HP0518 mutant 
Asakura et 
al. (2010)222 
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Proteomics, the large-scale analysis of cellular proteins, with the use of two-
dimensional gel electrophoresis for protein separation and identification by mass 
spectrometry, is the most applied technology in “omics” studies of H. pylori. The 
published studies in this field were mainly driven by the aim of discovering new proteins 
that can be used as vaccine candidates, or to investigate proteins differentially expressed 
under different conditions (mutant strains, environmental and / or stress conditions, 
among others). There are many different types of proteomic approaches that are being 
applied; notwithstanding, according to the aims of the present work, which include the 
reconstruction of a genome-scale metabolic model, the collection of proteomics data was 
focused on expression proteomics (Table 2.8).  
 
Regarding metabolomics or fluxomics, to our knowledge, there are no H. pylori 
data published. The studies that covered topics related with metabolite analysis only 
analyzed specific internal or external metabolites. 
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Table 2.8. Proteomics studies with H. pylori.  
Technologies: 1-DE – one-dimensional gel electrophoresis; 2-DE – two-dimensional gel electrophoresis; DIGE - Difference gel electrophoresis; MALDI – Matrix-assisted laser 
desorption/ionization; TOF – time of flight; MS – mass spectrometry; LC Nano-ESI QTOF MS - Liquid chromatography nano electrospray ionization- quadrupole time-of-flight mass 
spectrometry; IMAC - Immobilized-metal affinity chromatography; SELDI-TOF MS - Surface-enhanced laser desorption/ionisation time of flight mass spectrometry.  
Objectives 
Methodology 
(technology 
used) 
H. pylori Strains Results/Conclusions Reference 
Analysis of the proteins secreted by H. pylori, 
with optimization of culture conditions for 
minimal autolysis and efficient recovery 
method for extracellular proteins 
2-DE 
MALDI MS 
26695 
Identification of 26 protein species (redox-active enzymes, 
components of flagellar apparatus, fragments of VacA, 
serine protease chaperone HtrA and uncharacterized 
proteins). 
Bumann et al. 
(2002)223 
Detect candidate antigens of H. pylori for 
diagnosis, therapy and vaccine development 
and to investigate potential associations 
between specific immune responses and 
manifestations of disease 
2-DE 
MALDI MS 
Immunoblotting 
26695 
310 antigenic protein species were recognized by H. pylori 
positive sera (9 new antigens). 
Haas et al. 
(2002)224 
Establish a dynamic two-dimensional 
electrophoresis-polyacrylamide gel 
electrophoresis (2-DE-PAGE) database with 
multiple subproteomes of H. pylori 
(http://www.mpiib-berlin.mpg.de/2DPAGE) 
Elucidate protein composition of H. pylori 
soluble and structure-bound fractions 
(including membrane proteins). 
Subcellular 
fractionation 
2-DE 
MALDI MS 
26695 
P12 
B128 
Structure-bound fraction: 800 protein spots; Soluble protein 
fraction: 1000 protein spots. Generation of a subcellular 
reference map with a large number of structure-bound and 
soluble proteins identified in H. pylori. 
Backert et al. 
(2005)225 
Proteome characterization and comparative 
immunoproteomic analysis to identify antigenic 
patterns of H. pylori strains, by probing them 
against sera from patients affected by diverse 
gastrointestinal pathologies 
2-DE 
Western blotting 
MALDI-TOF-MS 
Edman degradation 
analysis 
Clinical isolates: 
328 (Chronic gastritis) 
G39 (Duodenal ulcer) 
10K (Gastric 
adenocarcinome) 
Identification of 30 antigens (including 9 new antigens). 
Heterogeneous antigenic patterns, consequence of strain 
and a host-specificity. 
Mini et al. 
(2006)226 
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Table 2.8. Proteomics studies with H. pylori. (Continued) 
Objectives 
Methodology 
(technology 
used) 
H. pylori Strains Results/Conclusions Reference 
Comparison of protein compositions of rod shaped 
H. pylori cells and coccoid cells. 
2-DE 
MALDI-TOF MS 
26695 
1500 protein species were detected under both 
culture conditions. Identification of all 16 rod-shape-
specific proteins and 11 of the 14 coccoid-specific 
proteins. 
Bumann et al. 
(2004)227 
Comparison of protein composition of three 
different strains, growth at different pH and 
identification of antigens. 
2-DE 
MALDI-TOF MS 
26695 
J99 
SS1 (mouse-adapted, “Sidney 
Strain”) 
Strain 26695: 1863 spots detected; Strain J99: 1622 
spots identified; Strain SS1: 1448 spots identified.  
Identification of 10 protein spots common in strains 
26695 and J99. 152 protein spots of strain 26695 
identified in MALDI-MS. In pH dependent protein 
composition, 5 spots were identified as different at 
different pH for strain 26695. 
Jungblut et al. 
(2000)228 
Comparison of protein expression profiles of H. 
pylori grown under normal and high-salt conditions. 
2-DE 
MALDI-TOF MS 
Clinical isolates: 
HC28 (Human gastric 
cancer) 
HD30 (Human duodenal 
ulcer) 
More than 40 spots identified in each gel. 190 
proteins changed their expression levels after growth 
at high salt concentrations. 
Proteins with large differences in expression identified 
by peptide-mass fingerprinting (10 proteins: 9 
upregulated and 1 downregulated). 
Liao et al. 
(2013)229 
Identification of proteins associated with H. pylori 
colonization in mice by comparing proteomic 
analysis of the wild-type H. pylori 26695 and the 
motile, mouse-passaged variant 88-3887. 
2-DE 
MALDI-
TOF/TOF MS 
26695 
Mouse-passaged homolog 88-
3887 (isolated after 3 
passages through the 
stomach of a C57BL/6 
mouse) 
Membrane proteins: 213 spots (strain 26695) and 
215 spots (strain 88-3887). Cellular-protein fractions: 
1532 spots (strain 26695) and 1546 spots (strain 88-
3887). 
29 proteins were differentially expressed between 2 
strains (16 membrane-associated proteins and 
soluble-cellular-protein fragments). 
Zhang et al. 
(2009)230 
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Table 2.8. Proteomics studies with H. pylori. (Continued) 
Objectives 
Methodology 
(technology 
used) 
H. pylori Strains Results/Conclusions Reference 
Identification of outer membrane proteins using the 
sarcosine-insoluble outer membrane fraction. 
2-DE 
MALDI-TOF MS 
26695 
A total of more than 80 protein spots were detected. 
Identification of 62 protein spots, representing 35 genes, 
including 16 kinds of OMP. 
Baik et 
al.(2004)231 
Identification of proteins released by mechanisms 
other than specific lysis. 
2-DE 
MS 
11637 (ATCC 43504) 
More than 160 spots were identified in pellets. Mass 
spectrometry analysis of proteins increased in radioactivity 
in the supernatant (18 proteins). 
Kim et al. 
(2002)232 
Proteome analysis of H. pylori NCTC 11637 
2-DE 
MALDI-TOF MS 
NCTC 11637 
Consistent 318 protein spots were identified. Analysis by 
MALDI-TOF MS of 93 proteins. Identification of potential 
post-translational protein modifications. 
Lock et al. 
(2001)233 
Improve proteomic knowledge on coccoid cells 
formation by protein analysis of H. pylori coccoid 
cells under oxidative stress. 
2-DE 
MALDI-TOF MS 
Clinical isolate: HD13 
(duodenal ulcer) 
Protein spots detected: 635 for bacillary forms, 614 for 
coccoid forms. Analysis by MALDI-TOF/MS of 10 protein 
spots with most significant difference between forms. 
Proteins related to coccoid forms: 10 protein spots were 
overexpressed under different conditions (7 protein spots 
were identified, being 5 protein spots highly expressed and 
2 protein spots lowly expressed in coccoid forms, compared 
to bacillary forms). 
Zeng et al. 
(2008)234 
Study the influence of oxidative stress. Proteomic 
approach to characterize and compare protein 
expression profile of H. pylori under aerobic stress 
(20% O2) and microaerophilic (5% O2) conditions. 
2-DE 
MALDI-TOF MS 
 
Clinical isolates: 
HC28 (Human gastric 
cancer) 
HD30 (Human 
duodenal ulcer) 
More than 50 protein spots identified in 2-DE gels of H. 
pylori grown under microaerophilic and hiperoxia conditions. 
In total 11 protein were differentially expressed under 
aerobic and microaerophilic conditions (2 protein spot areas 
with apparently reduced expression) (analyzed by MALDI-
TOF/MS). 
Chuang et al. 
(2005)235 
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Table 2.8. Proteomics studies with H. pylori. (Continued) 
Objectives 
Methodology 
(technology 
used) 
H. pylori Strains Results/Conclusions Reference 
Define the adaptive response of H. pylori to 
nitrosamine stress. Simulation of antimicrobial 
process of NO in H. pylori in vitro, with sodium 
nitroprusside (SNP) as NO donor. 
2-DE 
MALDI-
TOF/TOF-
tandem MS 
26695 
Based on 2-DE gels, and comparison of protein lysates of 
treated and untreated cells, 38 protein spots, which showed 
differential expression in response to nitric oxide, were 
digested and analyzed by MALDI-TOF/TOF-tandem mass 
spectrometer. 
Zhou et al. 
(2009)236 
Identification of outer membrane proteins (OMP) of 
H. pylori that contribute to antibiotic resistance 
using a comparative proteomics strategy of 
clarithromycin-resistant and susceptible strains. 
1-DE 
MALDI-
TOF/TOF-
tandem MS 
ATCC 43504 
(clarithromycin 
susceptible) 
ATCC 700684 
(clarithromycin 
resistant) 
12 major proteins identified by 1-DE in sarcosine-insoluble 
fraction. Different level of protein expression for OMPs was 
found between resistant and sensitive strains. The 7 
proteins that showed the most significant difference in 
protein expression were digested and analysed by MALDI-
TOF/TOF MS. 
Smiley et al. 
(2013)237 
Understand the growth phase-dependent global 
regulation of proteins in H. pylori. 
2-DE 
MALDI-TOF MS 
26695 
Approximately 1200 protein spots identified at 12 hours of 
culture. A total of 366 spots detected in all gels and 
selected for cluster analysis. The intensity of 151 protein 
spots significantly changed at any time point. 57 protein 
spots were identified (46 with increased intensity and 11 
with decreased intensity during culture) by MALDI-TOF MS 
analysis. Protein levels were compared with mRNA 
transcript of each gene. 
Choi et al. 
(2008)238 
Explore the functions of SpoT, a global regulator for 
defending against oxidative stress in vitro, by 
comparison of protein expression profiles of a spoT 
deficient (∆spoT) strain with wild-type after 
exposure to ambient atmosphere. 
2-DE 
MALDI-
TOF/TOF MS 
26695 
26695 spoT deficient 
(∆spoT) 
In total, 51 protein spots were differentially transcribed in 
strain ∆spoT and analysed by MALDI-TOF MS. Results 
confirmed in mRNA levels by RT-PCR, proved the 
downregulation in ∆spoT strain. 
Sun et al. 
(2012)239 
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Table 2.8. Proteomics studies with H. pylori. (Continued) 
Objectives 
Methodology 
(technology 
used) 
H. pylori Strains Results/Conclusions Reference 
Identify changes in the proteome of H. pylori in 
response to low pH using a proteomics approach 
to study protein expression under neutral (pH 7) 
and acidic (pH 5) conditions. 
2-DE 
LC-nanoESI- 
MS/MS 
Clinical isolate HD30 
(duodenal ulcer) 
More than 412 protein spots were detected in 2-DE profiles 
of H. pylori grown under neutral or acidic conditions. About 
10 proteins were differentially expressed under acidic 
conditions (increased amounts in 8 proteins and decreased 
amounts in 2 proteins), analysed by nano-LC-MS/MS. 
Huang et al. 
(2010)240 
Identify additional members of the ArsRs regulon 
and investigate the regulatory role of the ArsRs 
system by the analysis of protein expression in 
wild-type and arsS null mutant strains. 
DIGE 
MALDI-
TOF/TOF MS 
J99 wild-type 
Mutant strain J99: J99A 
(arsS::kan) 
Mutant strain J99: J99B 
(arsS::kan) 
Experiment 1: 639 protein spots in all gels. At pH 5.0, 25 
differentially expressed proteins were identified by MS, in 
wild-type compared to the isogenic arsS mutant strain (also 
differentially expressed at pH 7.0). 
Experiment 2: similar results to experiment 1. 15 proteins 
identified as differentially expressed in wild-type and mutant 
strains in both proteomic experiments. 
Loh et al. 
(2010)241 
Investigate bismuth action against H. pylori by 
comparative proteomic analysis of H. pylori cells 
before and after treatment with colloidal bismuth 
subcitrate. 
2-DE 
MALDI MS 
IMAC 
11637 
800 protein spots detected in 2-DE gels. Proteins 
differentially expressed (at least 2-fold) digested and 
analysed by MALDI-MS, 8 proteins identified. 7 bismuth-
binding proteins were identified from cell extracts using 
IMAC. 
Ge et al. 
(2007)242 
Identify acid-related proteins (other than the urease 
system) by comparison of proteome profiles of H. 
pylori exposed to different levels of external pH, in 
absence of urea. 
2-DE 
MALDI-
TOF/TOF MS 
26695 
Differentially expressed protein spots analysed by MALDI-
TOF/TOF MS; identification of 36 proteins with altered 
expression (more than two-fold) in response to acid (26 
proteins induced and 10 proteins repressed). 
Shao et al. 
(2008)243 
Compare proteome maps of H. pylori clinical 
isolates. 
2-DE 
MALDI-TOF MS 
Clinical isolates from 
patients with duodenal 
ulcers and chronic 
gastritis: 
500 protein spots analyzed by MALDI-TOF MS. 12 proteins 
identified with differences in proteome maps of clinical 
isolates. 
Govorun et al. 
(2003)244 
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Table 2.8. Proteomics studies with H. pylori. (Continued) 
Objectives 
Methodology 
(technology used) 
H. pylori Strains Results/Conclusions Reference 
Identify extracellular proteins from H. pylori. LC-nanoESI- MS/MS 
26695 
ATCC 43504 
(nonsequenced strain) 
172 different proteins identified in the cell-associated 
samples and 130 proteins from extracellular samples 
identified in at least two biological replicates. 45 of the 
extracellular proteins enriched in the extracellular fraction 
(11 previously identified). 
Smith et al. 
(2007)245 
Investigation of global gene regulation by Fur 
in response to iron in H. pylori by the 
comparison of protein expression profiles of 
wild-type and fur mutant grown under iron- 
rich and iron-depletion conditions. 
2-DE 
MALDI-TOF MS 
26695 
Isogenic fur mutant 
strain of 26695 
93 protein spots were found to be up or down-regulated by 
more than 2-fold by either a fur mutation or iron-depletion. 
39 spots identified (MALDI-TOF MS) to be 29 different 
proteins. Expression of 6 proteins was higher in fur mutant 
than in wild-type.11 proteins activated by Fur (5 responded 
to iron). 12 proteins not Fur-regulated but responded to 
iron. 
Lee et al. 
(2004)246 
Establish the use of ProteinChip technology 
to compare outer membrane proteins profiles 
between fresh clinical isolates and strains 
that have been passaged in vitro. 
ProteinChip array 
(WCX-2) 
SELDI-TOF MS 
 
Clinical isolates: strain 
119/95, strain 32, 
strain 33 (Sweden) 
CCUG 17874 
CCUG 17875 
Six proteins identified to be common in the strains studied. 
Clinical isolates strain 119/95 and strain 33 showed a 
similar profile. 
Hynes et al. 
(2003)247 
Establish the correlation of H. pylori clinical 
isolates with the prevalence of H. pylori-
associated iron deficiency anaemia by the 
comparison of proteomic profiles of H. pylori 
strains from H. pylori-positive patients with or 
without iron deficiency anaemia. 
2-DE 
MALDI-TOF MS 
Clinical isolates from 
10-18 years-old Korean 
adolescents: 8 strains 
from patients with 
gastritis; 7 strains from 
patients with iron 
deficiency anaemia 
26695 
Protein expression profiles displayed, in total, 1746 protein 
spots. Expression patterns of 189 protein spots were used 
to construct a phylogenetic tree. 18 spots expressed in iron 
deficiency anaemia strains identified by MALDI-TOF. 
Park et al. 
(2006)248 
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Table 2.8.Proteomics studies with H. pylori. (Continued) 
Objectives 
Methodology 
(technology 
used) 
H. pylori Strains Results/Conclusions Reference 
Proteomics and genomics approaches for 
identification of genetic and phenotypic changes in 
H. pylori obtained from different locations of the 
stomach from patients with early gastric cancer or 
chronic gastritis. 
 
2-DE 
2D DIGE 
MALDI-
TOF/TOF MS 
 
Clinical isolates from fundus, 
corpus and antrum of the 
stomach o two patients (6 
samples). 
32 differentially expressed proteins detected related 
to early gastric cancer and 14 differentially 
expressed proteins related to chronic gastritis. In 
total, 28 variable proteins in all the H. pylori isolates 
were identified. 
Momynaliev et 
al. (2010)249 
Characterization of H. pylori’s phosphoproteome. 
Affinity 
chromatography 
LC-MS/MS 
26695 
67 phosphoproteins were identified. An interaction 
network with 28 phosphoproteins was constructed 
with a total of 163 proteins. 
Ge et al. 
(2011)250 
Analysis of cellular and antigen proteins. 
Comparison of automatic and manual procedures 
of data generation and Identification. 
2-DE 
MALDI MS 
26695 
384 protein spots analysed by MALDI MS. 24 new 
protein identified. 
Krah et al. 
(2003)251 
Investigate the changes in protein expression of H. 
pylori under oxidative stress, induced by hydrogen 
peroxide. 
2-DE 
LC Nano-ESI 
QTOF MS 
Clinical isolates: 
HC28 (Human gastric cancer) 
HD30 (Human duodenal ulcer) 
HS65 (Human gastritis) 
Around 390 spots identified in each gel. Most 
overexpressed proteins were identified under 
oxidative stress (9 proteins). 
Huang and 
Chiou (2011)240 
Analysis of urea-solubilized proteins, proteins 
insoluble in urea but solubilized by SDS, proteins 
precipitating in the Sephadex layer at the 
application side of IEF and proteins precipitating 
close to the application side within the IEF gel. 
2-DE 
1-DE-LC/MS 
26695 
567 proteins identified (36.6% proteome coverage) 
Data stored at http://www.mpiib-berlin.mpg.de/2D-
PAGE/ 
Jungblut et al. 
(2010)252 
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2.5.2 Genome-scale metabolic models (GSMM) 
The ultimate aim of systems biology is to develop mathematical models so that the 
response of biological complex systems to any kind of perturbation can be predicted in 
silico, even under conditions that are not easily accessible with experiments, and iteratively 
producing polished models and insight into the system253. Each biological process can be 
described using different mathematical models, depending on the problem, and the 
purposes of the investigation253. 
In the last years, several mathematical models for many organisms have been 
developed. In particular, the development of mathematical models of metabolism and 
more specifically genome-scale metabolic models is now considered a fundamental part of 
the study of the cell168. 
Among several types of metabolic networks, the stoichiometric models are the 
most broadly used, encompassing a set of stoichiometric equations representing the 
metabolic pathways of the system. Mass balance constrains on the metabolites, in a 
steady state assumption, are then used to determine intracellular fluxes through all the 
biochemical reactions occurring in the cell254,255. Due to the lack of information on cellular 
processes such as regulatory events, this type of models does not account for information 
on kinetics, regulatory or other cellular processes 256. 
Since the first genome-scale metabolic model reconstruction in 1999257 by 
Edwards and Palsson, an increasing number of metabolic model reconstructions are being 
published with over 100 reconstructed models for more than 60 different organisms 
available258. 
 
2.5.2.1 Reconstruction process 
The reconstruction of a genome-scale metabolic model is an iterative process that 
begins with the collection of information about genome annotation and organism-specific 
metabolic knowledge from various sources of information. After several intermediate steps, 
the metabolic model is constructed and simulations are performed to compare in silico 
obtained results with experimental data. The model is revised until the in silico predictions 
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reasonably agree with experimental data,259 (                                 Figure 2.5). The 
process of reconstructing a metabolic network is a very laborious task, requiring manual 
evaluation on several steps to achieve a high-quality reconstruction259. To settle this 
problem, in the last years a series of software tools and platforms has been developed, 
and a recent review was published, addressing the use of software platforms that facilitate 
metabolic model reconstruction in several steps260. In the last years, a few reviews with 
guidelines to develop genome-scale metabolic models have been published 259,261–263. 
According to the protocol published by Thiele and Palsson, the generation of a 
metabolic network includes more than 90 steps, and encompasses four main stages 
which are briefly discussed in the next pages262. 
 
 
                                 Figure 2.5. Genome-scale metabolic model reconstruction overview. 
 
i. Draft model creation  
This first step can be a manual or an automatic (or semi-automatic) process, with 
several software tools available to generate the draft reconstruction such as Pathway 
tools264, The Seed265, merlin266, or RAVEN267, among others262.  
Genome Sequencing
Information
Omics data
Physiology
Reconstructed metabolic
model network
Constraints
applied
Informations and 
predictions
Model revision
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As each model is organism specific, the draft model creation is based on genome 
annotation and specific biochemical information available for the target organism261. When 
available, it is important to use the latest genome annotation for the creation of the draft 
reconstruction, since the annotation is the backbone of the draft model, thus contributing 
to the quality of the reconstructed model262. Nowadays, several databases with genome 
annotations for a variety of organisms are available. Some of them are organism-specific 
such as the PyloriGene268 (H. pylori), SGD269 (S. cerevisiae), or Ecocyc264 (E. coli), while 
others contain annotations for a large spectrum of organisms, such as EntrezGene270 or 
IMG271 (Integrated Microbial genome) (for a review see Thiele and Palsson (2010)262). From 
these databases, data about genes, open reading frames (ORF), cellular function, 
sequence similarities, and Enzyme commission (EC) number for the enzyme coding genes 
can be retrieved. Only genes encoding enzymes and membrane transporters are included 
in the reconstruction259. In the identification of candidate metabolic functions, other 
databases that contain information about pathways and biochemical reactions can also be 
used259,262, such as KEGG272, Brenda273, MetaCyc274, or Transport DB275. At this point, a list of 
possible metabolic functions, possibly incomplete or with functions that are not considered 
in metabolic model reconstructions (such as proteins involved in DNA methylation) is 
obtained262. Subsequently, the draft reconstruction is assembled.  
 
ii. Curation and refinement 
At this stage, manual curation of the draft model has to be done by inspecting all 
gene-protein-reactions to identify wrong information, gaps in network, and inconsistencies. 
It is a very important step, since the databases used are not always organism-specific, and 
sometimes wrong information is included262,263. In order to curate and refine the model, 
there are several steps to be performed (Table 2.9), according to Rocha et al. (2007)259 
and Thiele and Palsson (2010)262.  
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Table 2.9. Model curation steps259,262.  
Steps of model curation Sources of information/Comments 
Metabolic function verification 
Experimental data and literature; 
Information about phylogenetically close organisms (for less-characterized 
organisms). 
Substrates and cofactors Literature and databases search for organism-specific biochemical studies. 
Charged formula for 
metabolites 
Predict with software packages 
Reaction stoichiometry 
Based on online databases (if an EC number has been assigned) 
and literature data. 
Reaction directionality 
Estimation of standard Gibbs free energy can be used; 
No information available: the reaction is set reversible. 
Gene and reaction localization 
Online databases and literature 
Algorithms to predict cellular localization (such as PSORT276) 
Gene-protein-reaction 
association 
Important to determine the existence of enzyme complexes or isoenzymes 
Extracellular and periplasmic 
transport reactions 
Extracellular reactions can occur with interconversions. 
Exchange reactions Considered system inputs and outputs. 
Intracellular transport reactions Applicable to multi-compartment networks. 
Biomass compositions 
Experimental determination from cells growing in log phase of all known 
biomass constituents and fractional contributions to the overall biomass; 
A generic biomass equation can be used but taking into account that 
biomass composition can change depending on physiological conditions. 
Growth associated ATP and 
maintenance ATP 
Included in biomass equation and in a reaction converting ATP to ADP; 
ATP molecules needed per gram of biomass formed and needed for 
maintenance processes; 
Experimentally determined from chemostat growth experiments; 
Biomass ATP can be estimated by determining the energy required for 
macromolecular synthesis. 
Growth medium requirements Experimentally determined or retrieved from literature. 
 
iii. Generation of a stoichiometric steady-state metabolic model 
At this stage, the reconstructed metabolic network is converted to a mathematical 
format, that is the basis of the genome-scale model261. This conversion can be performed 
automatically262. A stoichiometry matrix (S) of the reaction list is generated, in which rows 
represent network metabolites and columns the network reactions. For each reaction, 
substrate and product coefficients are entered in the corresponding cell of the matrix255,262. It 
was defined that substrates in reactions have a negative coefficient and products a positive 
coefficient262. After that, the system boundaries need to be defined. For that, for all 
metabolites that are produced or consumed to or from the external medium, an exchange 
reaction needs to be added to the model. In mass balances, the mass conservation is 
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applied. Thus, the steady-state can be described by S.v = 0, where v is a vector of reaction 
fluxes262,277. The definition of constraints for the exchange reactions, indicating for example 
availability of medium components, completes the mathematical formulation of the model. 
The definition of an objective function is important to perform simulations, as the 
previous model by itself represents a variety of solutions. Usually, the objective function is 
defined to be the maximization of the generation of biomass261. This requires a previous 
inclusion of an additional biomass formation reaction that represents the macromolecular 
cell composition, including building blocks, and requirements of energy needed to 
generate biomass261,278. The use of objective functions within stoichiometric models requires 
the formulation of a Linear Programming problem, within the so-called flux balance 
analysis (FBA) approach. FBA was developed with the aim of characterizing the capabilities 
and properties of a biochemical network277. The maximization of the biomass objective 
function is usually applied, using FBA to identify the flux distribution through the metabolic 
network, considering the constraints imposed by the mass balance equations and reaction 
bounds, thus predicting the organism growth rate277.  
Standards for model representation were developed, and one extensively used is 
the Systems Biology Markup Language (SBML), which is XML-based and is used to 
represent and exchange models between simulation tools279,280.  
 
iv. Model evaluation 
At this stage, the reconstructed model, predicting biomass formation, is evaluated 
and validated by several tests and additional experimental data262,263. Phenotypes of gene-
deletion strains provide very useful data to test the network, but are not always available. 
Physiological parameters (such as growth rates, yields, substrate utilization and product 
formation rates), preferentially from chemostat experiments, represent additional data that 
are very useful for model validation263. The model should agree with the measured fluxes or 
predict some of the fluxes263. The steps to be done are summarized in Table 2.10. 
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Table 2.10. Steps to be performed to evaluate the reconstructed metabolic model262. 
Model debugging Procedure/Comments 
Metabolic dead-ends 
verification and gap analysis 
Gap analysis (search for missing reactions and functions) in order to 
identify dead-end metabolites (not connected to the metabolic network); 
Literature search to find information to fill the gaps. 
Biomass precursor production Test if the model is able to produce all biomass precursors. 
Test other growth media for 
biomass precursor production 
The model should produce biomass in a variety of different media. 
Blocked reactions verification 
Verify if there is a reaction that cannot carry any flux in any situation 
(blocked reactions). 
Simulate single gene deletion 
phenotypes 
If there is information available about deletions, should be compared with 
model predictions. 
Check known incapacities of 
the organism 
Such as auxotrophies, etc. 
Evaluate growth rate 
Compare experimental with in silico predicted growth rates; 
If the in silico growth rate is very low, a component in the growth medium 
may be growth limiting; 
If the growth rate is very high, one possible explanation is that the 
objective function was not correctly set. 
 
Once the model reaches a satisfactory agreement with experimental data, it can 
be used for a variety of applications. 
 
2.5.2.2 H. pylori 26695 GSMMs 
H. pylori 26695 is a highly pathogenic strain that was originally isolated from a 
patient with gastritis in the United Kingdom. Its complete genome was sequenced by 
whole-genome random sequencing and published in 1997131. This pathogenic organism 
presents a small genome with 1.67 Mbp, with an average G+C content of 39% and 
approximately 1590 predicted coding regions131.  
H. pylori strain 26695 is motile, catalase, urease and oxidase positive. Regarding 
virulence, it possess a cytotoxin-associated gene A (cagA gene) and expresses the 
vacuolating cytotoxin (VacA) encoded by the vacA gene, contributing to this strain’s 
pathogenicity281. 
In 2002, the first genome-scale metabolic model of H. pylori 26695 was 
published282. This reconstruction was based on the first genome annotation provided by the 
TIGR Microbial Database and Genebank282. A genome re-annotation of H. pylori 26695 was 
published in 2003, generating a specific database – Pylorigene268 (publically available at 
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http://genolist.pasteur.fr/PyloriGene/). In 2005, a GSMM reconstruction (iIT341 
GSM/GPR) was published for the same strain, where the genome information was 
updated for the revised annotation of the H. pylori 26695 genome and also accounted for 
the new experimental data made available283. The metabolic network characterization for 
both published models is showed in Table 2.11. This new reconstruction accounts for 50 
new gene loci, 88 new reactions, and 82 more metabolites than the first model created by 
Schilling et al. (2002) (Table 2.11). Also, some pathways were more accurately described 
and gene-protein-reaction associations were introduced283.  
 
Table 2.11. In silico H. pylori 26695 metabolic networks characterization. 
In silico metabolic networks iCS291 (2002)282 iIT341 GSM/GPR (2005)283 
No. genes included 291 341 
No. of reactions 388 476 
No. of metabolites (internal/external) 339/64 411/74 
S matrix 649 x 403 554 x 485 
Note: The “i” in the model name refers to an in silico model, the following initials correspond to the person 
who developed the model and then the number of genes are presented. “GSM” indicates “Genome Scale 
Model” and “GPR” refers to “Gene-Protein-Reaction” association. 
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3.1. Abstract 
Helicobacter pylori is known to be associated with gastric diseases. The lack of 
physiological data has hampered the uncovering of mechanisms associated with infection 
and consequently, many aspects related with the appearance of diseases remain unclear.  
It is well known that H. pylori can change cell morphology from spiral to coccoid forms 
when exposed to adverse conditions. Moreover, in those circumstances, H. pylori cells can 
aggregate in clusters when in liquid culture. Such phenomenon makes it difficult to assess 
growth using conventional methods. Also, some authors have reported the existence of a 
viable but nonculturable state of this bacterium. The development of robust methods to 
grow this bacterium and reliable methods for the assessment of growth are thus needed 
for a better characterization of its physiology.  
The purpose of this work was thus to study H. pylori’s growth in a chemically 
semi-defined medium, to compare different methods to assess growth, and observe the 
changes in morphology. Cultures were grown at 37ºC under controlled conditions in a 
Ham´s F-12 medium supplemented with fetal bovine serum. In order to evaluate total cell 
counts, viability and cell morphology, the following methods were used and compared, 
when appropriate: cultivable cell counts, total cell counts using DAPI staining, evaluation of 
viability with the Live/Dead viability kit and a PNA FISH probe which evaluates the 
presence of stable rRNA. Additionally, a method that allows efficient cell disaggregation 
was developed, since an increasing number and size of cell clusters were observed during 
cell growth, accompanied by cell morphology conversion.  
Differences of cell counts between methods were observed. The Live/Dead 
viability kit was not suitable for analysis of H. pylori’s viability after the exponential cell 
phase, especially during morphological cell conversion. In comparison to total counts using 
DAPI, cultivable cell counts displayed, in general, lower counts, particularly after cells have 
reached the stationary phase, indicating the presence of nonculturable cells. Changes in 
morphology and viability were also observed, with viable and culturable coccoid cells 
identified, besides spiral cells. Moreover, after 60 hours of culture, cells were mainly 
coccoid and nonviable.  
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3.2. Introduction 
H. pylori is a pathogenic, spiral-shaped bacterium, but it has been described that 
it can change cell morphology from spiral to coccoid when exposed to adverse conditions, 
such as aerobiosis1,2, alkaline pH3, low temperature4, nutrient starvation2,5, extended 
incubation6, use of proton pump inhibitors3 or treatment with antibiotics7,8. This 
pleomorphic nature of H. pylori has been intensively studied in order to understand its 
importance and implications in the transmission of infection. However, the nature of 
coccoid forms is a controversial topic, with some studies yielding opposite evidences. 
Essentially, different types of behavior for coccoid forms were reported with respect to 
viability and culturability. It is thought that this different behavior might be associated with 
different types of coccoid cells, which are associated with different processes of 
transformation9,10. Some authors concluded that the mentioned cell forms represent a 
degenerative nonviable bacterial form11 or a “morphological manifestation of cell death”12. 
Culturable H. pylori coccoid cells were described9,10,13, in opposition to the most commonly 
found viable but nonculturable (VBNC) form7,9,10, also proved in other bacteria14,15. This last 
type of cells is the most plausible and accepted by the scientific community.  
The aim of morphological change in H. pylori is a key question, being pointed out 
as a strategy of survival inside and outside of the human host16,17, with some authors 
claiming that coccoid forms can revert to spiral when exposed to favorable conditions, as 
proved in experiments with mice18,19.  
Whether coccoid forms are capable of inducing disease remains another open 
question, with several authors proving that coccoid cells, like spiral cells, express virulence 
factors, emphasizing their potential pathogenicity20–22. Saito et al. (2012) showed in their 
experiments that, similarly to spiral cells, coccoid forms can infect human gastric epithelial 
cells23. 
The conversion from spiral to coccoid forms occurs through intermediary forms 
such as the U-shape24, C-shape and doughnut shape. In the last years, several studies 
have been published, addressing topics related with bacterial cell shape and its 
modifications, with the peptidoglycan layer having a prominent role25, including in H. pylori 
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26–28. Some genetic determinants involved in cell morphology and shape transition in H. 
pylori were also revealed29–32.  
If there is indeed a viable but nonculturable (VBNC) form of H. pylori, then the use 
of culturing techniques for growth assessment is not always adequate. Since the number 
of cells can be underestimated using culturable cell counts, the enumeration of total cells 
by direct count of stained cells in epifluorescent microscopy can be an alternative, also 
allowing to enumerate viable and nonviable cells.  
In addition, H. pylori cell-to-cell aggregation in liquid culture (complex and defined 
media)4,33–35, as well as in water36, was described. It has been reported that this 
phenomenon is more noticeable for H. pylori in liquid culture when oxygen is scarce34. Cell-
to-cell aggregation was reported in several other gram-negative species37–39 and it is 
hypothesized that aggregation represents a strategy to survive and grow in unfavorable 
environments34. 
In previous experiments, we observed cell-to-cell aggregation on Ham’s F-12 
nutrient mixture, making it difficult to assess the growth of H. pylori using conventional 
methods such as cultivable cell counts and total cell counts using fluorochromes. 
The development of robust methods to grow this bacterium and reliable methods 
for the assessment of growth and morphology are thus needed for a better 
characterization of its physiology and morphology.  
The goals of this work were to study the growth of H. pylori in a semi-chemically 
defined liquid medium using optimal environmental conditions previously found by 
experimental design40. More specifically, we aimed at comparing different methods for 
growth assessment and morphology evaluation, in order to be able to observe changes in 
morphology during growth, giving special relevance to clusters formation. Furthermore, we 
aimed at developing a method that allows to disaggregate cell clusters in order to achieve 
a more reliable and accurate assessment of growth. 
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3.3. Methods 
3.3.1. Culture conditions  
Helicobacter pylori 26695 (strain NCTC 12455) was cultivated in Columbia Base 
Agar (CBA) (Liofilchem, Italy) supplemented with 5% (v/v) defibrinated horse blood 
(Probiologica, Portugal) at 37 °C under microaerophilic conditions (5% O2, 10% CO2, 85% 
N2) in a Cell Culture Incubator (Incubator HERAcell 150, Kendro Laboratory, Germany) for 
3 days. 
An inoculum was prepared in Ham’s F-12 nutrient mixture with glutamine (catalog 
no 21765-037, Invitrogen-Gibco, Spain) previously supplemented with 5% (v/v) FBS 
(catalog no 10500-064, origin: South America, Invitrogen-Gibco, Spain)41, incubated at 37 
°C under 120 rpm of shaking speed (Heidolph Unimax 1010 orbital shaker, Germany) in 
microaerophilic (5% O2, 10% CO2, 85% N2) conditions for approximately 17 h, in order to 
reach the exponential phase.  
The initial cell concentration of the culture was adjusted to an optical density at 
600 nm (OD600) of 0.1 (corresponding to approximately 107 CFU/mL) in 1000 mL 
Erlenmeyer flasks with the same medium as described for the inoculum by manipulating 
the amount of cells incubated from the inoculum. The pH was adjusted to 8.0 with 5M 
NaOH (Panreac). The culture was incubated at 37 °C under 130 rpm of shaking speed 
under microaerophilic conditions (6.5% O2, 10% CO2, 83.5% N2). The experiment was 
carried out in triplicate and samples were collected at selected time points up to 72 hours 
of culture.  
 
3.3.2. Cell-to-cell disaggregation  
At each time point 1 mL of culture was vortexed (Press-to-Mix model 34524, 
Snidjers) at maximum speed during 5 minutes in a 2-mL tube with 8-10 glass beads (1 
mm diameter, Sigma). Subsequently, growth and morphology were assessed using the 
methods described in the following subsections. 
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3.3.3. Growth assessment 
At each time point, after the application of the disaggregation method, optical 
density (OD) at 600 nm was immediately assessed by using an ELISA microplate reader 
(Model Sunrise, Tecan, Switzerland)  
 
3.3.4. Colony forming unit assay 
The cultivable cell counts represented by Colonies Forming Units (CFU/mL) were 
assessed at each time point by the method of serial dilutions in phosphate saline buffer 
(PBS) (pH 7.2), after disaggregation. For each dilution, five spots of 10 µl were plated in 
CBA medium and the plates were incubated under microaerophilic conditions (5% O2; 10% 
CO2; 85% N2) for 5 to 7 days at 37°C. Three to thirty colonies per spot were considered for 
the counting. To determine CFU/mL the dilution rate was taken into account. 
Purity control was carried out at each time of sample collection by plating each 
sample in Trypticase Soy Agar (TSA) (Liofilchem, Italy). 
 
3.3.5. Staining methods 
3.3.5.1. Total Cell Counts 
The total cell counts at each time point were determined using 4',6-diamidino-2-
phenylindole (DAPI) (Sigma-Aldrich). Briefly, 10 µL of disaggregated bacterial culture were 
filtered under vacuum in a black Nucleopore® polycarbonate membrane (0.2 µm pore size, 
25 mm diameter, Whatman). Subsequently, 40 µL of the DAPI solution (100 µg/mL 
dissolved in water) were added to the membrane that was then covered with a coverslip 
and kept for 10 minutes in the dark at room temperature. The membrane was washed 
with 10 mL of filtered water and air dried. Then, it was placed in a microscope slide and a 
drop of nonfluorescent immersion oil (Merck) was placed on the top of the membrane that 
was covered with a coverslip before microscopy observation.  
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3.3.5.2. Viability evaluation 
A bacterial viability Live/Dead® BacLight™ (Molecular Probes, USA) kit was used 
to determine cellular viability at each time point. In short, 1 mL of bacterial culture was 
centrifuged at 10 000 rpm during 5 minutes, the supernatant was discarded and the pellet 
re-suspended in 1 mL of phosphate saline buffer (PBS) (pH 7.2) and 3 µL of a mixture of 
Syto9 and propidium iodide (1:1) (included in kit), and stained for 15 minutes in the dark. 
5 µL of suspension were placed in a clean glass microscope slide and covered with a 
coverslip. All samples were observed within 15 minutes. 
 
3.3.5.3. Evaluation of stable rRNA 
The presence of stable rRNA was evaluated at each time point using a peptic 
nucleic acid fluorescence in situ hybridization (PNA FISH) probe (Hpy 769)42. The whole 
procedure was performed according to Guimarães et al., 200742. The composition of 
solutions (hybridization and washing) and chemicals used are described in supplementary 
material 1. 
Ten microliters of H. pylori culture (after disaggregation) were placed in an 8-mm 
well slide and let to air dry. The samples were fixed at room temperature by covering the 
sample with 30 µL of 4% (w/v) paraformaldehyde (Sigma-Aldrich) for 10 minutes. 
Afterwards, 30 µL of 50% (v/v) ethanol (Fisher Chemical) were added to the wells with 
care to cover the entire well surface for another 10 minutes. Then, slides were allowed to 
air dry. The PNA FISH probe Hpy 769 (30 µL, 200 nM prepared in hybridization solution) 
was added to each well. A negative control was prepared by adding 30 µL of hybridization 
solution to another well slide. The wells were covered with coverslips and incubated in the 
dark, during 90 minutes at 57°C. After that, the slides (without coverslips) were placed in 
a coplin jar, immersed in prewarmed washing solution for 30 minutes at 57°C. After the 
washing step the slides were left to dry in the dark. A drop of nonfluorescent immersion oil 
(Merck) was placed on the wells and covered with a coverslip.  
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3.3.5.4. Microscopic visualization 
Samples were observed in an epifluorescence microscope (BX51 Olympus, 
Hamburg, Germany) equipped with a camera (DP71; Olympus) with filters adapted to the 
fluorochromes used in each method at a magnification of x1000. Pictures of each sample 
were taken and a total of 10-20 random fields per sample were enumerated. The total 
cells per mL of sample, percentage of viable cells, as well as percentages of spiral, coccoid 
and intermediate forms (U-shape, C-shape and doughnut-shape) were determined at each 
time point in three biological replicates.  
 
3.4. Results and Discussion 
3.4.1. Cell-to-cell disaggregation 
We observed the cell-to-cell aggregation phenomenon on Ham’s F-12 nutrient 
mixture supplemented with FBS, making it difficult to assess the growth of H. pylori using 
the conventional methods such as cultivable cell counts and total cell counts using 
fluorochromes. Other authors also reported the presence of cell aggregates, particularly for 
coccoid cells, explained by the adhesive properties of these cells43. The described behavior 
was associated with an answer to adverse conditions34. In the present work, the increase 
of cell clumps was also observed with the time of culture; also, bigger coccoid cell clusters 
were found to be more difficult to disaggregate.  
During the optimization of the cell-to-cell disaggregation method, different 
numbers of glass beads and different times of shaking in the vortex were tested in order to 
achieve the best cell-to-cell disaggregation, breaking the clumps of cells without cell lysis. 
The influence of the time of shaking using 8-10 glass beads in CFU/mL and  OD600, in a 
culture of H. pylori, at exponential phase, growing in Ham’s F-12 liquid medium 
supplemented with 5% (v/v) FBS is displayed in supplementary material 2. The time of 
shaking was fixed in 5 minutes, with no significant difference in CFU/mL between the 
tested times of shaking (p=0.57, one-way ANOVA). 
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The application of the disaggregation method made possible to assess more 
accurately the cultivable cells (CFU/mL). In fact, an increase of the cultivable cells number 
was observed after applying the disaggregation method, being the difference between 
disaggregated samples and non-disaggregated samples more noticeable during the 
exponential and stationary phases (Figure 3.1 (B)). After 36 hours of culture, when cells 
start to change their morphology, there was no visible advantage in the application of the 
disaggregation method. There are some facts that can explain this result, namely: 1) when 
cells are undergoing a morphological transition they may be more susceptible to the 
process of disaggregation, the viability becoming compromised by this procedure; 2) when 
cells are in the coccoid form, the disaggregation of the cell clumps is more difficult to 
achieve (as observed in microscopic visualization) and 3) after 36 hours of culture, the 
culturable cells are declining, and the aggregated cells are proportionally less viable than 
non-aggregated cells.  
The same increase was observed in optical density after cell-to-cell disaggregation, 
although in this case the increase is constant through the entire culture time, showing that 
cell-to-cell disaggregation is performed in both viable and non-viable cells and also in all 
cell forms (Figure 3.1(A)). By combining these two sets of results, hypothesis 2 mentioned 
above is less likely as it would originate a similar profile in the OD curve as the one 
observed for the CFU data. 
 
 
Figure 3.1. Growth of H. pylori 26695, Mean of three biological replicates with standard deviations. OD600 
with and without cell-to-cell disaggregation (A); log10 CFU/mL with and without cell-to-cell disaggregation (B). 
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3.4.2. Growth assessment and cell counts 
The growth was assessed by optical density at 600 nm and by microscopy using 
DAPI and PNA FISH. In order to estimate the total cell counts, DAPI, a fluorescent dye that 
binds strongly to DNA with a binding preference for A-T rich regions, was used. It passes 
through an intact cell membrane, stains both live and dead cells, being suitable to 
determine total cell counts44. PNA FISH has been largely applied to identify45–49 and also to 
discriminate bacterial species50,51. A specific method based on a red fluorescent PNA FISH 
probe (Hpy769), developed by Guimarães et al. (2007) for the detection of H. pylori was 
applied in order to evaluate the stable rRNA (for a method review see Cerqueira et 
al.(2008) 52). The cells are stained red due to the Alexa fluor 546 fluorochrome used in the 
H. pylori probe referred above42.  
Comparing the methods used in terms of fluorescence for cells in the exponential 
phase of growth, cells stained with PNA FISH showed a brighter and more stable signal 
than cells stained with DAPI. In Figure 3.2, epifluorescence microscope images of H. pylori 
26695 growing in semi-defined liquid medium are shown. It is clearly visible that at 0 
hours of culture the cells present a higher fluorescence signal intensity with more defined 
contours, with both methods (Figure 3.2 A and C). This high fluorescence intensity 
observed is due to the high rRNA content in cells and the presence of intact DNA in 
growing cells, for the Hpy probe and DAPI staining application, respectively. In general, a 
decrease in the fluorescent signal for both fluorochromes (DAPI and Alexa fluor 546) and 
an increase in cell clusters were observed with time. In fact, cells were impossible to count 
at 60 and 72 hours of culture due to large aggregates of coccoid cells even after 
performing the disaggregation procedure. The referred fluorescent signal reduction and the 
increase of cell clusters are noticeably visible in Figure 3.2 (B and D) for cells at 36 hours 
of culture, which start undergoing morphological conversion.  
Figure 3.3 shows the results for cell counts using DAPI and PNA FISH (until 48 
hours of culture) and culturable cells and optical density (up to 72 hours of culture). In 
general, the Hpy 769 probe yielded the lesser cell counts and the DAPI stain the higher 
cell counts, with significant differences in counts at 4 and 12 hours of culture (p<0.05; T-
test, equal variances). In order to evaluate the differences between methods, ratios 
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between counts were calculated (presented in supplementary material 3). Comparing PNA 
FISH probe counts with DAPI stain counts, the PNA FISH counts ranged from 24 to 63% of 
the DAPI cell counts. This may indicate that some of the cells that were counted with DAPI 
did not have stable rRNA, therefore were not observed with the PNA FISH probe. Similarly, 
the culturable cell counts varied between 2 and 86 % of the DAPI counts, with the biggest 
difference at 48 hours of culture (2% of DAPI counts), showing the decrease in 
culturability, with significant differences in all times of sampling (p<0.05; T-test, equal 
variances), with exception of 0 and 8 hours of culture. At the start of the experiment, 86% 
of the cells appear to be culturable. Regarding PNA FISH probe counts and CFUs, large 
differences were observed, with 28 to 93% of culturable cells counted with the PNA FISH 
probe until 8 hours of culture, and a higher number of cells counted with PNA FISH after 
that time. The observed differences are significant in all times of sampling (p<0.05; T-test, 
equal variances), with the exception of 4, 8 and 12 hours of culture. After 36 hours, a 
considerable decrease in culturable cell counts accompanied by an OD decrease was 
observed, although not observed in the DAPI and PNA FISH counts (Figure 3.3.). In fact, at 
this time of culture, cells start becoming very aggregated, which may impact OD 
measurements and CFU/mL counts, but that does not impair cell counts using 
fluorochromes. 
In general, all methods used make predictions that follow the same trend, except 
for the OD and CFUs. Since they are affected, as stated above, by aggregation 
phenomena, the OD data are less reliable than fluorescence for total cell counts, while the 
results for culturability should also be questioned after 36 hours. 
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Figure 3.2. Epifluorescence microscope images of H. pylori 26695 in liquid culture after cell 
disaggregation. DAPI staining, 0 hours of culture (A); DAPI staining, 36 hours of culture (B); PNA FISH probe 
(Hpy469), 0 hours of culture (C); PNA FISH probe, 36 hours of culture (D). Magnification: 1000x. 
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Figure 3.3. Measurements of optical density (600 nm), culturable cells, and total cell counts with DAPI 
stain and PNA FISH probe counts. Mean of three biological replicates. Error bars represents standard 
deviation. 
 
3.4.3. Cellular Viability 
Cellular viability was evaluated using a Live/Dead Baclight Viability Kit which is 
based on cell’s membrane integrity by the staining of nucleic acids with Syto 9 and 
propidium iodide fluorochromes. If a cell has an intact membrane it will stain green with 
Syto 9 and is considered to be viable, whereas if a cell has a damaged or compromised 
membrane it will stain red with propidium iodide and is considered to be nonviable53. In the 
last years, this commercial kit has been extensively applied in viability evaluation of 
bacterial species54–56 including H. pylori17,36,57,58.  
Figure 3.4 depicts the percentage of viable and total cell counts obtained with the 
Live Dead kit by epifluorescence microscope visualization, and culturable cell counts 
represented by CFU/mL in the same samples of an H. pylori 26695 liquid culture in 
optimized environmental conditions. 
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Figure 3.4. Percentage of viable cells and total cell counts (Live/Dead kit) and culturable cell counts along 
time in an H. pylori 26695 culture in liquid medium. Mean of three biological replicates. Error bars represent 
standard deviation. 
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thus, the appearance of nonviable cells in microscopy, explaining the discrepant results 
between culturable and viable cells at these time points (Figure 3.4. and detailed results in 
supplementary material 4). Berney et al. (2007) also reported that a specific gram-
negative bacteria phenomenon can occur in stationary-phase cells, which is related with 
the presence of the outer membrane, being to some degree a barrier to the Syto9 stain55.  
After the conversion phase (60 hours of culture), from spirals to coccoids, the 
viable cells become significantly higher than culturable cells, showing the viable but non 
culturable (VBNC) state of the coccoid cells17,57. This result also proves that culturability and 
viability are two independent features. Moreover, the presence of a higher number of cells 
with stable rRNA identified in PNA FISH probe compared with CFUs at 36 and 48 hours 
(results detailed in supplementary material 3) can also be associated to the VBNC state, 
allowing to conclude that several methods have to be applied to obtain a detailed 
characterization of viability59. 
Figure 3.5 shows epifluorescence microscope images for 0, 36 and 72 hours of 
culture, where it is possible to observe the increase of intermediate and coccoid cells and 
the decrease of viable cells (stained green) with culture time.  
 
 
 
Figure 3.5. Epifluorescence microscope images of a H. pylori 26695 culture stained with Syto9/Propidium 
iodide (Live/Dead kit). 0 hours of culture (A); 36 hours of culture (B); 72 hours of culture (C). Magnification: 
1000x. 
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3.4.4. Cellular Morphology 
Cell morphology can be observed using different fluorochromes, such as 
Syto9/Propidium iodide36,57, Acridine orange or DAPI44. In agreement with Guimarães et al. 
(2007) the Hpy769 probe was able to detect not only spiral cells but also cells with 
intermediate shapes (U, C and doughnut) and coccoid morphology, which have a low 
number of rRNA copies per cell42. In the present study, cell morphology was evaluated 
using DAPI, Syto 9/Propidium iodide and the Hpy 769 probe (PNA FISH probe) (Figure 
3.6). The standard deviation among the methods applied is presented in supplementary 
material 5 (Table 3.5 and Table 3.6) with the higher standard deviation at 48 hours of 
culture, due to large differences observed between the Live/Dead kit and the other 
methods applied. Even after applying the cell-to-cell disaggregation method, DAPI and PNA 
FISH were not suitable to analyze cell morphology after cell conversion to the coccoid 
shape, due to the formation of cell clusters, which were higher in number and size (Figure 
3.6). Curiously, the application of Syto 9/Propidium iodide dyes allowed observing and 
counting cells with different morphologies during the entire experiment, including coccoid 
shape samples, which had smaller cell clusters with these stains.  
As shown in Figure 3.6, the percentage of spiral cells decreases during the time of 
experiment, with cells remaining mainly in the spiral shape until 48 hours of culture 
(although showing a decrease, especially after the exponential phase -  24 hours). Until 24 
hours of culture, no significant difference in the percentage of spiral cells was observed 
(p=0.66; one-way ANOVA test). However, there was a significant difference between the 
methods performed to estimate the percentage of spiral cells (p<0.05; one-way ANOVA 
test) (detailed results in supplementary material 5, Table 3.5). In general, the percentage 
of spiral cells observed with the Hpy 759 probe until 24 hours is higher than the 
percentage of spiral cells counted with the other methods (supplementary material 5, 
Table 3.6). As discussed above, after 48 hours of culture, it was only possible to observe 
cell morphology using Syto 9/Propidium iodide stains and a huge decrease in the number 
of spiral cells was observed with around 7% of spiral cells at 72 hours of culture.  
In general, a slight decrease in the coccoid cells was observed in the exponential 
phase (until 12 hours), and a subsequent increase was observed, with mostly coccoid cells 
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observed at 60 hours of culture. (around 80%, evaluated with Syto9/Propidium iodide 
dyes) (Figure 3.6). The presence of coccoid cells using Ham’s F-12 nutrient mixture, 
analyzed by Live/Dead kit, was also observed by Azevedo and co-workers, with 100% of 
coccoid cells at 48 hours of cells in F-12 medium and in contact with a copper surface17. 
Mean percentage of intermediate cells, in general, is increasing with time (results detailed 
in supplementary material 5, Table 3.6.).  
 
  
Figure 3.6. Cell morphology of H. pylori 26695 along culture time. For each time the mean of cells in 
different morphologies counted using the DAPI stain, PNA FISH probe and Live/Dead kit are shown for three 
biological culture replicates. Error bars represents standard deviation of values for three biological replicates. 
* - values obtained only with Live/Dead staining. 
 
3.5. Conclusions 
Although the application of staining methods to enumerate cells and evaluate cell 
morphology, as well as the use of the Live/Dead kit to evaluate viability have been largely 
applied, the comparison of the results obtained between methods in H. pylori has, to our 
knowledge, never been reported. Another important comparison, performed in this work, 
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cell-to-cell disaggregation method was applied, allowing improvements in the counting of 
cells using “conventional” methods. 
In general, differences between methods used to enumerate cells were observed, 
with DAPI yielding the higher number of total cell counts when compared with the PNA 
FISH probe applied. Culturable cell counts were in general less than total cell counts 
performed with DAPI, especially after the exponential phase, showing the presence of 
nonculturable cells. The viable but non-culturable state was observed after 60 hours of 
culture. The number of culturable cells was, in general, similar to the viable cells during 
the exponential phase. The evaluation of cell viability using Syto9/propidium iodide was 
not effective to analyze cell morphological changes, giving exaggerated numbers of 
nonviable cells, explained by the entrance of propidium iodide through the permeable 
cytoplasmatic membrane. Under the referred conditions, another method to estimate cell 
viability must be used, such as measurement of membrane potential59. The culturable cell 
counts at 60 and 72 hours of culture were higher compared with the spiral cells observed 
at these time points, thus, proving the presence of culturable coccoid cells, previously 
shown by other authors9,10,57, however under controversy. After 60 hours of culture, mainly 
coccoid cells were observed. Taking into account that coccoid forms represent a cell 
adaptation to less favorable conditions17, the present results suggests that some stressing 
factor is present that causes morphological changes, probably the unavailability of an 
essential nutrient. The presence of an increasing number and size of cell clusters also 
support this hypothesis.  
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3.7. Supplementary material  
3.7.1. Supplementary material 1 
Table 3.1 describes the composition and chemicals used to make the 
hybridization solution for the PNA-FISH experiments, according to Guimarães et al. 
(2007)42. The solution was prepared in distillate sterilized water and the pH was adjusted 
to7.5. 
 
Table 3.1. Composition of the hybridization solution.  
Compounds Chemicals Concentration 
Dextran sulphate Sigma-Aldrich 10% (w/v) 
NaCl Sigma-Aldrich 10 mM 
Formamide Sigma-Aldrich 30% (v/v) 
Sodium pyrophosphate Sigma-Aldrich 0.1% (w/V) 
Polyvinylpyrrolidone Sigma-Aldrich 0.2% (w/v) 
FICOLL Sigma-Aldrich 0.2% (w/v) 
Disodium EDTA Pronalab 5 mM 
Triton X-100 Sigma-Aldrich 0.1% (v/v) 
Tris-HCl Sigma-Aldrich 50 mM 
 
Table 3.2 describes the composition and chemicals used to prepare the washing 
solution, according to Guimarães et al. (2007)42. The solution was prepared in distilled 
water and the pH was adjusted to10. The solution was sterilized (121°C, 15 minutes) and 
kept at 4°C until use. 
 
 Table 3.2. Composition of the washing solution.  
Compounds Chemicals Concentration 
Tris Base Sigma-Aldrich 5 mM 
NaCl Sigma-Aldrich 15 mM 
Triton-X Sigma-Aldrich 1% (v/v) 
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3.7.2. Supplementary material 2 
Figure 3.7 depicts the results of disaggregation assays, showing the influence of 
the vortex shaking time (3, 5, 7, 10 and 15 minutes) in Optical Density (600 nm) and 
Colonies Forming Units (CFU/mL) using 8-10 glass beads. The assay was performed with 
cells in the exponential phase, growing in liquid medium (Ham’s F-12) supplemented with 
5% (v/v) FBS. 
 
 
Figure 3.7. OD600 and CFU/mL in disaggregation assays using 8-10 glass beads and vortex shaking 
(3,5,7,10 and 15 minutes)  
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3.7.3. Supplementary material 3 
Table 3.3 shows the mean values (± standard deviation) of cell counts for three 
biological replicates for each method applied. A ratio between methods is also presented, 
showing the differences between counts among methods. 
 
Table 3.3. Mean values (±SD) of cell counts for each method performed for three biological replicates. 
Time 
(hours) 
log10 
CFU/mL 
Mean ± SD 
CFU/DAPI 
(%) 
log10 
cells/mL 
DAPI 
Mean ± SD 
PNA/DAPI 
(%) 
log10 cells/mL 
Hpy769 probe 
Mean ± SD 
PNA/ 
CFU 
(%) 
0 7.86±0.14 86.30 7.90±0.22 24.51 7.32±0.10 28.40 
4 8.08±0.13 37.24 8.50±0.15 33.48 8.01±0.19 89.91 
8 8.13±0.07 60.00 8.27±0.35 56.05 8.10±0.06 93.41 
12 8.02±0.19 24.23 8.66±0.05 25.71 7.99±0.35 106.11 
24 7.90±0.05 30.81 8.41±0.09 63.44 8.20±0.15 205.90 
36 7.62±0.12 13.85 8.41±0.32 51.71 8.19±0.11 373.46 
48 6.55±0.33 1.92 8.28±0.28 49.91 8.02±0.16 2601.54 
60 5.76±0.05 - - - - - 
72 5.81±0.01  - - - - 
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3.7.4. Supplementary material 4 
Table 3.4 depicts the percentage and log10 of viable cell counts obtained using 
Syto9/propidium iodide stains contained in the Live/Dead kit. The values presented are 
the mean of three biological replicates (± standard deviation). 
 
Table 3.4. Total and viable cell counts using the Live/dead kit performed for three biological replicates. 
Mean ± Standard deviation. 
Time (hours) 
Total Cells Viable Cells 
log10 cells 
Mean ± SD 
log10cells 
Mean ± SD 
% cells 
Mean ± SD 
0 8.23±0.46 8.13±0.46 79.89±4.18 
4 8.29±0.19 8.26±0.19 91.95±3.49 
8 8.18±0.13 8.12±0.20 88.79±15.25 
12 8.39±0.03 8.36±0.02 92.66±5.81 
24 8.45±0.10 8.41±0.09 90.57±3.50 
36 8.43±0.06 7.05±0.85 12.61±19.06 
48 8.15±0.16 4.16±3.61 0.77±0.86 
60 8.43±0.11 8.23±0.13 63.68±3.48 
72 8.26±0.22 7.33±0.42 12.76±6.38 
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3.7.5. Supplementary material 5 
 
Table 3.5 shows the percentage of spiral cell counts for each method performed. 
Mean of three biological replicates for each method and mean values (± standard 
deviation) for all the methods performed. 
 
Table 3.5. Mean percentage of spiral cell counts for each method performed for three biological replicates. 
Time (hours) 
% Spiral cells 
Mean ± SD 
DAPI Hpy 769 probe Syto9/PI 
0 86.90 94.29 81.36 87.52±6.48 
4 87.89 94.33 78.35 86.86±8.04 
8 85.62 92.57 83.18 87.12±4.87 
12 83.97 89.47 84.96 86.13±2.93 
24 80.93 98.99 85.09 88.34±9.46 
36 76.58 87.36 68.67 77.54±9.38 
48 67.86 75.69 20.49 54.68±29.87 
60 - - 5.37 - 
72 - - 6.76 - 
 
 
Table 3.6 shows the percentage of intermediate (U-shape, C-shape and doughnut 
shape) and coccoid cell counts for each method performed. Mean of three biological 
replicates for each method and mean values (± standard deviation) of the methods 
performed. 
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Table 3.6. Mean percentage of intermediate and coccoid cell counts for each method performed for three 
biological replicates. 
Time 
(hours) 
% Intermediate forms % Coccoid cells 
DAPI 
Hpy 769 
probe 
Syto9/PI Mean ± SD DAPI 
Hpy 769 
probe 
Syto9/PI Mean ± SD 
0 9.62 4.97 7.65 7.41±2.34 3.48 0.75 10.99 5.07±5.30 
4 11.22 4.48 13.53 9.75±4.70 0.89 1.18 8.12 3.40±4.09 
8 11.79 6.24 6.61 8.22±3.10 2.59 1.19 10.20 4.66±4.85 
12 13.39 6.68 9.16 9.74±3.39 2.64 3.85 5.89 4.13±1.64 
24 14.79 0.97 9.30 8.35±6.96 4.28 0.04 5.61 3.31±2.91 
36 16.98 8.70 17.45 14.38±4.92 6.44 3.94 13.88 8.09±5.17 
48 17.24 12.95 14.77 14.99±2.15 14.91 11.35 64.74 30.33±29.85 
60 - - 14.66 - - - 79.97 - 
72 -  16.39 - - - 76.86 - 
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4.1. Abstract 
Helicobacter pylori is a human pathogen associated with gastric diseases. 
Understanding the growth of pathogenic organisms inside the host is of major importance 
to develop new and efficient drugs that can be used to treat and eradicate these microbes. 
However, uncovering the mechanisms associated with H. pylori’s associated diseases has 
been hindered by the difficulties found in growing this organism under defined conditions. 
The present study was conducted with the goal of clarifying H. pylori’s nutritional 
requirements, using a metabolic footprinting approach and bringing together in vitro and in 
silico data. For that purpose, H. pylori 26695 was grown under controlled conditions, 
without strain adaptation, in a defined medium supplemented with fetal bovine serum and 
samples were collected to analyze extracellular metabolites using GC-MS after a chemical 
derivatization.  
Discrepancies among in vitro studies were found, as well as between in vitro and 
in silico predictions, revealing the importance of data reconciliation. Under the conditions 
used, some amino acids were identified as absolutely required for H. pylori 26695 growth: 
L-arginine, L- histidine, L-isoleucine, L-leucine, L-methionine, L-phenylalanine and L-valine. 
In addition, other amino acids were identified as possible preferential carbon sources, 
namely, aspartate, glutamate, alanine and proline, although some doubts persist regarding 
the need of proline and alanine in H. pylori. The clarification of H. pylori nutritional 
requirements will allow not only to adjust the culture medium components and perform 
experiments under more defined conditions, but especially to gain new insights about H. 
pylori’s physiology and metabolism.  
 
Keywords: Helicobacter pylori, exometabolome, nutritional requirements, in 
silico, in vitro. 
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4.2. Introduction 
H. pylori is a microaerophilic, gram negative, fastidious organism, requiring 3-4 
days of growth in complex solid media. Over the last 20 years, scientists have pursued the 
development of defined liquid media for in vitro growth of H. pylori 1–4; however, the cell 
densities obtained using these defined media are quite low, and the addition of 
supplements5 (cyclodextrins, bovine serum albumin (BSA) or fetal bovine serum (FBS)) 
significantly improves growth, hence hampering the identification of nutritional 
requirements. Moreover, growth in defined media has required previous strain adaptation 
or has been mostly achieved with non-reference strains, as discussed in the state of the art 
section. Also, despite several studies that tried to identify the nutritional requirements of 
this pathogenic organism, there are discrepancies between published studies.  
Additionally, relevant information is still missing in terms of metabolic capabilities, 
and different published studies lead to different conclusions. It has been described that H. 
pylori can metabolize glucose, although evidences suggest the operation of the pentose 
phosphate and Entner Doudoroff pathways6,7 rather than glycolysis as the major routes for 
catabolism. Nevertheless, most of the glycolytic enzymes are present, which may fulfill the 
requirement for gluconeogenesis8. Mendz et al. (1995) proved that H. pylori can grow 
employing aminoacids as carbon and energy sources, and suggested that even though 
oxygen is essential for the growth of this organism, some aminoacids are utilized via 
fermentative pathways characteristic of anaerobiosis9. H. pylori also uses some amino 
acids, urea and ammonium as nitrogen sources. According to some authors, there are few 
absolute requirements for H. pylori growth: nine amino acids (arginine, histidine, leucine, 
methionine, phenylalanine, valine, alanine, cysteine and proline), sodium and potassium 
chloride, thiamine, iron, zinc, magnesium, hypoxanthine and pyruvate3. However, those 
experiments have been performed with more than one carbon source.  
Uncovering the mechanisms associated with H. pylori infection has been hindered 
by the lack of physiological data and consequently, many aspects related with the 
appearance of diseases remain unclear. 
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Metabolites, the intermediates of biochemical reactions, have a key role in 
connecting the many different pathways that operate within a living cell10. The group of all 
metabolites synthesized or used by a biological system is called the metabolome11,12. In the 
metabolomics field, metabolic footprinting has been extensively used to understand cell 
physiology under diverse states or conditions on various biological systems13,14, relying on 
the investigation of metabolites consumed from and secreted into the culture medium15.  
Genomic information, combined with biochemical knowledge made possible the 
development of metabolic models for several organisms16,17, which can be used to predict 
the phenotypic behavior under different genetic and environmental conditions16. Nowadays, 
there are several software tools for using stoichiometric models of microbial metabolism 
for simulation and optimization18. The genome sequence of H. pylori, together with 
accumulated biochemical and physiological knowledge, allowed the construction of 
genome-scale metabolic models for this organism19,20. The first one was published in 2002 
(iCS291)19 and an updated version was published in 2005 (iIT341 GSM/GPR)20. 
Nevertheless, the predictions obtained with these stoichiometric models are only as good 
as allowed by the data used to build the model. In the particular case of H. pylori, 
physiological data collected under defined conditions are scarce, hindering model 
validation, and consequently making the models unrealistic and inaccurate. 
The present study was conducted with the main goal of elucidating H. pylori’s 
preferences and nutritional requirements, with special relevance for carbon and energy 
sources. One of the applications of this study is the design of a more rational H. pylori 
growth medium. For those purposes, H. pylori was grown in liquid medium and samples 
were collected to analyze the extracellular metabolites. Simulations were performed using 
the existing genome-scale metabolic model in order to link the in vitro obtained results with 
the predictions made by the model and gain new insights about the metabolism of this 
pathogenic organism. The development of robust methods to grow H. pylori would allow 
for a much faster and reproducible path to obtain biomass, and consequently lead to a 
significant development in studies on H. pylori physiology and metabolism, as well as 
protein characterization. Moreover, the identification of the nutritional requirements and 
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active metabolic pathways of this organism is of major importance to understand its 
growth in the host and to help to design alternative strategies for microbial inactivation. 
 
 
4.3. Methods 
4.3.1. Culture conditions  
Helicobacter pylori 26695 (strain NCTC 12455) was cultivated in Columbia Blood 
Agar (CBA) at 37 °C under microaerophilic conditions (5% O2, 10% CO2, 85% N2) in a Cell 
Culture Incubator (Incubator HERAcell 150, Kendro Laboratory, Germany) for 3 days. 
An inoculum was prepared in 150 mL of Ham’s F-12 nutrient mixture with 
glutamine (catalog no 21765-037, Invitrogen-Gibco, Spain) (composition detailed in 
supplementary material 1), previously supplemented with 5% of FBS (catalog no 10500-
064, origin: South America, Invitrogen-Gibco, Spain)21, incubated at 37 °C under 120 rpm 
of shaking speed (Heidolph Unimax 1010 orbital shaker, Germany) in microaerophilic 
conditions for approximately 17 h, in order to reach the exponential phase.  
Cultivations were performed in 1000-mL Erlenmeyer flasks with the same medium 
as described for the inoculum at 37 °C under 130 rpm of shaking speed, under 
microaerophilic conditions (6.5% O2, 10% CO2, 83.5% N2). The initial cell concentration was 
adjusted to an optical density at 600 nm (OD600) of 0.1 (corresponding to approximately 107 
CFU/mL). The experiment was carried out in triplicate during 72 hours. More details can 
be found on previously published work22 in which the culture conditions were optimized by 
experimental design.  
 
4.3.2. Growth assessment 
In order to assess growth, for each experiment performed, samples were collected 
at defined time points (until 72 hours), and the optical density (OD) at 600 nm was read 
using a microplate reader (TECAN Sunrise, Switzerland) after performing the 
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disaggregation procedure described in the previous chapter. Cell dry weight (CDW) was 
determined by using a calibration curve (as described in Chapter 6). A conversion factor of 
0.82 was achieved to convert OD (600nm) to CDW (g/L). Based on the growth curve, the 
specific growth rate (µ) was calculated. To ensure that all samples collected had not been 
contaminated, aliquots were plated both on Tryptic Soy Agar (TSA) and CBA plates, at 
each time point for all experiments.  
 
4.3.3. Extracellular metabolite analysis 
The extracellular metabolite analysis was performed according to the method 
described by Smart et al. (2010)23, with minor modifications. 
4.3.3.1. Chemicals 
Amino and organic acids standards stock solutions were prepared at a 
concentration of 500 mM in ultra-pure water, with the exception of lactic acid and isocitric 
acid which were prepared at a concentration of 250 mM and 2-oxoadipic acid which was 
prepared at 100 mM. In working standard solutions, prepared at 10 mM, the pH was set 
to values above 12 with sodium hydroxide (1 M). A range of standard solutions between 
0.0005 and 10 mM was prepared and a total of three replicates per standard 
concentration were analyzed. The standard solutions were treated the same way as the 
samples. All solutions were stored at -20 ºC while not in use. Information about standard 
compounds used in this study is detailed in supplementary material 2. 
 
4.3.3.2. Sample preparation 
At each time point (0, 4, 8, 12, 24, 48 and 72 hours) samples were collected for 
exometabolome analysis by Gas Chromatography coupled with Mass Spectrometry (GC-
MS). 1-mL samples at each time point (in triplicate) were filtered through a syringe 
cellulose acetate filter (0.2-µm pore size, 25 mm), to remove bacterial cells, and 20 µL of 
d4- alanine (2,3,3,3-d4-alanine) (internal standard) at 10 mM were added to each sample. 
1-mL samples (3 in total) of noninoculated culture medium were prepared in the same 
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way, and were used as controls (blank samples). The samples were frozen at -80 °C and 
then lyophilized during 24 hours.  
 
4.3.3.3. Sample derivatization 
The samples for extracellular metabolites analysis were derivatized using the 
methyl chloroformate (MCF) method described by Smart et al. (2010)23. All solutions and 
standards used were prepared according to the same protocol. Together with the samples, 
one blank of derivatization (all derivatization reagents without sample) was prepared. After 
derivatization, the samples were analyzed in 24 hours, to avoid sample degradation.  
 
4.3.3.4. GC-MS analysis 
GC-MS analysis was performed with a Varian 4000 GC-MS (Varian, USA) with a 
gas chromatograph (Varian CP-3800) equipped with an autosampler (CP-8410), coupled 
to a mass spectrometer with an Ion Trap analyzer (Varian 4000), operating in electron 
impact (EI) ionization mode (70eV). The chromatographic column used was a ZB1701 – 
GC capillary column (30 m x 0.25 mm ID x 0.15 µm film thickness) with a 5-m guard 
column (Phenomenex, USA).  
The 1-µL sample was injected using a splitless mode, and after 1 minute of 
injection the split ratio was 1:20. The GC oven temperature was initially held at 45 ºC for 2 
min. Thereafter the temperature was raised at 9ºC/min until 180ºC and held for 5 min. 
Then, the temperature was raised at 40ºC/min until 220ºC, and held for 5 min. After that 
the temperature was again raised at 40ºC/min until 240ºC and held for 11.5 min. Then, 
the temperature was raised at 40ºC/min until 280ºC and held for 2 min, totalizing 43 min 
of analysis time. Helium was used as the carrier gas, at a constant flow rate of 1.0 
mL/min.  
The injector temperature was set to 290 ºC, and the interface temperature to 250 
ºC, while the trap temperature was set to 190 ºC. The MS was operated in the full-scan 
acquisition mode (38-650 m/z – mass to charge ratios), after 5 minutes at 1.64 scan/s. 
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The GC-MS software used to control the system was the Varian MS Workstation System 
Control – version 6.6. 
 
4.3.3.5. Data analysis 
A standard library with retention times and mass spectra of derivatized standards 
was created. Retention times, molecular ions, and major fragment ions identified for all 
analyzed compounds are detailed in supplementary material 3. The metabolite 
identification was based on the matching of retention times and mass spectra against the 
created library. The peak intensity of MCF derivatives of standards (amino and nonamino 
organic acids) was used to quantify the metabolites in samples. The data normalization 
was achieved by the normalization of the peak intensities by the intensity of the internal 
standard (d4 –alanine) in each sample.  
Data processing and statistical analysis were performed with Excel and Multi 
Experiment Viewer (MeV)24. 
In order to evaluate if there were significant differences between the mean values 
of each compound identified in MS spectra of the biological replicates (three), an analysis 
of variance (ANOVA) was performed. An ANOVA analysis was also applied to examine if the 
consumption of each compound along time was significant.  
To further examine the relation between the amino acids profile and to evaluate 
which amino acids had a similar profile along time, a hierarchical clustering (HCL) and K-
Means analysis were applied on the GC-MS data acquired until 72 hours of culture. Thus, 
percentage values of biological replicates were averaged and the MeV24 software was used 
to perform clustering analysis. Hierarchical clustering, based on Kendall’s Tau metrics, 
was used to have a global view of the possible clusters. Additionally, in order to categorize 
the amino acids into clusters, a K-Means clustering analysis was performed using the 
same metrics as described for HCL, with the following parameters: number of clusters – 
3; maximum iterations – 50.  
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4.3.3.6. Acetate and glucose analysis 
For glucose and acetate analysis, 1-mL samples at each time point were filtered 
by a 0.2-µm syringe filter, to remove bacterial cells, and were immediately frozen at -20 
°C until analysis. The analysis of acetate and glucose were performed using an acetic acid 
UV-method (Cat. No. 10 148 261 035, Boehringer Mannheim/R-Biopharm, Roche, 
Germany) and a D-glucose UV-method (Cat. No. 10 716 251 035, Boehringer 
Mannheim/R-Biopharm, Roche, Germany) kits, respectively. In order to stop enzymatic 
reactions, according to the kit’s instructions, prior to analysis samples were heated in a 
water-bath at 80ºC during 15 min, and then were centrifuged at 5000 rpm for 5 min. 
Afterwards, the experimental procedure was performed according to the manufacturer’s 
instructions.  
 
4.3.3.7. Metabolic model simulations 
In order to compare the experimental data with the simulated data supplied by the 
existing genome-scale metabolic model, simulations using Flux Balance Analysis (FBA) 
were performed. The model used to predict the behavior of H. pylori under the conditions 
used in vivo was the iIT341 GSM/GPR, published by Thiele et al. (2005)20. Optflux18, an 
open source software, was the platform used to perform the simulations using the 
Systems Biology Markup Language (SBML) file of the aforementioned model. In the 
simulated environmental conditions the uptake rates for the metabolites present in the 
culture medium were set to 10 mmol/h/g (dry weight). Additionally, the uptake rates for 
sodium, sulphate, iron, ammonia, phosphate and protons were not constrained. The 
mentioned uptake rates were set based on the information contained in the model for the 
minimal medium20.  
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4.4. Results  
To shed light on preferences and nutritional requirements of H. pylori, experiments 
(in triplicate) in Erlenmeyer flasks were performed. From each experiment, samples were 
harvested at regular intervals, during 72 hours of culture. Under the conditions used, H. 
pylori was in the exponential phase from 2 to 6 hours (µ=0.163 h-1) (consistent with results 
from a previous work by the authors22) (Figure 4.1).  
 
 
 
Figure 4.1. Evolution of organic acids (lactate, pyruvate, citrate, succinate) percentage along time in the 
extracellular medium and Optical Density measured at 600 nm. Mean values of biological replicates (n=3) 
with 3 technical replicates. 
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The extracellular medium was analyzed by GC/MS to evaluate the consumption 
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value represents the mean of three biological replicates (replicates of the culture), each 
with three technical replicates (replicates of each time point of the same culture).  
 
4.4.1.1. Organic acids 
Pyruvate, citrate, lactate and succinate were identified in the supernatant of H. 
pylori cultures. In Figure 4.1, the evolution of organic acids in the extracellular medium is 
depicted until 24 hours of culture. Samples were collected until 72 hours but their 
percentages presented no significant changes after 24 hours (p>0.05, one-way ANOVA). 
Citrate, lactate and succinate were detected in the culture medium used (Ham’s F-12+5 % 
FBS). Since they are not part of the composition of Ham’s F-12, they should have been 
present in the FBS. All compounds detected in the liquid medium with the respective 
percentage and variations are detailed in supplementary material 4. 
In general, at 4 hours of culture the concentration of all organic acids had 
decreased in the culture medium, with the exception of succinate, that had approximately 
tripled. Before 24 hours of culture, all organic acids had been consumed with a significant 
decrease in percentage in the extracellular medium (p<0.05, one-way ANOVA). Pyruvate, 
which was in culture medium with an initial concentration of about 1 mM, was almost 
completely exhausted, remaining only approximately 2% of the initial concentration at the 
end of the culture. Citrate, lactate and succinate, which were present in the culture 
medium with initial concentrations of about 0.08 mM, 1.21 mM and 0.02 mM, 
respectively, were not completely consumed.  
 
4.4.1.2. Amino acids 
Based on the hypothesis that metabolites that show similar time profiles are 
somehow related, the amino acids detected in the extracellular medium along time were 
classified into clusters by Hierarchical (HCL) and K-Means clustering (KMC), using a 
Kendall’s Tau metrics (Figure 4.2). Although the culture medium contains 20 amino acids, 
not all were detected, owing to problems of suitability of the derivatization method used 
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(arginine), instability of the derivatized compounds (histidine), or low concentrations 
(glutamine, glycine and serine). As such, a total of 15 amino acids were detected.  
From the HCL analysis (Figure 4.2a), three main clusters can be distinguished 
(clusters I-III), and it is possible to observe that clusters II and III are the closest ones. 
Furthermore, the examination of the clusters obtained with K-Means (Figure 4.4b), reveals 
that amino acids classified in the same cluster follow a similar profile along the culture. In 
these plots, each grey line represents one amino acid, while the centroid of each cluster 
profile is also shown (blue line).  
Cluster I includes amino acids that were completely (alanine, aspartate, 
glutamate, methionine and proline), or partially consumed (isoleucine, leucine, and valine), 
with percentages of consumption higher than 50%. Performing a statistical test allowed to 
verify that all amino acids in this cluster were significantly consumed (p<0.05, one-way 
ANOVA). 
Asparagine, tryptophan and cysteine were grouped in cluster II, with a decrease in 
percentage at 4 hours of culture, and a subsequent increase, remaining at a percentage 
higher than 50% in the supernatant at the end of the culture. The amino acids included in 
cluster II did not show further significant changes (p>0.05, one-way ANOVA). 
Cluster III groups amino acids which were not consumed (lysine, phenylalanine, 
threonine and tyrosine), being some of them accumulated in the extracellular medium 
(lysine and tyrosine) at the end of the culture with a percentage about twofold higher than 
initially. However, a decrease in percentage was observed for all amino acids of cluster III 
at 4 hours of culture. Though these amino acids were not consumed, a significant change 
(p<0.05, one-way ANOVA) in their percentage on the extracellular medium until 72 hours 
of culture was observed. Phenylalanine was the exception, with no significant changes 
(p=0.300, one-way ANOVA) in its percentage in the supernatant.  
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Figure 4.2. Analysis of the amino acids profiles obtained from the H. pylori culture. (a) Hierarchical 
clustering (HCL) representing in vertical the extracellular samples taken until 72 hours of growth (mean of 
replicates) and three amino acid clusters (horizontal clusters) that characterize the changes on the amino 
acid profiles in the extracellular medium, based on Kendall’s Tau metrics. (b) K-Means clustering (KMC) 
giving the results of amino acid clusters (same groups as for HCL) based on the KMC input parameters; 
each individual line represents the profile of one amino acid and the blue line in the middle represents the 
centroid (average of all compounds) of the amino acids profile grouped in each cluster. Amino acid 
abbreviations: ile - isoleucine; leu - leucine; met - methionine; glu - glutamate; ala - alanine; val - valine; asp - 
aspartate; pro - proline; asn - asparagine; trp - tryptophan; cys - cysteine; tyr - tyrosine; lys - lysine; thr - 
threonine; phe - phenylalanine. 
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4.4.1.3. Results reproducibility 
In order to evaluate the precision of the obtained results, the relative standard 
deviation expressed as a percentage (%RSD) was calculated for technical (n=3) and 
biological replicates (n=9) for each compound at each time point analyzed. This calculation 
was made after normalization of compound intensity by the internal standard intensity in 
each analysis. 
The %RSDs observed for the detected compounds for technical replicates were in 
general lower than 40%. The low concentration levels for the metabolites detected can 
contribute for the high level of variation between technical replicates. In general, the 
%RSDs observed for the metabolites detected between biological replicates were in the 
order of 50%, with some exceptions. Taking together the %RSDs obtained for technical and 
biological replicates, there seems to be evidence that the variations observed in the 
amount of the metabolites analyzed were due to the method used rather than biological 
variability. 
 
4.4.1.4. Glucose consumption and acetate formation 
Glucose and acetate along time in the culture medium were analyzed using UV-
kits. A significant consumption of glucose was observed during the experiments’ time 
series (p < 0.05; one-way ANOVA). However, glucose was not completely consumed, 
remaining at almost 50% in the end culture (Figure 4.3). Formation of acetate was 
observed with a pronounced increase in the concentration, mainly after 12 hours of culture 
(Figure 4.3).  
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Figure 4.3. Evolution of glucose and acetate concentrations (g/L). Mean values of biological replicates 
(n=3), error bars represent the standard deviation. 
 
4.4.1.5. Metabolic model simulations 
With the purpose of reconciliating the in silico with the in vitro H. pylori metabolic 
capabilities and to collect relevant metabolic information, simulations using the H. pylori 
genome-scale metabolic model (iIT341 GSM/GPR)20, were performed. Flux Balance 
Analysis, a linear programming method, based on the steady-state assumption and the 
application of constraints, was applied to maximize biomass production in a wild type 
strain. This approach allows the analysis of the metabolic network and prediction of an 
organism’s growth rate25, even in absence of detailed kinetic information. The conditions 
tested in silico (environmental conditions) were based on the in vitro conditions used. 
Thus, simulations with all 20 amino acids, organic acids and glucose present in the in vitro 
medium were performed. In order to evaluate the effect of compounds individually or in 
group, simulations were also performed by removing one or more compounds, as well as 
by removing the compounds that were not consumed in vitro. The predicted biomass for 
each environmental condition tested is given in Table 4.1 and is represented as a specific 
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growth rate (h-1) and as a percentage of the nominal value obtained with the minimum 
medium described20. It is clearly visible an increase of the predicted biomass when all the 
Ham’s F12 ingredients are added. Moreover, in the presence of glucose, a noteworthy 
increase in the predicted biomass was observed. Individually, threonine and pyruvate 
seem to have important effects. On the other hand, other carbon sources (citrate, lactate 
and succinate) added to the in silico medium resulted in a low (lactate) or even null effect 
(citrate and succinate) in the predicted biomass. The in silico secreted metabolites were 
also assessed, being acetate, ammonia, carbon dioxide and succinate predicted to be 
secreted in all simulations. However, the secretion rates for the metabolites predicted to 
be excreted are not the same for all conditions tested. For instance, an increase on the 
ammonia flux was observed when organic acids and glucose were added to the in silico 
medium. Besides that, for the minimal medium described20, formate and ornithine were 
also predicted to be excreted. The detailed flux distribution obtained for each simulation is 
given in supplementary material E1 (Electronic version). 
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Table 4.1. Results of the simulations performed with the iIT 341 GSM/GPR model, using Flux Balance Analysis in Optflux, showing the environmental conditions tested 
and the biomass predicted for each simulation. Abbreviations: cit – citrate; D-ala – D-alanine; glc – D-glucose; lac – lactate; L-ala – L-alanine; L-arg – L-arginine; L-cys – L-cysteine; L-
his – L-histidine; L-ile – L-isoleucine;  L-lys – L-lysine; L-met – L-methionine; L-phe – L-phenylalanine; L-thr – L-threonine; L-trp – L-tryptophan; L-tyr – L-tyrosine; L-val – L-valine; pyr - 
pyruvate; succ – succinate. 
in silico Components Predicted biomass 
Environmental conditions Amino acids Other carbon sources (h-1) % 
1* L-ala, D-ala, L-arg, L-his, L-ile, L-met, L-val - 0.693 100 
2 all 20 glc, pyr 1.568 226 
3 all 20 glc, pyr, cit, lac, succ 1.593 230 
4 all 20 glc, pyr,  lac, succ 1.593 230 
5 all 20 glc, pyr, cit, succ 1.568 226 
6 all 20 glc, pyr, cit, lac 1.593 230 
7 all 20 glc, cit, lac, succ 1.493 216 
8 all 20 pyr, cit, lac, succ 1.299 187 
9 all, except L-cys glc, pyr, cit, lac, succ 1.593 230 
10 all, except L-trp glc, pyr, cit, lac, succ 1.588 229 
11 all, except L-tyr glc, pyr, cit, lac, succ 1.586 229 
12 all, except L-phe glc, pyr, cit, lac, succ 1.586 229 
13 all, except L-thr glc, pyr, cit, lac, succ 1.286 186 
14 all, except L-lys glc, pyr, cit, lac, succ 1.581 228 
15 all, except L-cys, L-lys, L-thr, L-trp, L-tyr, L-phe glc, pyr, cit, lac, succ 1.261 182 
16 all, except L-cys, L-lys, L-thr, L-trp, L-tyr, L-phe pyr, cit, lac, succ 0.963 139 
* Simulation performed with the minimal medium described by Thiele et al. (2005)20. 
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4.5. Discussion 
4.5.1. Exometabolome analysis 
The characterization of microbial phenotypes is of major importance in 
understanding cell’s metabolism, and the analysis of the extracellular metabolome can 
help in that characterization, since the level and the variety of the secreted metabolites are 
associated with the metabolic state of the cell26. The metabolites detected in the 
extracellular medium can represent metabolites secreted/excreted by the cells or 
metabolites present in the culture medium that were not completely depleted. The 
detection and quantification of the compounds present in the extracellular medium can 
thus aid in the identification of nutritional requirements and contribute to rationally adjust 
the components of the culture medium.  
 
4.5.1.1. Organic acids analysis 
Some organic acids (citrate, lactate and succinate) that were detected in blank 
samples (without cells), had not been described as part of the composition of the defined 
culture medium used (Ham’s F-12). Pyruvate was also detected, but it is present in Ham’s 
F-12 medium. Since the culture medium was supplemented with Fetal Bovine Serum 
(FBS), the aforementioned acids might have been present in FBS. FBS is considered an 
undefined component and is almost uncharacterized, although some components have 
been identified, such as protein components, hormones, growth factors and cytokines, 
fatty acids and lipids, vitamins and trace elements, carbohydrates and non-protein 
nitrogens27,28. The presence of some organic acids, such as malate, fumarate and succinate 
in fetal bovine serum was also reported29. 
The evolution of pyruvate, citrate, lactate and succinate (Figure 4.1) shows that all 
organic acids were totally or partly consumed. After the end of the exponential phase (8h), 
pyruvate and lactate had been almost fully depleted, whilst the consumption of citrate and 
succinate was slower and only partial. A 3-fold increase in the succinate concentration at 
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4h of culture was observed (Figure 4.1) and it can be interpreted as this compound might 
be a metabolic by-product of amino acids and pyruvate catabolism30,31. The consumption of 
pyruvate, D-lactate and succinate by H. pylori, had also been reported; nevertheless, these 
compounds were reported as not being the preferred carbon sources30, which could not be 
confirmed in the present study, at least for lactate and pyruvate. However, another 
experiment was performed with an increased concentration of organic acids in the culture 
medium, but that did not lead to a pronounced increase in growth (data not shown).  
Regarding the consumption of pyruvate, published studies have reported that 
acetate is the main product when pyruvate is metabolized by H. pylori under aerobic 
conditions, whereas acetate, lactate and ethanol were detected when H. pylori cells where 
submitted to anaerobic conditions with labeled pyruvate7,31. Under microaerophilic 
conditions, Mendz et al. (1994) observed the formation of lactate, acetate, formate, 
succinate and alanine from pyruvate32 Ethanol and formate were not detected in the 
present study (ethanol analyzed by liquid chromatography, data not shown).  
 
4.5.1.2. Glucose consumption and acetate formation 
In the present study, glucose was partially consumed, as previously reported by 
other authors6 (Figure 4.3). Some studies stated that glucose can be utilized by H. pylori, 
since the penthose phosphate and the Entner-Doudoroff pathways have been identified33,34. 
In addition, a glucose transporter was identified in H. pylori35,36 and further confirmed by the 
genomic sequence37. In the present study, glucose consumption occurs until 48 hours of 
growth, but with a more pronounced consumption after 12 hours of culture, matching with 
the depletion of some amino acids, such as alanine, proline, aspartate and glutamate. This 
result suggests that glucose is not the preferred carbon and energy source and is in 
agreement with the conclusions taken by other authors, that also reported that in the 
presence of amino acids, glucose was not consumed until the amino acids were 
exhausted6,31 and therefore could be removed from the culture medium9. It is also worth 
mentioning that most of the glucose consumed (50%) did not contribute significantly for 
growth, as cells stopped growing at around 8 hours of cultivation, when glucose 
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consumption had only just started. The presence of acetate in the extracellular medium 
was observed, specially between 12 and 48 hours of growth, in agreement with the 
decrease of glucose in the culture medium, indicating that glucose might be contributing 
to acetate production, as described by other authors7, although the amounts of acetate 
accumulated are quite low compared with the levels of glucose consumed.  
 
4.5.1.3. Amino acids analysis 
Amino acids have been described as potential sources of carbon, nitrogen and 
energy in H. pylori31. There are several studies describing the in vitro amino acid 
requirements for H. pylori. Some of published studies are based on essentiality analysis by 
the evaluation of growth when a given amino acid is present or not in the culture medium1–
3. Other studies are based on consumption4,9,38, measuring the concentration of a given 
amino acid by analytical methods. In addition, the in silico amino acids requirements were 
also described19,20. It is important to highlight that environmental cultivation conditions, 
culture media and the strains used in published studies are not standardized, and the 
essentiality of a compound could be related to the mentioned factors, hampering results 
comparison, and making difficult to conclude about the amino acid requirements for H. 
pylori growth. There is an extra difficulty in the evaluation and comparison of the results 
obtained in different studies, since the analytical procedures are not uniform and 
sometimes the results presented are not sufficiently clear to conclude about a specific 
compound consumption and/or essentiality. Table 4.2 summarizes the results obtained in 
the aforementioned studies, together with the results obtained in the present study. In 
order to facilitate the comparison and interpretation, an attempt of standardization was 
made. The term “essential” was used to refer amino acids that are required for H. pylori 
growth, with no growth in the absence of that specific compound. Additionally, the term 
“preferential” is applied when a given amino acid is not absolutely required for growth but, 
when present, it is preferable and firstly consumed. In studies where it was not possible to 
conclude about the essentiality or preferences, the amino acids were classified as 
“consumed”, “not consumed” or “accumulated”. The term “no consensus” was applied 
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when the published studies are contradictory, and it is not possible to conclude about 
essentiality or consumption. 
 
Table 4.2. Comparison of amino acids essentiality (in vitro and in silico), or consumption reported in the 
published studies for H. pylori and results of the present study.  
Amino acids 
in vitro 
essentiality
a
 
in silico 
essentiality
b
 
in vitro 
consumption
c
 
This study 
Glycine Not essential1 Not essential No consensus Not detected 
L - Alanine Essential1 Essential Consumed 
Consumed, not 
essential 
L - Asparagine Not essential Not essential Consumed Consumed 
L - Aspartate Not essential1 Not essential Consumed Consumed 
L - Arginine Essential Essential Consumed Not analyzed 
L - Cysteine No consensus Not essential Consumed 
Not consumed, not 
essential 
L - Glutamate Not essential1 Not essential Consumed Consumed 
L - Glutamine Not essential Not essential Consumed Not detected 
L - Histidine Essential Essential Consumed Not analyzed 
L - Isoleucine No consensus Essential Consumed Consumed, essential 
L - Leucine Essential Essential Consumed Consumed 
L - Lysine Not essential1 Not essential No consensus 
Accumulated, not 
essential 
L - Methionine Essential Essential Consumed Consumed 
L - Phenylalanine Essential Not essential Consumed2 Not consumed,essential 
L – Proline Essential1 Not essential Consumed Consumed 
L – Serine Not essential1 Not essential Consumed Not detected 
L – Threonine Not essential1 Not essential No consensus 
Not consumed, Not 
essential 
L – Tryptophan Not essential1 Not essential No information 
Not consumed, not 
essential 
L – Tyrosine Not essential1 Not essential No consensus 
Accumulated, not 
essential 
L – Valine Essential Essential Consumed Consumed 
a
The essentiality was based on the growth results when amino acids were present or absent
1–3
. 
b 
Based on 
the existing genome-scale metabolic models
19,20. cBased on measurement of amino acids consumption in in 
vitro studies
4,9,38
. 
1
For most of the strains analyzed; 
2
Very low percentage of consumption. 
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i. Essential Amino acids  
There is a general consensus about some amino acids requirements: L-arginine, 
L- histidine, L-leucine, L-methionine and L-valine, results corroborated with the present 
study. In fact, for those reported amino acids there are no biosynthetic capabilities 
described in H. pylori 31,39.  
 
ii. Non-essential Amino acids 
Preferential 
Asparagine, aspartate, glutamine and glutamate were consumed in the present 
study, results in accordance with other studies4,9,38. There is a general consensus about the 
non-essentiality of these amino acids, with no auxotrophies having been identified, and 
with biosynthetic capabilities being predicted from the genomic sequence39. In fact, 
aspartate and glutamate were completed consumed in this study, being aspartate the first 
amino acid to be completely depleted from the extracellular medium. Asparagine was not 
completely consumed, 60% of the initial amount remaining at the end of the culture. The 
deamination of asparagine and glutamine was reported38, yielding ammonia and aspartate 
or glutamate, respectively. The incorporation of asparagine and glutamine was proved to 
be via indirect pathways, with the deamination reactions taking place in the periplasm40. 
These amino acids can serve as carbon sources and it has also been speculated that the 
role of this type of incorporation is not only for nutrient acquisition but could also be 
associated with H. pylori’s pathogenesis40,41. The production of ammonia and fumarate in 
the presence of aspartate, due to the aspartase activity was also described9, although 
fumarate was not detected in the extracellular medium in this study. 
Based on the hypothesis that amino acids which were completely consumed (L-
alanine, L- aspartate, L-glutamate, L-methionine and L-proline) could be growth limiting, 
these amino acids were added to the medium (Ham’s F-12) at a concentration tenfold 
higher, but such change did not increase H. pylori’s growth (data not shown). Interestingly, 
the same result was not obtained when all amino acids were increased tenfold, resulting in 
a threefold increment in growth. This result is contradictory with the one reported by 
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Testerman et al. (2006), that verified that a twofold increase in the amino acids 
concentration in Ham’s F-12 had no effect in H. pylori’s growth3.  
 
Non-preferential 
There is a general consensus between in vitro and in silico studies (Table 4.2) 
regarding dispensability of L-lysine, L-serine, L- threonine, L-tryptophan and L- tyrosine in 
the culture medium. This study corroborates that information, with the exception of L-
serine, which was not detected. These results are in accordance with the predicted 
biosynthetic abilities based on the genome sequence information39 and on the genome 
annotation42. However, some studies reported requirements or the consumption of lysine, 
threonine, tyrosine and tryptophan for some H. pylori strains1,2,4,9. Lysine and tyrosine, in 
the present study, were accumulated in the extracellular medium at the end of the culture, 
suggesting that these amino acids are not being used as carbon sources.  
 
iii. Non-consensus Amino acids  
Regarding the essentiality of proline, the in vitro and in silico information are 
contradictory, as this amino acid was deemed as essential in most in vitro studies whilst it 
was classified as not essential in in silico studies. However, according to published studies, 
this compound is not needed for the growth of some strains 1,2. In the present study proline 
was completely depleted from the culture medium after 12 hours of culture, indicating that 
it is either essential or can be a preferential substrate for H. pylori’s growth. Looking at the 
metabolic pathways in which proline could be biosynthesized, there are two possibilities, 
the first one from glutamate (via L-glutamate 5-semialdehyde synthesis), and the second 
one from arginine (via urea cycle, with production of ornithine and subsequent production 
of L-glutamate 5-semialdehyde). While for the first alternative all the genes have been 
identified in H. pylori (HP0056 and HP1158), for the second case the gene associated 
with the conversion of L-ornithine to L-glutamate 5-semialdehyde, so far, was not proved as 
present in H. pylori, which indicates that proline synthesis might be achieved from 
glutamate.  
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Isoleucine is another amino acid for which there is no consensus about its 
requirement for H. pylori growth. Some studies referred the essentiality of isoleucine, but 
other studies reported that isoleucine is not essential, although the addition of this 
compound together with tryptophan enhances growth, without any effect when added 
alone3. In the present study, isoleucine was partially consumed. In order to evaluate its 
essentiality, isoleucine was removed from the culture medium and no growth was 
observed in the absence of this amino acid. Like leucine and valine, for which there are 
missing enzymes in the biosynthetic pathways, H. pylori is not able to synthesize 
isoleucine as well, owing to similar constraints31,39.  
Regarding the essentiality of cysteine, different studies lead to different 
conclusions. Some authors conclude that cysteine is required to grow H. pylori in specific 
conditions (serum absence)3 or that it is needed for some strains1, whilst other authors 
conclude that cysteine is not required at all2. Regarding in silico models19,20, both studies 
concluded that cysteine is not essential for H. pylori’s growth if another source of sulfur is 
present. The sulfur source utilized by H. pylori can be methionine20 or sulfide, as it is 
unable to use sulphate as a source of inorganic sulfur39. In the present study cysteine was 
not consumed, and since methionine was present in the culture medium, this might have 
enabled the network to synthesize other sulfur-containing compounds. 
Based on the obtained results, the amino acids that were not consumed (L-
cysteine, L-lysine, L- phenylalanine, L- treonine, L-tryptophan and L-tyrosine) were removed 
from the culture medium, one by one. However, H. pylori was not able to grow in media 
without L-phenylalanine, indicating that this amino acid is essential. Indeed, in the present 
study, phenylalanine is consumed in a very small amount, and consumption is masked by 
the method’s precision (20% RSD in the case of phenylalanine). Other studies also 
reported the non-exhaustion of phenylalanine from de extracellular medium9,38. Analyzing 
the minimal in silico medium20, phenylalanine was not deemed as essential. In silico, the 
biosynthesis of phenylalanine is made via the shikimate pathway with D-erythrose 4-
phosphate as precursor, with sequential formation of prephenate from chorismate (genes 
identified in H. pylori). However, the enzymatic conversion of prephenate in phenylpyruvate 
(precursor of phenylalanine) is not proven, since the domain of prephenate dehydratase in 
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the PheA protein in H. pylori is missing20,42. Nevertheless, it is reported that prephenate can 
be converted spontaneously into phenylpyruvate42. The need of phenylalanine in some 
studies, according to some authors, can thus be due to experimental growth conditions, 
although these conditions have not been reported20,42.  
Although having been considered essential at least for some strains, L-alanine has 
been totally consumed, which is in accordance with data in the online43. An experiment 
was thus performed where alanine has been removed from the medium and growth was 
still verified. Thus, alanine essentiality was questioned and it has been removed from the 
set of essential amino acids in H. pylori in this work. 
For some amino acids, which were not detected or not analyzed, it was not 
possible to conclude about their roles. These compounds include arginine, glutamine, 
glycine, histidine and serine. Nevertheless, arginine and histidine auxotrophies have been 
reported and are in agreement with the genomic sequence31,39. The dispensability of 
glycine, serine and glutamine was also proved, being glutamine and serine possible carbon 
sources for H. pylori’s growth. 
In Figure 4.4, the main H. pylori’s metabolic pathways are outlined, giving an 
overview of the central metabolism together with profiles of the metabolites analyzed in the 
present work.  
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Metabolite Abbreviations 
3pg 3-phosphoglycerate etoh ethanol met methionine 
ac acetate f16bp fructose-1,6-biphosphate oaa oxaloacetate 
accoa acetyl-coa f6p fructose-6-phosphate orn ornithine 
akg alpha-ketoglutarate for formate pep phosphoenolpyruvate 
ala alanine fum fumarate phe phenylalanine 
arg arginine g3p glyceraldehyde-3-phosphate pro proline 
asn asparagine g6p glyceraldehyde-6-phosphate pyr pyruvate 
asp aspartate gln glutamine ser serine 
chor chorismate glu glutamate succ succinate 
cys cysteine gly glycine succ-coa succinyl-coa 
cit citrate icit isocitrate thr threonine 
cis-acon cis-aconitate ile isoleucine trp tryptophan 
dhap 
dihydroxyacetone 
phosphate 
lac lactate tyr tyrosine 
e4p erythrose-4-phosphate leu leucine val valine 
Figure 4.4. Schematic diagram of H. pylori’s metabolic map, and metabolites evolution analyzed in the extracellular medium during the culture. The metabolites highlighted in grey 
boxes were the ones analyzed in the present study, for which the profile is also displayed (connected with dashed lines). White boxes represent metabolites that were not detected in 
this study but which are known to be part of H. pylori’s metabolism. The profile of the metabolites that were analyzed for which no complete pathways are identified in H. pylori, 
such as methionine, isoleucine, leucine and valine, are shown in a separate box, disconnected from the map. 
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4.5.2. Metabolic model simulations 
The simulations performed using the most updated genome scale metabolic 
model20 were based on the environmental conditions used in vitro. The output of each 
simulation performed was the predicted biomass (h-1) and the secreted metabolites (Table 
4.1 and suplementary material E1 (electronic version)).Concerning the performed 
simulations, a twofold increment in the predicted biomass was observed when the Ham’s 
F-12 medium used was simulated, comparing with the conditions provided by the model 
(in silico minimal medium) (Table 4.1 simulation 2). Even though the addition of some 
organic acids (citrate, lactate and succinate) (simulations 3-6) to the in silico simulations 
did not lead to an increase in the predicted biomass, the effect of organic acids was 
observed in the in silico excreted metabolites, increasing the excretion of acetate. When 
pyruvate was removed from the in silico environmental conditions, a slight decrease in 
biomass was observed (simulation 7), showing that pyruvate has an effect on in silico H. 
pylori’s growth and is being used as a carbon and energy source, as opposed to the other 
organic acids tested. The existence of a mixed-acid fermentation pathway in H. pylori was 
proved in vitro, with accumulation of acetate and formate as metabolic products from 
pyruvate32. The succinate formation from pyruvate was also reported in vitro, suggesting 
the incorporation of the carbon derived from pyruvate into the Krebs cycle32. An increase in 
acetate and succinate production was also predicted when pyruvate is present on in silico 
medium (simulation 7 compared with simulation 3). 
Additionally, when glucose was removed from the in silico environmental 
conditions (simulation 8) a decrease in the biomass was observed. In fact, as previously 
discussed, glucose is not preferred or required for H. pylori’s growth, but in the metabolic 
model glucose is being used when present in culture medium. An increase of in silico 
acetate excretion was also observed in the presence of glucose. Additionally, lactate and 
glucose are contributing to the in silico succinate formation.  
When the amino acids that were not in vitro consumed (cysteine, tryptophan, 
tyrosine, phenylalanine, threonine and lysine) were individually removed from 
environmental conditions (simulations 8-14), no difference in the predicted biomass was 
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observed, with the exception of threonine. When the aforementioned amino acids were 
removed from the in vitro medium, no effect on the growth was observed as well, with the 
exception of phenylalanine, which showed to be essential for H. pylori under the in vitro 
used conditions, as already discussed. Furthermore, when those amino acids were 
removed together from the environmental conditions (simulation 15), a remarkable 
decrease on the predicted biomass was observed, becoming more pronounced when 
glucose is also removed (simulation 16) from the in silico medium. 
As outlined by other authors, amino acids are important sources of carbon and 
nitrogen for H. pylori. The main metabolic products reported from amino acids 
consumption are acetate, formate, succinate and lactate31, although in the performed in 
silico simulations lactate was not secreted into the culture medium, and formate was only 
secreted with the minimal medium suggested by Thiele et al. (2006)20. In present study, 
formate was not detected in the extracellular medium, while lactate, although being 
detected, it is not possible to conclude if was or not secreted, since it was present in the 
culture medium. Acetate and succinate were detected, with a 3-fold increase of succinate 
in the extracellular medium observed at 4 hours of culture, which can be related to amino 
acids and pyruvate consumption and the incorporation of carbon into the Krebs cycle.  
Taking together the in vitro and in silico results it can be inferred that amino acids 
are being used as the preferred carbon sources, while organic acids are being consumed 
but are not preferential.  
In addition, when the in silico prediction for biomass maximization using Ham’s F-
12 medium (simulation 2) is compared with in vitro obtained results, the predicted 
biomass (µ=1.593 h-1) is far from the biomass achieved in vitro (µ=0.163 h-1). Thereby, an 
adjustment of the existing genomic scale metabolic model is needed to minimize the 
differences between the in silico predictions and in vitro results. 
 
 
Exometabolome analysis in H. pylori for the elucidation of nutritional requirements and preferences 
151 
4.6. Conclusions 
In the present study, the suggestion made by other authors concerning the non-
preference of glucose as a carbon source by H. pylori was corroborated. According to the 
obtained results and previous studies, some aminoacids are absolutely required, namely, 
L-arginine, L- histidine, L-isoleucine, L-leucine, L-methionine L-phenylalanine and L-valine. 
Some aminoacids for which there was no consensus between in vitro or in silico data, 
such as phenylalanine and isoleucine, were proved to be essential for H. pylori 26695 
growing under the conditions used. Regarding preferences and possible carbon sources, 
aspartate, glutamate, proline and alanine are potentially preferred by H. pylori, since they 
were completely consumed in the mentioned order. Organic acids were not the preferred 
carbon sources, and, among the identified compounds, pyruvate seems to be the 
preferred one.  
The present work provides a review on the existing experimental data about amino 
acids requirements and makes a comparison with in silico data, revealing discrepancies 
between in vitro and in silico predicted metabolic capabilities. At the same time, as far as 
we know, this is the first metabolomics approach applied to H. pylori growing in vitro under 
optimized environmental culture conditions and with metabolite analysis along time, 
revealing the metabolic behavior along the different growth phases. It is also important to 
highlight that the present in vitro results were obtained without strain adaptation to the 
culture medium, with fetal bovine serum. Moreover, some of the identified discrepancies 
among in vitro results could be related with the strains used, culture conditions or even the 
experimental procedures used. The data presented here will be very useful to adjust and 
rationalize the culture medium in order to obtain a more defined medium, that could be 
used to validate a genome-scale metabolic model reconstruction. 
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4.8. Supplementary material  
4.8.1. Supplementary material 1 
 
Table 4.3. Composition of the Ham’s F-12 medium  
Compounds 
Molecular weight 
(g/mol) 
Concentration 
(mM) 
Amino acids 
Glycine 75.07 0.10 
L-alanine 89.09 0.10 
L-arginine hydrochloride 211.00 1.0 
L-asparagine 132.12 0.098 
L-aspartate 133.10 0.10 
L-cysteine hydrochloride 157.62 0.23 
L-glutamate 147.13 0.10 
L-glutamine 146.15 1.0 
L-histidine hydrochloride 209.63 0.10 
L-isoleucine 131.18 0.030 
L-leucine 131.18 0.10 
L-lysine hydrochloride 182.65 0.20 
L-methionine 149.21 0.030 
L-phenylalanine 165.19 0.030 
L-proline 115.13 0.30 
L-serine 105.09 0.10 
L-threonine 119.12 0.10 
L-tryptophan 204.23 0.010 
L-tyrosine 181.19 0.030 
L-valine 117.15 0.10 
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Table 4.3.  Composition of the Ham’s F-12 medium. (Continue) 
Compounds 
Molecular weight 
(g/mol) 
Concentration 
(mM) 
Vitamins 
Biotin 244.31 0.000030 
Choline chloride 139.62 0.10 
D- Calcium panthotenate 476.54 0.0010 
Niacinamide 122.13 0.00030 
Pyridoxine hydrochloride 205.64 0.00030 
Riboflavin 376.37 0.000098 
Thiamine hydrochloride 337.27 0.00089 
Vitamin B12 1355.00 0.0010 
i-inositol 180.16 0.10 
Folic acid 441.41 0.0030 
Inorganic Salts 
Calcium chloride (CaCl2.2H2O) 147.02 0.30 
Cupric sulphate (CuSO4.5H2O) 249.69 0.000010 
Iron sulphate (FeSO4.7H2O) 278.02 0.0030 
Zinc sulphate (ZnSO4.7H2O) 287.54 0.0030 
Potassium chloride (KCl) 74.56 2.98 
Magnesium chloride (MgCl2.6H2O) 203.30 0.601 
Sodium bicarbonate (NaHCO3) 84.01 14 
Sodium chloride (NaCl) 58.44 131 
Sodium phosphate dibasic (Na2HPO4) 177.99 1.0 
Other components 
Thymidine 194.00 0.0030 
Putrescine 88.15 0.0010 
Linoleic acid 280.00 0.00030 
Lipoic acid 206.33 0.0010 
Phenol red 354.38 0.0030 
Hypoxanthine 136.11 0.029 
Sodium pyruvate 110.04 1.0 
D-glucose 180.00 10 
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4.8.2. Supplementary material 2 
 
Table 4.4 lists the compounds used as standards for GC-MS analysis. 
 
Table 4.4. Compounds used to prepare the standards for GC-MS analysis. 
Compound Chemical Formula M.W. (g/mol) Purity (%) Company 
     
Organic Acids 
    
α-Ketoglutaric acid C5H6O5 146.10 >99.0 Fluka 
Adipic acid C6H10O4 146.14 >99.5 Fluka 
Citraconic acid C5H6O4 130.10 >99.0 ACROS Organics 
Citric acid C6H8O7 192.12 >99.5 Sigma-Aldrich 
Fumaric acid C4H4O4 116.07 >99.0 ACROS Organics 
Glyoxylic acid monohydrate C2H6O3.H2O 92.05 >98.0 Aldrich 
Itaconic acid C5H6O4 130.10 >99.0 ACROS Organics 
D-Lactate sodium C3H5NaO3 112.06 >99.0 Aldrich 
Oxaloacetic acid C4H4O5 132.07 >98.0 Sigma 
2-oxodipic acid C6H8O5 160.12 >97.0 Sigma 
Pyruvic acid C3H4O3 88.06 98.0 ACROS Organics 
Succinic acid C4H6O4 118.09 >99.0 Sigma-Aldrich 
DL-Isocitric acid trisodium salt C6H5Na3O7 258.07 17.9% H2O; 98.0% Sigma 
DL-Malic acid C4H6O5 134.09 >98.0 Aldrich 
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Table 4.4. Compounds used to prepare the standards for GC-MS analysis. (Continue) 
Compound Chemical Formula M.W. (g/mol) Purity (%) Company 
     
Amino Acids 
    
Glycine C
2
H
5
NO
2
 75.07 >99.0% Biochemika. Fluka 
L-Aspartic acid C
4
H
7
NO
4
 133.10 >99.0% Sigma-Ultra. Sigma 
L-Glutamic acid C
5
H
9
NO
4
 147.13 >99.0% Sigma 
L-Alanine C
3
H
7
NO
2
 89.09 >99.5% BioUltra. Fluka 
L-Arginine C
6
H
14
N
4
O
2
 174.20 >99.5% Biochemika. Fluka 
L-Asparagine anhydrous C
4
H
8
N
2
O
3
 132.12 >99.5% BioUltra. Sigma 
L-Cysteine hydrochloride anhydrous C
3
H
7
NO
2
.S.HCl 157.62 >99.0% Fluka Analytical 
L-Phenylalanine C
9
H
14
NO
2
 165.19 >99.0% Biochemika. Fluka 
L-Glutamine C
5
H
10
N
2
O
3
 146.15 >99.0% Sigma 
L-Histidine C
6
H
9
N
3
O
2
 155.16 >99.5% Biochemika. Fluka 
L-Isoleucine C
6
H
13
NO
2
 131.18 >99.5% Biochemika. Fluka 
L-Leucine C
6
H
13
NO
2
 131.18 >99.0% Aldrich 
L-Lysine Monohydrochloride C
6
H
14
N
2
O
2
 182.65 No information Sigma 
L-Methinonine C
5
H
11
NO
2
S 149.21 >99.5% BioUltra. Sigma 
L-Proline C
5
H
9
NO
2
 115.15 >99.0% Aldrich 
L-Serine C
3
H
7
NO
3
 105.09 >99.5% Biochemika. Fluka 
L-Tyrosine C
9
H
11
NO
3
 181.19 >99.0% Sigma-Ultra. Sigma 
L-Threonine C
4
H
9
NO
3
 119.12 >99.5% Biochemika. Fluka 
L-Tryptophan C
11
H
12
N
2
O
2
 204.23 >98.0% Sigma-Aldrich 
L-Valine C
5
H
11
NO
2
S 117.15 >99.5% Biochemika. Fluka 
L-Alanine- 2,3,3,3-D4 C
3
H
3
D
4
NO
2
 93.13 98 atom % D ISOTEC 
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Table 4.5 depicts the mass to charge ratio (m/z) of the molecular ions and major 
fragments detected for each compound derivatized with methylchloroformate and analyzed 
by GC/MS. 
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Table 4.5. Mass to charge ratios for the molecular ions and major fragments and retention times for each 
compound in the in-house library. 
Compound 
RT Molecular ion Major fragments ions 
(min.)  (m/z)  (m/z) 
Organic Acids 
   
2-oxoadipic acid 14.664 188 101,129,59 
α-Ketoglutaric acid/2-oxoglutaric acid 13.213 174 115,55,87 
Adipic acid 12.557 175 175,114,143 
Citraconic acid 10.416 158 127,99 
Citric acid 16.495 235 235,143,236 
D-Lactate sodium 9.361 104 59,163,177 
DL-Isocitric acid trisodium salt 21.361 234 129,157 
DL-Malic acid 9.330 162 113,115,85 
Fumaric acid 9.354 144 113,85 
Glyoxylic acid monohydrate 11.328 106 75,106,62 
Itaconic acid 10.329 159 127,126,69,99,159 
Oxaloacetic acid 10.848 160 101,69 
Pyruvic acid 7.507 102 89,117,57 
Succinic acid 9.228 166 115,87,147 
Amino Acids 
   
Glycine 11.628 148 148,44,88 
L-Alanine 11.275 162 162,102,58 
L-arginine Not derivatized 
L-Asparagine 16.735 262 187,56,127 
L-Aspartic acid 16.521 220 220,128, 160 
L-Cysteine 21.145 192 117,192,176 
L-Glutamic acid 18.431 234 234,114,174 
L-Glutamine 25.200 276 84,219,114 
L-Histidine 26.888 285 210,140,85 
L-Isoleucine 14.349 204 204,144,205 
L-Leucine 14.245 204 204,144,205,58 
L-Lysine 26.817 277 142,277 
L-Methionine 18.655 222 222,190,162 
L-Phenylalanine 20.670 238 238,162,161 
L-Proline 15.211 188 128,188,84 
L-Serine 15.900 178 178,115,74,118 
L-Threonine 15.814 192 192,115,174 
L-Tryptophan 34.812 277 130,131 
L-Tyrosine 29.410 253 121,236,161,192 
L-Valine 13.045 190 190,130,191 
L-Alanine – 2, 3, 3, 3 – D4 (Internal standard) 11.181 174 106,166,62 
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4.8.4. Supplementary material 4 
Table 4.6 shows the compounds detected in the extracellular culture medium and 
the respective percentage relative to the initial amounts. Mean of three biological 
replicates, with three technical replicates (± Standard deviation). 
 
Table 4.6. Percentage of compounds detected in the extracellular culture medium along time, 
with 0 hours representing the 100%. 
 
Compounds 
% Mean (± SD) 
4h 8h 12h 24h 48h 72h 
ala 73 (± 35) 12 (± 5) 3 (± 1) 0 0 0 
asn 61 (± 34) 75 (± 16) 81 (± 12) 70 (± 16) 61 (± 12) 60 (± 25) 
asp 7 (± 3) 0 0 0 0 0 
cys 93 (± 56) 186 (± 115) 203 (± 138) 151 (± 76) 127 (± 78) 109 (± 77) 
glu 65 (± 18) 4 (± 1) 0 0 0 0 
ile 38 (± 7) 11 (± 5) 5 (± 2) 6 (± 3) 19 (± 7) 25 (± 5) 
leu 49 (± 18) 14 (± 8) 6 (± 2) 8 (± 3) 24 (± 6) 26 (± 5) 
lys 84 (± 1) 202 (± 1) 261 (± 2) 208 (± 1) 209 (± 1) 219 (± 1) 
met 35 (± 21) 0 0 0 0 0 
phe 66 (± 24) 99 (± 16) 118 (± 24) 109 (± 17) 100 (± 29) 107 (± 24) 
pro 104 (± 33) 90 (± 20) 3 (± 2) 0 0 0 
thr 87 (± 44) 121 (± 27) 146 (± 22) 133 (± 23) 128 (± 22) 130 (± 21) 
trp 65 (± 27) 113 (± 45) 140 (± 45) 95 (± 37) 80 (± 33) 95 (± 22) 
tyr 78 (± 25) 169 (± 40) 40 (± 56) 236 (± 48) 224 (± 62) 263 (± 66) 
val 63 (± 24) 50 (± 14) 31 (± 5) 30 (± 4) 43 (± 10) 44 (± 15) 
cit 37 (± 17) 31 (± 16) 30 (± 14) 24 (± 11) 32 (± 15) 33 (± 13) 
lac 9 (± 24) 2 (± 24) 11 (± 24) 9 (± 24) 6 (± 24) 8 (± 24) 
pyr 95 (± 82) 115 (± 6) 10 (± 5) 8 (± 4) 3 (± 2) 2 (± 1) 
succ 306 (± 160) 29 (± 11) 26 (± 14) 15 (± 3) 16 (± 8) 18 (± 8) 
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4.9. Supplementary material (Electronic version) 
Supplementary material E1  - Simulation_iIT341.xlsx 
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5.1. Abstract 
Helicobacter pylori is considered to be a fastidious pathogenic organism that 
colonizes the human stomach. Like other pathogenic organisms, H. pylori developed 
mechanisms and evolved to survive and inhabit in its host, specifically in the human 
gastric mucosa. 
The gastric environment is a rich medium for H. pylori, with a large variety of 
carbon sources available, including amino acids. However, no previous experiments were 
conducted to identify the preferred carbon sources for H. pylori growth that could then be 
used for designing a minimal medium. 
In the present study, H. pylori 26695 was grown using several amino and organic 
acids as the main substrates in order to determine which are the preferential carbon 
sources. A metabolic footprinting approach was also applied to conclude about substrate 
consumption and identify secreted metabolites. Under the conditions used, L-glutamine 
was identified as the preferred carbon source for H. pylori 26695 growth, evaluated by the 
highest biomass concentration achieved using this substrate and the highest growth rate 
obtained. However, L-glutamate allowed to achieve also high growth rates and biomass 
concentrations and presented a greater efficiency in terms of the biomass produced per 
substrate consumed. In addition, it is now clear that L-glutamine is a substrate for the 
production of L- glutamate in H. pylori in the periplasm, being L-glutamate then 
transported and catabolized. Therefore, we suggest L-glutamate as the most suitable 
carbon source for H. pylori in vitro growth.  
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5.2. Introduction 
Animal tissues contain a variety of nutrients (sugars, amino acids and other 
nitrogen-containing compounds), being outstanding sources of nutrients for bacteria1. 
Additionally, in the human body, the nutrients needed for bacterial growth are replenished 
over time2.  
The compounds found in the host environment are used by pathogenic bacteria to 
extract the energy, carbon and nitrogen needed to grow and replicate1. Thus, pathogens 
have evolved specific mechanisms to access host nutrients and use them by various 
specific pathways and uptake systems1,3.  
Unfortunately, in host-pathogen interactions, the in vivo metabolism of bacterial 
pathogens is not well understood3. In fact, the preferred in vivo carbon sources of a variety 
of pathogens persist unidentified and the growth conditions in numerous sites of infections 
are poorly defined, hampering the nutritional modeling of infections2. 
H. pylori is a pathogenic organism that dwell in the mucous layer of the human 
stomach, causing gastric diseases4. H. pylori is known to be adhered to gastric epithelial 
cells, next to tight junctions5,6. That particular location gives some advantages to H. pylori, 
namely, wash-out prevention from the stomach, favorable pH near the gastric epithelium, 
and access to nutrients released by gastric epithelial cells6. The gastric environment is a 
rich medium, providing the nutritional requirements for H. pylori growth, with several 
possible carbon and nitrogen sources. It is known that H. pylori utilizes amino acids and 
uses them as preferred carbon sources7,8. Also, a chemotactic motility in response to 
amino acids was reported, with some acting as attractants9,10; however, if this mechanism 
contributes to virulence and transmission, beside nutritional acquisition, is still an open 
question11.  
Gastric juice, which results from the secretion of many gastric glands into the 
stomach12, contains amino acids at relative high concentrations. Segawa and coworkers 
(1985) were able to identify 15 amino acids in human gastric juice of healthy subjects and 
in patients with gastric diseases (gastric ulcer, duodenal ulcer, gastroduodenal ulcers and 
gastric cancer)13. D and L-amino acids were also detected in gastric juices of subjects 
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infected with H. pylori, as well as in the gastric juice of uninfected subjects. Among the 
detected amino acids, proline, alanine, serine, aspartate and glutamate were detected at 
higher concentrations4,12. In addition, increased levels of aromatic amino acids 
(phenylalanine, tryptophan and tyrosine) were detected in the gastric juice of patients with 
malign gastric lesions when compared to benign gastric lesions14,15. The concentration of 
amino acids in the gastric mucous layer is unclear but it is likely that it is approximately 
the same as in the gastric juice16. The amino acids present in the gastric juice are derived 
in part from the blood plasma amino acid pool and by secretion from the cells of the 
gastric mucosa17. Proteolysis, to which proteins are subjected in the stomach by the action 
of pepsins, also contribute to the presence of amino acids in the gastric juice 15-17. Some 
organic acids were also detected in the gastric juice, such as lactate18, pyruvate, or 
citrate19.  
Several strategies to grow H. pylori in vitro have been delineated, being the use of 
complex media supplemented with growth factors the most common one. Recently, some 
liquid media for H. pylori growth were compared, being the defined medium Ham’s F-12 
nutrient mixture supplemented with 5% of horse serum the best option, since it gives the 
most consistent growth even using a small inoculum size20. Several other chemically 
defined or semi-defined media were developed for H. pylori growth with focus on the 
determination of amino acids requirements8,21–24. However, in none of these studies the 
carbon sources were clearly identified, being various amino acids co-metabolized 
simultaneously, together with glucose or pyruvate. Furthermore, there is a lack of 
knowledge about the preferential substrate used by H. pylori, with some authors pointing 
alanine, arginine, aspartate, asparagine, glutamate, glutamine, proline and serine as the 
potential carbon sources7,8. The identification of the preferential in vivo carbon sources and 
their use as substrates for H. pylori growth in vitro would result in more reliable growth, 
leading to a significant breakthrough in its study by contributing to understand how this 
organism lives in the host and delineate new strategies to eradicate it. On the other hand, 
it would extend the knowledge about bacterial pathogenesis. 
The main goal of the present work was thus to study H. pylori’s potential carbon 
sources in order to determine the preferential ones and use the obtained information to 
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design a culture medium containing only one carbon source that could be used to grow H. 
pylori under more defined conditions and thus contribute to understand better the 
physiology and metabolism of that pathogenic organism. Also, a metabolic footprinting 
strategy was applied in order to determine the consumption and secretion of metabolites 
into the culture medium. 
 
 
5.3. Methods 
5.3.1. Culture conditions  
Helicobacter pylori 26695 (strain NCTC 12455) was cultivated in Columbia Base 
Agar (CBA) (Liofilchem, Italy) supplemented with 5% (v/v) defibrinated horse blood 
(Probiologica, Portugal) at 37 °C under microaerophilic conditions (5% O2, 10% CO2, 85% 
N2) in a Cell Culture Incubator (Incubator HERAcell 150, Kendro Laboratory, Germany) for 
3 days. 
An inoculum was prepared in Ham’s F-12 nutrient mixture with glutamine (catalog 
no 21765-037, Invitrogen-Gibco, Spain) previously supplemented with 5% of fetal bovine 
serum (FBS) (vol/vol) (catalog no 10500-064, origin: South America, Invitrogen-Gibco, 
Spain), incubated at 37 °C under 130 rpm of shaking speed (Heidolph Unimax 1010 
orbital shaker, Germany) in microaerophilic conditions for approximately 16 h, in order to 
reach the exponential phase. Afterwards, cells were harvested by centrifugation (5000 x g, 
10 min.), washed twice in phosphate buffer saline solution (PBS) and ressuspended in 
culture medium. The initial Optical Density of the culture at 600 nm (OD600) was adjusted 
to 0.03-0.06. Each experiment was performed in 100 mL Erlenmeyer flasks with 15 mL of 
media with different carbon sources. A single inoculum was used to inoculate all 
Erlenmeyer flasks. The initial pH was adjusted to 7.0. The culture was incubated at 37 °C 
under 130 rpm of shaking speed under microaerophilic conditions. The experiment was 
carried out during 48 hours.  
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5.3.2. Media and Carbon Sources 
The culture medium used in the experiments was a modified version of the Ham’s 
F-12 nutrient mixture, in which the amino acids that had not been consumed in the 
previous work (Chapter 4) were removed from the medium and only one carbon source 
was used in each experiment. The remaining compounds from Ham’s F-12 were kept 
(inorganic salts, vitamins and other components) in the same concentrations (detailed in 
Supplementary Material 1). The carbon sources tested were based on screening growth 
experiments previously performed. The following carbon sources were tested: L-alanine, L-
asparagine, L- aspartic acid, L-glutamine, L-glutamic acid, L-proline, L-serine, pyruvate and 
alpha-ketoglutarate. The concentration of each carbon source was the same in terms of 
moles of carbon (10 mM). All media were supplemented with 5% fetal bovine serum (FBS) 
(vol/vol). A control experiment without any carbon source and with only the essential 
components was performed. The composition of each medium tested is described in Table 
5.1. All media were prepared in distilled water and filter-sterilized using a filtration unit 
Sartolab P20, 0.2 µm (Sartorius, Germany). 
 
Table 5.1. Composition of the media tested. 
Abbreviations of compounds: L-ala – L-alanine,  L-asn - L-asparagine, L-asp – L-arginine, L-gln - L-glutamine, 
L-glu – L-glutamate; L-pro – L-proline; L-ser – L-serine; pyr – pyruvate; α- ket – alpha-ketoglutarate. 
Compounds 
Media 
1 2 3 4 5 6 7 8 9 10* 
Carbon sources 
(mM) 
L-ala 
(3.34) 
L-asn 
(2.50) 
L-asp 
(2.50) 
L-gln 
(2.00) 
L-glu 
(2.00) 
L-pro 
(2.00) 
L-ser 
(3.34) 
pyr 
(3.34) 
α-ket 
(2.00) 
- 
Essential 
Amino acids 
L-arginine (10.00 mM), L-histidine (1.00 mM), L-isoleucine (0.30 mM), L-leucine (1.00 
mM), L-methionine (0.30 mM), L-phenylalanine (0.30 mM) L-valine (1.00 mM). 
Inorganic salts 
Calcium chloride (0.2993 mM), Cupric sulphate (0.00001 mM), Ferric sulphate (0.003 
mM), Magnesium chloride (0.6010 mM), Potassium chloride (2.981 mM), Sodium 
bicarbonate (14 mM), Sodium chloride (131.017 mM), Sodium phosphate dibasic 
anhydrous (1 mM), Zinc sulphate (0.0030 mM). 
Vitamins 
Biotin (0.00003 mM), Choline chloride (0.1 mM), D-calcium panthothenate (0.0010 mM), 
Folic acid(0.0029 mM), Niacinamide (0.0003 mM), Pyridoxine hydrochloride(0.0003 
mM), Riboflavin(0.0001 mM), Thiamine hydrochloride (0.0009 mM), Vitamin B12 
(0.0010 mM), i-inositol (0.1 mM). 
Other 
components 
Hypoxanthine (0.0294 mM), Linoleic acid (0.0003 mM), Lipoic acid (0.0010 mM), Phenol 
red (0.0032 mM) Putrescine (0.0010 mM), Thymidine (0.0029 mM). 
* Control experiment with only essential amino acids, without carbon source. 
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5.3.3. Growth assessment and carbon source consumption 
During the cultures, samples were collected at different time points (0, 4, 6, 8, 10, 
12, 24, 36 and 48 hours) to evaluate the Optical Density at 600 nm by using a microplate 
reader (TECAN Sunrise, Switzerland). To verify culture purity at each time point a sample 
of the bacterial culture was plated in Columbia base agar (CBA) (Liofilchem, Italy) 
supplemented with 5% (v/v) defibrinated horse blood and Tryptic Soy Agar (Liofilchem, 
Italy) media and then incubated at 37°C in microaerophilic and aerobic conditions, 
respectively, during 5-7 days. 
At 0 and 48 hours of each experiment, samples of the supernatant were collected 
to analyze amino and non-amino organic acids by GC-MS in order to measure the 
consumption of the carbon source and other amino acids and detect possible by-products 
secreted by H. pylori (method detailed in Chapter 3). 
Acetate and formate production were assayed by an enzymatic kit (Acetic acid UV-
method - Cat. No. 10 148 261 035, Boehringer Mannheim/R-Biopharm, Roche, Germany 
and Formic acid UV method - Cat. No. 10 979 732 035, Boehringer Mannheim/R-
Biopharm, Roche, Germany) (Experimental procedure according to kits’ instructions). 
The specific growth rates (h-1) were determined by plotting the logarithm of the 
absorbance of the culture at 600 nm along time.  
 
 
5.4. Results and discussion 
5.4.1. H. pylori growth with different carbon sources 
It has been described that amino acids can be used by H. pylori as carbon and 
energy sources. In our previous experiments, H. pylori 26695 was grown in the Ham’s F-
12 medium, which contains all 20 amino acids in concentrations between 0.03 and 1 mM 
(medium composition detailed in supplementary material 1). Additionally, some organic 
acids (citrate, lactate and succinate) were detected in the culture medium when 
supplemented with fetal bovine serum (FBS).  
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Two experiments using 10-fold higher concentrations of amino acids and organic 
acids (citrate, lactate, succinate, and pyruvate) were also performed. The obtained results 
showed that an increase in amino acids concentrations originated and increase in H. 
pylori’s growth, while the same increase was not observed for the experiment with higher 
concentration of organic acids. These results suggest that either essential amino acids are 
found in limiting conditions in the original medium formulation or that the remaining amino 
acids are the preferential carbon sources.  
In addition, the analysis of extracellular metabolites, previously performed, 
enabled us to determine which amino and organic acids were consumed by H. pylori 
growing in Ham’s F-12 (Chapter 3). Based on these results, some L-amino acids (alanine, 
asparagine, aspartate, glutamate, glutamine, proline and serine) and one organic acid 
(pyruvate) were chosen to be tested as possible carbon sources for H. pylori 26695 in 
liquid medium.  
Additionally, alpha-ketoglutarate was also tested, since glutamine and glutamate 
are assimilated via alpha-ketoglutarate in the TCA cycle25. Although the transporter for that 
organic acid was identified in H. pylori 26695’s genome26,27, in our experiments, when 
using alpha-ketoglutarate as the sole carbon source, we observed no growth, indicating 
that possibly this transporter is not active under the conditions used. As such, the results 
of that experiment are not presented next. 
It should be emphasized that, although an effort was made such that in each 
experiment only one compound was serving as the carbon source, this was not completely 
achieved given the presence of additional carbon sources in FBS (used in 5% v/v), such as 
organic acids. In fact, it was not possible to remove FBS from the culture medium, which 
suggests that some nutrients are still missing in the defined medium, or that FBS has 
another unknown function that is not supported by the medium without this complex 
supplement. FBS was also analyzed by GC-MS (results detailed in supplementary material 
2) and it is clear that, although several of the carbon sources were found, those are in low 
concentrations in the final medium, and it is possible to separate their influence (as also 
shown in supplementary material 2).  
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To assess H. pylori’s growth using different carbon sources, the optical density at 
600 nm (OD600) was analyzed for each time point until 48 hours of culture. The growth 
along time using different carbon sources is showed in Figure 5.1. The OD600 increase and 
the respective specific growth rate (µ) for each carbon source tested are depicted in Figure 
5.2. As expected, no growth was observed in the control experiment without any carbon 
source (results not shown). 
 
Figure 5.1. Growth (OD600) of H. pylori 26695 using different carbon sources. 
 
 
Figure 5.2. Factor increase in optical density (OD 600nm) after 48 hours of culture and specific growth 
rate (exponential phase) for each carbon source tested.  
0,00
0,05
0,10
0,15
0,20
0,25
0 4 6 8 10 12 24 48
 O
D
 6
0
0
n
m
 
Time (hours) 
Alanine
Asparagine
Aspartic acid
Glutamine
Glutamic acid
Proline
Serine
Pyruvate
0,000
0,020
0,040
0,060
0,080
0,100
0,120
0,140
0,0
0,5
1,0
1,5
2,0
2,5
3,0
3,5
4,0
4,5
5,0
ala asn asp gln glu pro ser pyr
S
p
e
ci
fi
c 
g
ro
w
h
 r
a
te
 (
h
-1
) 
O
D
 (
6
0
0
n
m
) 
in
cr
e
a
se
 
Carbon source 
OD600 increase Specific growth rate
Evaluation of different carbon sources for the growth of H. pylori 26695 in liquid medium 
173 
 
The tested carbon sources have different effects on growth, as shown by the 
specific growth rates obtained, which range from 0.125 h–1 with glutamine to 0.029 h–1 
with proline (Figure 5.2). 
The analysis of these results suggests that the amino acids that are catabolized by 
conversion to intermediates of the TCA cycle, such as aspartate and glutamate, are the 
preferred substrates. The maximum specific growth rates were achieved for glutamine and 
glutamate as carbon sources (0.125 h-1 and 0.103 h-1, respectively). Moreover, glutamine 
allowed to achieve the higher optical density, indicating that it is the best among the 
carbon sources tested for H. pylori growth. These results can be justified by several facts, 
first and foremost the abundance of glutamine in the human body and its functions 
besides nutrition, being essential for the correct function of a variety of tissues and cells28,29. 
Concerning glutamate concentration in the gastric environment, it is present in the gastric 
juice of infected and uninfected subjects, although in lower amounts than other amino 
acids4,12,13. 
However, before entering the metabolism, glutamine must be converted to 
glutamate by gamma-glutamyltranspeptidase (GGT) in the periplasm with ammonium 
production, being then the resulting glutamate transported to the cytoplasm by the GltS 
transporter in a Na+- dependent process16,30. GGT was detected in the extracellular medium 
and in the periplasm of growing H. pylori 30,31. The referred transporter was also identified 
by homology in the last H. pylori 26695 genome reannotation as a sodium/glutamate 
symporter (HP1506)27.  
It is likely that these specific mechanisms that allow H. pylori to use glutamine and 
glutamate are not restrict to nutrient acquisition, contributing to H. pylori’s virulence by the 
depletion of amino acids that have a protective role of the gastric mucosa (such as 
glutamine, as referred above)32 and the production of ammonia16,30, which causes damage 
in gastric epithelial cells32. Moreover, it was suggested that GGT in H. pylori contribute to 
maintain a constant level of ammonia16,33, which can be used by H. pylori as a nitrogen 
source, as well as a neutralizing agent against acidic gastric environment34. A recent review 
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about the role of GGT in H. pylori’s pathogenesis stresses the importance of ammonia 
production in gastric damage during H. pylori infection34.  
Thus, H. pylori does not possess a direct glutamine transporter, using glutamine 
as a source of glutamate16, which in turn is converted to alpha-ketoglutarate by glutamate 
dehydrogenase (GdhA) and incorporated into the TCA cycle16,25,35. Moreover, the 
spontaneous hydrolysis of glutamine in aqueous buffer solutions at 37ºC and pH of 7.4 
has been described8,36, thus limiting its use in in vitro liquid culture medium. 
The use of aspartate and asparagine as sole carbon sources to grow H. pylori 
resulted in low specific growth rates, with the maximum biomass achieved at 24 hours of 
culture (Figure 5.1 and Figure 5.2). Like for glutamate and glutamine, a specific aspartate 
transporter (DcuA) was described30 and predicted27, and asparagine catabolism starts with 
its deamination in the periplasm by L-asparaginase (AnsB), resulting in ammonia and 
aspartate, which is assimilated via fumarate in the TCA cycle30. It is presumed that the 
fumarate used in the TCA cycle is formed preferentially from aspartate than from malate, 
in contrast with C. jejuni37. L-aspartate was detected in the gastric juice of patients with 
cancer and without cancer, but a controversy exists regarding its correlation with the 
existence of cancer 12,134. Concerning virulence, the transport of aspartate was proved to be 
essential in the colonization of the gastric mucosa in mice30. 
When proline was used as the sole carbon source, the specific growth rate 
(µ=0.029 h–1) was the lowest obtained, being the maximum optical density obtained at 24 
hours of growth (Figure 5.1 and Figure 5.2). This result suggests that proline was not 
being efficiently used by H. pylori. L-proline can also be transported by a Na+--dependent 
transporter (PutP)27,38. The use of L-proline as a carbon source was also reported by other 
authors7,8 as well as its high concentration in the human gastric juice4,12. An evidence on the 
usage of proline in the catabolism comes from the identification of the gene (putA), 
encoding for proline dehydrogenase, in H. pylori’s 26695 genome26,27, which is also 
associated with the respiratory chain4. 
It is thought that proline is not an essential amino acid for H. pylori growth, but the 
specific precursor for its formation is unknown, as mentioned in the previous chapter: L-
glutamate39 or L-arginine6 are two possible precursors for proline biosynthesis.  
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Alanine and serine as carbon sources resulted in a low OD increase when 
compared with glutamine or glutamate, with the maximum biomass achieved at 8 and 6 
hours of culture, respectively, but with low specific growth rates (Figure 5.1 and Figure 
5.2). L-alanine and L-serine have been described to be essential amino acids for some 
strains21, but results from this work presented in the previous chapter indicated that under 
the conditions used, alanine and serine are not essential for H. pylori. Regarding the 
composition of the gastric juice, alanine and serine are both present at high amounts4,12. L-
serine uptake is accomplished by the SdaC transporter, a specific serine transporter27,37, 
while, although a transporter for D-alanine was predicted on H. pylori’s 26695 genome 
(dagA, HP0942)27,39,40, a specific L-alanine transporter has not been identified. For 
promoting L-alanine transport only a non-specific amino acid ABC (ATP binding cassette) 
transporter was predicted27,40,41. Regarding the catabolic pathways, L-serine and L-alanine 
can be both incorporated into the metabolism via pyruvate by a one-step conversion to 
pyruvate and ammonia, by serine deaminase (sdaA)6,26,39 and alanine dehydrogenase 
(ald)26,39, respectively. However, OD600 achieves higher values when pyruvate is used as the 
carbon source in comparison with L-alanine and L-serine, showing that these carbon 
sources have different effects, being pyruvate more efficiently used. 
Pyruvate metabolism in H. pylori was studied by several authors42,43. Pyruvate can 
be used as a sole carbon source and is catabolized by the conversion to Acetyl-CoA and 
subsequent incorporation into the TCA cycle. Evidence of the reductive part of TCA cycle 
was obtained by Mendz et al. (1994) by detecting succinate when cells were incubated 
with pyruvate42. Mendz et al. (1994) also detected the formation of alanine and lactate, in 
addition to acetate and formate as by-products when pyruvate was used as carbon source, 
proving the existence of the mixed-acid fermentation pathway in H. pylori42. In contrast, 
Chalk et al. (1994) only detected acetate as a by-product of pyruvate under aerobic 
conditions43.  
In summary, the observed discrepancies in consumption of different compounds 
used as carbon sources confirm their differential use and different effectiveness, and 
suggest that some amino acids also have other functions related with host colonization 
and virulence. A connection between carbon source availability and bacterial virulence 
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based on a mechanism identical to the one that controls carbon catabolite repression was 
established in Proteobacteria44.  
H. pylori 26695’s catabolic pathways for the studied carbon sources are 
summarized in Figure 5.3. The specific transporters, when identified, are also indicated. 
 
Figure 5.3. Catabolic pathways predicted to be utilized by H. pylori 26695 for the utilization of the carbon 
sources tested. The rectangles indicate metabolites; black arrows indicate a reaction catalyzed by an 
enzyme, codified by the referred gene; grey arrows indicate a transporter;  a question mark indicates that the 
transporter for that specific compound is unknown. * Reactions occuring in the periplasm. 
Abreviattions of compounds: accoa – acetyl-coA, akg – alpha-ketoglutarate, ala- L-alanine, asn – L-
asparagine, asp – L- aspartate, fum – fumarate, glu- L-glutamate, gln – L-glutamine, lac – lactate, pro – 
proline, pyr – pyruvate, ser – L:serine.  
 
5.4.1. Metabolites analysis 
Metabolites detected in the samples represent metabolites that were present or 
were secreted/excreted into the medium. Extracellular metabolite analysis was performed 
in order to evaluate if the carbon sources and essential amino acids were being consumed 
from the culture medium and identify by-products excreted by H. pylori when different 
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carbon sources are used. The percentage of carbon source consumption in each 
experiment at 48 hours of culture, analyzed by GC-MS is displayed in Figure 5.4.  
 
Figure 5.4. Carbon source consumption after 48 hours of culture (Mean of three technical replicates).  
 
The analysis of the culture medium after 48 hours revealed that glutamine, 
asparagine and pyruvate were completely consumed by H. pylori when those were used as 
the main carbon sources (Figure 5.4). Aspartate, glutamate, proline and serine were not 
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serine have the lowest yields.  
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evolution in each experiment in order to inspect if they were also being used by the 
organism.  
As such, the exometabolome analysis performed allowed to detect the compounds 
consumed from the culture medium, besides the main compounds used as carbon 
sources (results detailed in supplementary materials 3). Analyzing the results, it can be 
seen that alanine, aspartate, glutamate, proline, citrate, lactate and succinate were 
identified in all experiments initially (0 h) in the culture medium. At 48 hours of culture, 
alanine and lactate were completely consumed. Lactate transport, by lactate permeases, 
was predicted from the genome (lctp1, HP0140; lctp2, HP01421)26,27. A D-lactate 
dehydrogenase was also identified by homology in the genome (dld, Hp1222) which is 
responsible for the conversion of D-lactate into pyruvate 26,27. Furthermore, Takahashi et al. 
(2007) proved that the L-lactic acid secreted by gastric mucosal cells has a stimulatory 
effect on H. pylori growth in microaerobic conditions, and since L-lactate dehydrogenase is 
not predicted from genome analysis, another unknown metabolic pathway might be 
present in H. pylori for L-lactate degradation18. The concentration of lactate detected in the 
culture media supplemented with FBS is about 0.8 mM, which is consistent with the 
concentration found in the human gastric juice (0.3-1 mM)18, although we were not able to 
identify which isoform is present in FBS.  
Aspartate and proline were almost 100% consumed in all experiments, coherent 
with the results in experiments where these compounds were used as carbon sources 
(where some consumption was verified when the initial concentrations were much higher). 
Glutamate, citrate and succinate were detected in the culture medium in all 
experiments at 0 h of culture, originating from FBS. These compounds were differently 
utilized by H. pylori, being consumed in some experiments and produced in others 
(supplementary material 3, Table 5.5) When it was not the main carbon source, glutamate 
was completely consumed in the experiments where glutamine and serine were the main 
carbon source. Since glutamine was completely consumed, it can be hypothesized that 
glutamate was used in this experiment as an “extra” carbon source. The same did not 
happen in the serine experiment, as serine was not completely consumed, suggesting a 
preference for glutamate. In experiments where asparagine, proline and pyruvate were the 
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main carbon source, glutamate was not consumed. As explained previously, the arrest in 
growth in those experiments was not associated with the carbon source, and can be 
associated with the production of some toxic compounds or other unknown factors and 
thus the presence of glutamate did not avoid growth arrest. 
The percentage of citrate in the culture medium at 48 hours increased in 
experiments using glutamine and aspartate. In experiments using alanine, asparagine, 
proline and pyruvate as main carbon sources, citrate was consumed by H. pylori 
(supplementary material 3, Table 5.5) The influence of citrate in H. pylori growth and 
viability was studied by Albertson et al. (1998) concluding that citrate did not enhance H. 
pylori’s growth, but increase its viability45.  
Succinate, which can be used by H. pylori as a carbon source, was not consumed 
in experiments using asparagine, proline, serine and pyruvate, whilst it was consumed in 
experiments using alanine, aspartate, glutamine and glutamate. Studies on by products 
formed by the catabolism of amino acids detected succinate as a by-product of alanine, 
aspartate, glutamate, fumarate and pyruvate7. Besides an increase in viability, Albertson et 
al. (1998) did not detect any growth improvement in H. pylori when succinate was added 
to culture medium45. In the published in silico metabolic models, succinate is pointed out 
as a possible carbon source25,46, although, in our previous experiments, succinate was not 
able to improve growth as discussed above in the case of citrate. 
Tyrosine was only detected in two experiments (with glutamine or glutamate as 
carbon sources), with a 2-fold increase of its percentage at 48 hours of culture. However, 
the concentrations detected are very low, indicating that it could be present in all 
experiments at concentrations below the limit of detection of the method used. 
The accumulation of L-tyrosine in the culture medium was also observed when the 
complete culture medium (with 20 amino acids) was used, as discussed in the previous 
chapter. 
Regarding essential amino acids, which were also analysed by GC/MS, the 
obtained results are detailed in supplementary material 3 (Table 5.5). Overall, the 
consumption of essential amino acids was not clearly noticeable in some cases. This fact 
can be explained by the relatively high concentrations of some amino acids (leucine, 
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phenylalanine and valine) in the medium, making the measurements of their consumption 
inaccurate since the utilization by H. pylori cells is small compared to the total content. 
Histidine was only detected in the experiments using glutamine and glutamate as 
the main carbon sources due to problems with the derivatization method for that specific 
compound, making its detection very difficult and unreliable. 
The formation of the by-products acetate and formate were also inspected by an 
enzymatic kit at 48 hours of culture. Acetate was detected in samples of the experiments 
using pyruvate and serine as carbon sources, with an increment of 0.029 g/L and 0.018 
g/L, respectively, comparatively to 0 hours of culture. Acetate formation when pyruvate is 
metabolized is in agreement with the results obtained by other authors. The same 
happens with L-serine42 since, as discussed, L-serine is metabolized by direct conversion 
into pyruvate. However, although L-alanine is also directly transformed into pyruvate, and 
acetate production has been reported7, that compound was not detected in the L-alanine 
experiment. Acetate was also reported to be a by-product of aspartate, asparagine, 
glutamate and glutamine metabolism in H. pylori7, but this was not verified in the present 
work.  
Formate was not detected in any sample. It was expected to be produced in 
experiments using pyruvate or using amino acids that are metabolized via pyruvate, since 
the mixed-acid fermentation was proved by Mendz et al.7,42. 
 
 
5.5. Conclusions 
In the present work, a comparison of H. pylori growing using different carbon 
sources was carried out. Even though other studies also reported experiments using amino 
acids as carbon sources, to our knowledge, this is the first work where different amino 
acids were tested as the main carbon sources using the same concentration (in terms of 
moles of carbon) and where growth parameters were compared using a semi-defined 
medium. Moreover, the measurement of the exometabolome is another novelty, allowing 
the comparison of H. pylori’s behaviour under several nutritional conditions.  
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Under the conditions used, glutamine was identified as the carbon source that 
yielded a higher growth. However, glutamine easily suffers degradation in aqueous 
medium. Moreover, it is converted to glutamate and ammonium by an enzymatic reaction 
in H. pylori’s periplasm. In addition, the use of glutamate as the main carbon source had a 
higher yield in biomass regarding substrate consumption. As such, we suggest glutamate 
as the carbon source of choice for H. pylori’s growth.  
In line with other authors, the obtained results also proved that H. pylori is not 
constrained to a unique carbon source and can switch to different substrates when the 
preferential carbon source is not available, although with lower growth rates. Nevertheless, 
the utilization of amino acids that are reported to be present in the gastric environment 
might be not only related with acquiring nutrients, and it can be speculated that by 
depleting the compounds that are important for gastric health, H. pylori has another 
advantage, contributing to injury and virulence, as occurs with glutamine.  
Notwithstanding, it should be emphasized that in our experiments FBS was used 
to supplement the defined medium used, having some impact in the results. Nevertheless, 
the FBS characterization performed in this work is also of interest and allowed the 
identification of some important components (amino and organic acids) and to estimate 
their impact in growth. Our attempts to grow H. pylori without FBS and without strain 
adaptation failed, indicating that some components are missing in the culture medium 
used or that FBS has another unknown function. Thus, further investigation is needed in 
this direction. 
 
  
Chapter 5 
182 
5.6. References 
1. Rohmer, L., Hocquet, D. & Miller, S. I. Are pathogenic bacteria just looking for food? 
Metabolism and microbial pathogenesis. Trends Microbiol. 19, 341–348 (2011). 
2. Brown, S. A., Palmer, K. L. & Whiteley, M. Revisiting the host as a growth medium. Nat. 
Rev. Microbiol. 6, 657–666 (2008). 
3. Eisenreich, W., Dandekar, T., Heesemann, J. & Goebel, W. Carbon metabolism of 
intracellular bacterial pathogens and possible links to virulence. Nat. Rev. Microbiol. 8, 
401–12 (2010). 
4. Nagata, K. et al. L-serine, D- and L -proline and alanine as respiratory substrates of 
Helicobacter pylori: correlation between in vitro and in vivo amino acid levels. Microbiology 
149, 2023–2030 (2003). 
5. Noach, L. A., Rolf, T. M. & Tytgat, G. N. J. Electron microscopic study of association 
between Helicobacter pylori and gastric and duodenal mucosa. J. Clin. Pathol. 47, 699–
704 (1994). 
6. Van Amsterdam, K. & van der Ende, A. Nutrients released by gastric epithelial cells 
enhance Helicobacter pylori growth. Helicobacter 9, 614–621 (2004). 
7. Mendz, G. L. & Hazell, S. L. Aminoacid Utilization by Helicobacter pylori. Int. J. Biochem. 
Cell Biol. 27, 1085–1093 (1995). 
8. Stark, R. M., Suleiman, M. S., Hassan, I. J., Greenman, J. & Millar, M. R. Amino acid 
utilisation and deamination of glutamine and asparagine by Helicobacter pylori. J. Med. 
Microbiol. 46, 793–800 (1997). 
9. Cerda, O., Rivas, A. & Toledo, H. Helicobacter pylori strain ATCC700392 encodes a 
methyl-accepting chemotaxis receptor protein (MCP) for arginine and sodium bicarbonate. 
FEMS Microbiol. Lett. 224, 175–181 (2003). 
Evaluation of different carbon sources for the growth of H. pylori 26695 in liquid medium 
183 
10. Abdollahi, H. & Tadjrobehkar, O. The role of different sugars, amino acids and few other 
substances in chemotaxis directed motility of helicobacter pylori. Iran. J. Basic Med. Sci. 
15, 787–794 (2012). 
11. Lertsethtakarn, P., Ottemann, K. M. & Hendrixson, D. R. Motility and chemotaxis in 
Campylobacter and Helicobacter. Annu. Rev. Microbiol. 65, 389–410 (2011). 
12. Nagata, Y. et al. High concentrations of D-amino acids in human gastric juice. Amino Acids 
32, 137–40 (2007). 
13. Segawa, K. et al. Amino acid patterns in human gastric juice in health and gastric disease. 
Japanose J. Med. 24, 244–249 (1985). 
14. Deng, K. et al. Three amino acids in gastric juice as potential biomarkers for gastric 
malignancies. Anal. Chim. Acta 694, 100–107 (2011). 
15. Deng, K. et al. High levels of aromatic amino acids in gastric juice during the early stages 
of gastric cancer progression. PLoS One 7, 1–10 (2012). 
16. Shibayama, K. et al. Metabolism of glutamine and glutathione via g-glutamyltranspeptidase 
and glutamate transport in Helicobacter pylori: possible significance in the pathophysiology 
of the organism. Mol. Microbiol. 64, 396–406 (2007). 
17. Komorowska, M., Szafran, H., Popiela, T. & Szafran, Z. Free amino acids of human gastric 
juice . Acta Physiol. Polish 32, 7336988 (1981). 
18. Takahashi, T. et al. L-lactic acid secreted from gastric mucosal cells enhances growth of 
Helicobacter pylori. Helicobacter 12, 532–540 (2007). 
19. Piper, D., Fenton, B. & Goodman, L. Lactic, pyruvic, citric, and uric acid content of gastric 
juice. Gastroenterology 53, 42–48 (1967). 
20. Sainsus, N., Cattori, V., Lepadatu, C. & Hofmann-Lehmann, R. Liquid culture medium for 
the rapid cultivation of Helicobacter pylori from biopsy specimens. Eur. J. Clin. Microbiol. 
Infect. Dis. 27, 1209–1217 (2008). 
Chapter 5 
184 
21. Nedenskov, P. Nutritional requirements for growth of Helicobacter pylori. Appl. Environ. 
Microbiol. 60, 3450–3453 (1994). 
22. Reynolds, D. J. & Penn, C. W. Characteristics of Helicobacter pylori growth in a defined 
medium and determination of its amino acid requirements. Microbiology 140, 2649–
2956 (1994). 
23. Testerman, T. L., Gee, D. J. M. C. & Mobley, H. L. T. Helicobacter pylori growth and urease 
detection in the chemically defined medium Ham ’ s F-12 nutrient mixture. J. Clin. 
Microbiol. 39, 3842–3850 (2001). 
24. Testerman, T. L., Conn, P. B., Mobley, H. L. T. & McGee, D. J. Nutritional requirements 
and antibiotic resistance patterns of Helicobacter species in chemically defined media. J. 
Clin. Microbiol. 44, 1650–1658 (2006). 
25. Schilling, C. H. et al. Genome-scale metabolic model of Helicobacter pylori 26695. J. 
Bacteriol. 184, 4582–4593 (2002). 
26. Tomb, J.-F. et al. The complete genome sequence of the gastric pathogen Helicobacter 
pylori. Nature 388, 539–547 (1997). 
27. Resende, T., Correia, D. M., Rocha, M. & Rocha, I. Re-annotation of the genome sequence 
of Helicobacter pylori 26695. J. Integr. Bioinform. 10(3), 1–13 (2013). 
28. Newsholme, P., Procopio, J., Lima, M. M. R., Pithon-Curi, T. C. & Curi, R. Glutamine and 
glutamate--their central role in cell metabolism and function. Cell Biochem. Funct. 21, 1–9 
(2003). 
29. Roth, E. Nonnutritive effects of glutamine. J. Nutr. 138, 2025S–2031S (2008). 
30. Leduc, D., Gallaud, J., Stingl, K. & Reuse, H. De. Coupled amino acid deamidase-transport 
systems essential for Helicobacter pylori colonization. Infect. Imunity 78, 2782–2792 
(2010). 
31. Bumann, D. et al. Proteome analysis of secreted proteins of the gastric pathogen 
Helicobacter pylori. Infect. Immun. 70, 3396–3403 (2002). 
Evaluation of different carbon sources for the growth of H. pylori 26695 in liquid medium 
185 
32. Nakamura, E. & Hagen, S. J. Role of glutamine and arginase in protection against 
ammonia-induced cell death in gastric epithelial cells. Am. J. Physiol. Gastrointest. Liver 
Physiol. 283, G1264–75 (2002). 
33. Ki, M. R., Yun, N. R. & Hwang, S. Y. Glutamine-induced production and secretion of 
Helicobacter pylori gamma-glutamyltranspeptidase at low pH and its putative role in 
glutathione transport. J. Microbiol. Biotechnol. 23, 467–472 (2013). 
34. Ricci, V., Giannouli, M., Romano, M. & Zarrilli, R. Helicobacter pylori gamma-glutamyl 
transpeptidase and its pathogenic role. World J. Gastroenterol. 20, 630–638 (2014). 
35. Marais, A., Mendz, G. L., Hazell, S. L. & Mégraud, F. Metabolism and genetics of 
Helicobacter pylori: the genome era. Microbiol. Mol. Biol. Rev. 63, 642–674 (1999). 
36. Bray, H. G., James, S. P., Raffan, I. M. & Thorpe, W. V. The enzymic hydrolysis of 
glutamine and its spontaneous decomposition in buffer solutions. Biochem. J. 44, 625–7 
(1949). 
37. Doig, P. et al. Helicobacter pylori physiology predicted from genomic comparison of two 
strains. Microbiol. Mol. Biol. Rev. 63, 675–707 (1999). 
38. Rivera-Ordaz, A. et al. The sodium/proline transporter putP of Helicobacter pylori. PLoS 
One 8, e83576 (2013). 
39. Caspi, R. et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc 
collection of pathway/genome databases. Nucleic Acids Res. 40, D742–D753 (2012). 
40. Reuse, H. De & Skouloubris, S. in Helicobacter pylori Physiol. Genet. (HLT, M., GL, M. & 
SL, H.) (ASM Press, 2001). 
41. Tomii, K. & Kanehisa, M. A Comparative Analysis of ABC Transporters in Complete 
Microbial Genomes. Genome Res. 1048–1059 (1998). doi:10.1101/gr.8.10.1048 
42. Mendz, G. L., Hazell, S. L. & van Gorkom, L. Pyruvate metabolism in Helicobacter pylori. 
Arch. Microbiol. 162, 187–192 (1994). 
Chapter 5 
186 
43. Chalk, P. A., Roberts, A. D. & Blows, W. M. Metabolism of pyruvate and glucose by intact 
cells of Helicobacter pylori studied by 13C NMR spectroscopy. Microbiology 140, 2085–
2092 (1994). 
44. Poncet, S. et al. in Bact. Sens. Signal. (Collin, M. & Schuch, R.) 16, 1–15 (Karger, 2009). 
45. Albertson, N., Wenngren, I. & Sjöström, J. E. Growth and Survival of Helicobacter pylori in 
Defined Medium and Susceptibility to Brij 78. J. Clin. Microbiol. 36, 1232–1235 (1998). 
46. Thiele, I., Vo, T. D., Price, N. D. & Palsson, B. Ø. Expanded Metabolic Reconstruction of 
Helicobacter pylori ( iIT341 GSM / GPR ): an In Silico Genome-Scale Characterization of 
Single- and Double-Deletion Mutants. J. Bacteriol. 187, 5818–5830 (2005).  
 
  
Evaluation of different carbon sources for the growth of H. pylori 26695 in liquid medium 
187 
5.7. Supplementary material  
5.7.1. Supplementary material 1 
Table 5.2 describes the composition of the Ham’s F-12 Nutrient Mixture, with the 
concentration and chemicals used to prepare the medium. 
 
Table 5.2. Composition of the Ham’s F-12 medium and characteristics of the compounds used to prepare 
the mixture. 
Compounds 
Purity 
(%) 
Chemicals 
Molecular weight 
(g/mol) 
Concentration 
(mM) 
Amino acids 
Glycine >99.0 Fluka 75.07 0.10 
L-alanine >99.5 Fluka 89.09 0.10 
L-arginine hydrochloride >99.5 Fluka 211.00 1.0 
L-asparagine >99.5 Sigma 132.12 0.098 
L-aspartate >99.0 Sigma Ultra 133.10 0.10 
L-cysteine hydrochloride >99.0 Sigma 157.62 0.23 
L-glutamate >99.0 Sigma 147.13 0.10 
L-glutamine >99.0 Sigma 146.15 1.0 
L-histidine hydrochloride >99.5 Sigma 209.63 0.10 
L-isoleucine >99.5 Fluka 131.18 0.030 
L-leucine >99.0 Aldrich 131.18 0.10 
L-lysine hydrochloride - Sigma 182.65 0.20 
L-methionine >99.5 Sigma 149.21 0.030 
L-phenylalanine >99.0 Fluka 165.19 0.030 
L-proline >99.0 Aldrich 115.13 0.30 
L-serine >99.5 Fluka 105.09 0.10 
L-threonine >99.5 Fluka 119.12 0.10 
L-tryptophan >98.0 Fluka 204.23 0.010 
L-tyrosine >99.0 Sigma 181.19 0.030 
L-valine >99.5 Fluka 117.15 0.10 
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Table 5.2.. Composition of the Ham’s F-12 medium and characteristics of the compounds used to prepare 
the mixture. (Continue) 
Compounds 
Purity 
(%) 
Chemicals 
Molecular 
weight 
(g/mol) 
Concentration 
(mM) 
Vitamins 
Biotin >98.5 Merck 244.31 0.000030 
Choline chloride 99.0 Acros 139.62 0.10 
D- Calcium panthotenate >99.0 Fluka 476.54 0.0010 
Niacinamide >98.0 Acros 122.13 0.00030 
Pyridoxine hydrochloride >99.5 Merck 205.64 0.00030 
Riboflavin >98.0 Riedel-de-Haen 376.37 0.000098 
Thiamine hydrochloride >99.0 Sigma 337.27 0.00089 
Vitamin B12 >98.5 Sigma 1355.00 0.0010 
i-inositol >99.0 Sigma 180.16 0.10 
Folic acid >95.0 Merck 441.41 0.0030 
Inorganic Salts 
Calcium chloride (CaCl2.2H2O) >99.0 Riedel-de-Haen 147.02 0.30 
Cupric sulphate (CuSO4.5H2O) >99.0 Riedel-de-Haen 249.69 0.000010 
Iron sulphate (FeSO4.7H2O) >99.0 Panreac 278.02 0.0030 
Zinc sulphate (ZnSO4.7H2O) >99.5 Panreac 287.54 0.0030 
Potassium chloride (KCl) >99.5 Fluka 74.56 2.98 
Magnesium chloride (MgCl2.6H2O) >99.0 Panreac 203.30 0.601 
Sodium bicarbonate (NaHCO3) - Fisher Scientific 84.01 14 
Sodium chloride (NaCl) >98.0 Riedel-de-Haen 58.44 131 
Sodium phosphate dibasic (Na2HPO4) >99.0 Fluka 177.99 1.0 
Other components 
Thymidine - Sigma 194.00 0.0030 
Putrescine 99.0 Acros 88.15 0.0010 
Linoleic acid >99.0 Sigma 280.00 0.00030 
Lipoic acid - Fisher 206.33 0.0010 
Phenol red - Acros 354.38 0.0030 
Hypoxanthine >99.5 Acros 136.11 0.029 
Sodium pyruvate >99.0 Sigma Ultra 110.04 1.0 
D-glucose >99.5 Sigma 180.00 10 
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5.7.2. Supplementary material 2 
Table 5.3 shows the compounds identified in fetal bovine serum (catalog no 
10500-064, origin: South America, Invitrogen-Gibco, Spain) by GC-MS. 
 
Table 5.3. Compounds identified in the fetal bovine serum by GC-MS, mean of two technical replicates and 
the corresponding concentration in the final broth. The original concentration of the same compounds added 
to the Ham’s F12 medium for carbon source experiments is also given for comparison purposes. 
Compound 
Concentration in FBS 
(Mean) 
(mM) 
Final concentration 
(Mean) (mM) in the 
culture caused by 5% 
FBS 
Concentration  
(mM) used in carbon 
source experiments 
Amino acids 
Alanine 1.39 0.079 3.34 
Aspartate 0.12 0.006 2.5 
Cysteine 0.04 0.002 - 
Glutamate 0.47 0.002 2.0 
Isoleucine 0.35 0.018 - 
Leucine 0.39 0.020 - 
Methionine 0.08 0.004 - 
Phenylalanine 0.13 0.007 - 
Proline 0.25 0.012 2.0 
Threonine 0.12 0.006 - 
Tyrosine 0.01 0.001 - 
Valine 0.31 0.016 - 
Organic acids 
Citrate 0.93 0.046 - 
Lactate 17.70 0.885 - 
Succinate 0.13 0.006 - 
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5.7.3. Supplementary material 3 
 
Table 5.4 and Table 5.5 show the compounds detected in the culture media and 
the respective percentage at 48 hours of culture (with reference to the initial 
concentration). Samples were analysed by GC-MS after derivatization with 
methylchloroformate (method described in Chapter 4). 
 
 
Table 5.4. Essential amino acids identified in the culture medium by GC/MS at 48 h of H. pylori culture in 
percentage (percentage ± standard deviation) compared to the concentration at 0 h of culture. Abbreviations: 
his – histidine; ile – isoleucine; leu - leucine; met – methionine; phe – phenylalanine; val – valine.  
Amino 
acids 
Experiments 
1 2 3 4 5 6 7 8 
his * * * 
102% 
(± 18) 
105% 
(±10) 
* * * 
ile 
86% 
(± 11) 
110% 
(± 5) 
26% 
(± 3) 
100% 
(± 15) 
110% 
(± 10) 
124% 
(± 4) 
105% 
(± 12) 
103% 
(± 9) 
leu 
92% 
(± 11) 
118% 
(± 6) 
34% 
(± 3) 
103% 
(± 21) 
106% 
(± 9) 
128% 
(± 5) 
116% 
(± 13) 
105% 
(± 10) 
met 
93% 
(± 24) 
120% 
(± 23) 
54% 
(± 21) 
94% 
(± 17) 
38% 
(± 1) 
107% 
(± 4) 
106% 
(± 6) 
103% 
(± 6) 
phe 
88% 
(± 4) 
108% 
(± 5) 
98% 
(± 75) 
100% 
(± 17) 
107% 
(± 12) 
111% 
(± 5) 
115% 
(± 7) 
102% 
(± 2) 
val 
12% 
(± 1) 
121% 
(± 4) 
43% 
(± 9) 
94% 
(± 18) 
103% 
(± 10) 
118% 
(± 4) 
112% 
(± 6) 
110% 
(± 4) 
* Not detected in those experiments.  
 
Carbon source Experiment number 
L-alanine 1 
L-asparagine 2 
L-aspartate 3 
L-glutamine 4 
L-glutamate 5 
L-proline 6 
L-serine 7 
Pyruvate 8 
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Table 5.5. Compounds identified in the culture medium by GC/MS at 48 h of culture in percentage 
compared to the concentration at 0 h of culture. Abbreviations: ala – alanine; asp – aspartate; glu - 
glutamate; pro – proline; thr – threonine; tyr – tyrosine; cit – citrate; lac – lactate; succ – succinate.  
Compounds 
identified 
Experiments 
1 2 3 4 5 6 7 8 
ala __  (0%)  (0%)  (0%)  (0%)  (0%)  (0%)  (0%) 
asp  (0%)  (0%) __  (0%)  (0%)  (0%)  (0%)  (0%) 
glu (83%) (106%)  (0%)  (0%) __ (108%)  (0%)  (99%) 
pro  (0%)  (0%)  (0%)  (0%)  (0%) __  (0%)  (18%) 
thr  *  *  *  * * n.d. n.d. n.d. 
tyr n.d. n.d. n.d. (274%) (265%) n.d. n.d. n.d. 
cit (36%)  (42%) (265%) (146%) (117%)  (57%)  (91%)  (42%) 
lac  (0%)  (0%)  (0%)  (0%)  (0%)  (0%)  (0%)  (0%) 
succ (81%) (105%)  (24%)  (64%)  (50%) (106%) (118%) (108%) 
 - represents a decrease of that compound in the culture medium from 0 to 48 h; - represents an increase 
of that compound in the culture medium; “n.d.” – means that the compound was not detected in neither at 
0 nor at 48 hours; __ – means that the compound was not accounted here since it is the chosen carbon 
source for that experiment. * means that this compound was not present at 0 hours of culture, only was 
detected at 48 hours of culture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Chapter 6 
6. Characterization of the growth of H. pylori 
using glutamate as the main carbon 
source 
 
 
 
 
 
 
 
 
 
 
 
 
Daniela Matilde Correia, Rafael Carreira, Maria João Vieira, Nuno Filipe Azevedo and Isabel Rocha.  
Characterization of the growth of H. pylori using glutamate as the main carbon source.  
(To be submitted) 
  
 
 
Characterization of the growth of H. pylori using glutamate as the main carbon source  
195 
6.1. Abstract 
The determination of nutritional requirements of pathogenic organisms is of great 
significance for understanding host-pathogen interactions. For H. pylori, some nutritional 
requirements have been disclosed; however, relevant information is still missing. Although 
amino acids have been identified as possible carbon sources for H. pylori, in the few 
described defined or semi-defined media several potential carbon sources are made 
available and the consumed ones are not clearly identified. Thus, the present work was 
conducted with the goal of uncovering the metabolic capacities of H. pylori, its nutritional 
requirements and the most commonly used metabolic pathways. 
As such, the growth of H. pylori 26695 in liquid medium using L-glutamate as the 
main carbon source was studied. Additionally, 13C L-glutamate was used to clarify some 
metabolic features. The obtained results confirmed L-glutamate as a potential sole and 
effective carbon source for H. pylori, also corroborating the essentiality of the amino acids 
isoleucine, histidine, leucine, methionine, phenylalanine and valine. We were also able to 
demonstrate that, under the conditions used, H. pylori makes full usage of the complete 
TCA cycle. Additionally, we hypothesized that L-proline is produced from L-arginine, while 
L-alanine is probably produced from pyruvate by alanine dehydrogenase. 
 
 
Keywords: Helicobacter pylori, metabolomics, 13C labeling. 
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6.2.  Introduction 
Despite the knowledge obtained so far concerning amino acid requirements in H. 
pylori, it is still unclear which are the metabolic pathways used for biosynthesis and 
catabolism. Thus, information on the carbon flow in this organism is required. Glutamate 
is a very important metabolite in bacterial metabolism that can be used as a carbon and 
nitrogen source. As described by other authors1,2 and shown in our previous studies, 
glutamate and glutamine can be used by H. pylori as sole carbon sources, with succinate, 
acetate and formate having been identified as metabolic by-products of glutamate 
consumption in H. pylori2. Glutamate plays yet another relevant role, as D-glutamate is an 
essential metabolite for the biosynthesis of peptidoglycan for the cell wall. Strategies of 
glutamate racemase inhibition have been investigated in the last years3, since this enzyme 
converts L-glutamate to D-glutamate. 
13C flux analysis has been largely applied to characterize phenotypes4 by 
quantifying in vivo the carbon fluxes. One of the most important applications of this 
approach is the identification of active pathways in less-studied organisms5. In 13C labeling 
experiments, an isotopic labeled substrate is used, and after an isotopic steady-state is 
achieved, free metabolites can be analyzed or proteinogenic amino acids can be measured 
after biomass hydrolysis. The analysis of the amino acids present in protein biomass is 
often preferred, since it provides broad labeling information and is less affected by errors, 
allowing to infer about active metabolic pathways and the carbon flow6.  
In order to characterize the growth of H. pylori using glutamate as substrate, this 
bacterium was grown under semi-defined conditions using a medium with L-glutamate as 
the main carbon source. A metabolic footprinting, together with a metabolite profiling 
approach was applied to identify the consumption and secretion of metabolites into the 
culture medium. This experiment was performed with different objectives: first, the results 
from the screening described in the previous chapter for the use of glutamate as the main 
carbon source needed to be validated with more replicates and it was also important to 
characterize in more detail the consumption of this compound. Furthermore, this 
characterization was important for the design of 13C labeling experiments with 13C-glutamate 
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that aimed at clarifying the metabolic pathways used by H. pylori under defined conditions 
by analyzing the labeled amino acids in biomass hydrolysates. 
 
 
6.3. Methods 
6.3.1. Culture conditions  
Helicobacter pylori 26695 (strain NCTC 12455) was cultivated in Columbia Base 
Agar (CBA) (Liofilchem, Italy) supplemented with 5% (v/v) defibrinated horse blood 
(Probiologica, Portugal) at 37 °C under microaerophilic conditions (5% O2, 10% CO2, 85% 
N2) in a Cell Culture Incubator (Incubator HERAcell 150, Kendro Laboratory, Germany) for 
3 days. 
An inoculum was prepared in Ham’s F-12 nutrient mixture with glutamine 
(Medium composition detailed in Chapter 5) previously supplemented with 5% of fetal 
bovine serum (FBS) (vol/vol) (catalog no 10500-064, origin: South America, Invitrogen-
Gibco, Spain), incubated at 37 °C under 130 rpm of shaking speed (Heidolph Unimax 
1010 orbital shaker, Germany) in microaerophilic conditions (5% O2, 10% CO2, 85% N2) for 
approximately 16 h, in order to reach the exponential phase. Afterwards, cells were 
harvested by centrifugation (5000 x g, 10 min.), washed twice in phosphate buffer saline 
(PBS) and ressuspended in culture medium. The initial Optical Density at 600 nm was 
adjusted to 0.06 - 0.07.  Each experiment was performed in 1000-mL Erlenmeyer flasks 
with 150 mL of the medium described in Table 6.1. Independent inocula were used to 
inoculate three Erlenmeyer flasks (biological replicates). The pH was adjusted to 7.0. The 
culture was incubated at 37 °C under 130 rpm of shaking speed under microaerophilic 
conditions (5% O2, 10% CO2, 85% N2). The experiment was carried out during 48 hours.  
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6.3.2. Culture medium 
The culture medium used was chosen based on the results described in Chapter 
5, with glutamate. The medium composition is described in Table 6.1, based on Ham’s F-
12 nutrient mixture. The medium was supplemented with 5% fetal bovine serum (FBS) 
(vol/vol) and was prepared in distilled water and filter-sterilized using a filtration unit 
Sartolab P20, 0.2 µm (Sartorius, Germany). 
 
Table 6.1. Culture medium composition.  
Compounds (concentration) 
Amino acids 
L-arginine (10 mM), L-histidine (1 mM), L-isoleucine (0.3 mM), L-leucine (1 mM), L-
methionine (0.3 mM), L-phenylalanine (0.3 mM), L-valine (1 mM), L-glutamate (1 mM) 
Inorganic 
salts 
Calcium chloride (0.2993 mM), Cupric sulphate (0.00001 mM), Ferric sulphate (0.003 
mM), Magnesium chloride (0.6010 mM), Potassium chloride (2.981 mM), Sodium 
bicarbonate (14 mM), Sodium chloride (131 mM),  
Sodium phosphate dibasic anhydrous (1 mM), Zinc sulphate (0.0030 mM) 
Vitamins 
Biotin (0.00003mM), Choline chloride (0.1mM), D-calcium panthothenate (0.0010mM), 
Folic acid (0.0029mM), Niacinamide (0.0003mM), Pyridoxine hydrochloride (0.0003mM), 
Riboflavin (0.0001mM), Thiamine hydrochloride (0.0009mM), Vitamin B12 (0.0010mM),  
i-inositol (0.1mM) 
Other 
components 
Hypoxanthine (0.0294mM), Linoleic acid (0.0003mM), Lipoic acid (0.0010mM), Phenol 
red (0.0032mM) Putrescine (0.0010mM), Thymidine (0.0029mM) 
 
6.3.3. Growth assessment 
During the cultures, biomass was determined by measuring the optical density 
(OD) to infer the cell dry weight (CDW). Samples were collected until 48 hours of culture to 
evaluate OD at 600 nm by using an ELISA microplate reader (TECAN Sunrise, 
Switzerland).  
For cell dry weight determination, a calibration curve was made by filtering 10 mL 
of culture in pre-weighted 0.2 µm mixed cellulose esthers filters (Advantec, Japan). The 
filtrate was then dried in a microwave to a constant weight. The calibration curve is shown 
in supplementary material 1. 
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To verify culture purity, at each time point the bacterial culture was plated in 
Columbia base agar (CBA) (Liofilchem, Italy) supplemented with 5% (v/v) defibrinated 
horse blood and Tryptic Soy Agar (Liofilchem, Italy) media and then incubated at 37°C in 
microaerophilic and aerobic conditions, respectively, during 5-7 days. 
 
6.3.4. Metabolites analysis 
At each time point (0-48 hours) samples of the culture supernatant (1 mL, in 
triplicate) were collected to analyze amino and non-amino organic acids by GC-MS in order 
to measure the consumption of amino acids and detect possible by-products secreted by 
H. pylori (method performed according to Smart et al. (2010)7 and detailed in Chapter 4). 
Acetate production was assayed enzymatically by a UV kit (Acetic acid UV-method - 
Cat. No. 10 148 261 035, Boehringer Mannheim/R-Biopharm, Roche, Germany). 
(Experimental procedure according to kit’s instructions). 
 
6.3.5. 13C labeling experiments  
Using the same culture protocols as described above (medium in Table 6.1), 
experiments (3 biological replicates) using 100% uniformly labeled 13C-glutamic acid ([U-
13C]-glutamic acid) (99%, Cambridge Isotope, USA) were performed. Biomass hydrolysates 
were analyzed to evaluate the incorporation of 13Carbon. Briefly, at the late-exponential 
phase (9 hours of culture), cultures were harvested (total volume of the culture) and 
pelleted by centrifugation (7000 x g, 10 min.). Cell pellets were hydrolyzed in 6 M HCl 
(495 µL) with thioglycolic acid (5 µL) (to preserve some amino acids), at 105 ºC for 24 
hours in sealed vials. After hydrolysis, samples were neutralized with 10 M NaOH (100 
µL). Then, samples were lyophilized during 24 hours and derivatized prior to GC-MS 
analysis, as described in Chapter 4 and summarized in Figure 6.1. 
Samples (1 mL, in triplicate) were collected at 0 h and 9 h of culture for analysis 
of extracellular metabolites and treated as described in Chapter 4 for extracellular 
metabolite analysis.  
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A control experiment (with three biological replicates) with 12C-glutamic acid was 
also performed.  
Figure 6.1. Flowchart applied for extracellular metabolites and biomass hydrolysates analysis by GC-MS. 
 
6.3.6. Data analysis 
Amino and organic acids present in the extracellular medium were identified using 
an in-house library, by matching retention time and mass spectrum, using the AMDIS 
software8. Data normalization was achieved by the normalization of the peak intensities by 
the intensity of the internal standard (d4 –alanine) in each sample. Data processing and 
analysis were performed with Excel and Multi Experiment Viewer (MeV)9. 
Amino acids present in the protein of biomass hydrolysates were identified using 
the same library as for extracellular metabolites. In order to analyze the 13C labeling 
patterns, from each major fragment (or molecular ion) generated by MS fragmentation of 
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the amino acids obtained from biomass hydrolysates, mass fractions were calculated for 
each mass isotopomers (m+0, m+1, m+2, m+3...m+n ) with n being number of carbons 
isotopicaly labeled. 
Those ratios were compared with those found in natural metabolites (from cells 
grown in 12C-glutamic acid). A correction of natural abundance of each atom was applied 
for the atomic composition of each mass fragment analyzed. A correction for unlabeled 
biomass was also performed by subtraction of the inoculum contribution (about 60% in the 
performed experiments). The mass fragments used for the final analysis were chosen 
based on abundance and on the amount of information that could be obtained from each 
one. Fractional labeling for those fragments were calculated based on Equation 6.110 using 
the mass fractions calculated. 
 
   
∑        
 ∑   
 
   
            Equation 6.1. 
 
Where n is the number of amino C atoms in the fragment, and mi is the mass 
isotopomers fractions, iis the number of labeled carbons in each fraction 
The labeling patterns of the amino acids were used to infer about active metabolic 
pathways. 
 
 
6.4. Results and Discussion 
6.4.1. Growth of H. pylori with glutamate  
Based on previous experiments, glutamate was selected as the most suitable 
carbon source for the growth of H. pylori. The growth curve of H. pylori 26695 growing 
using glutamate as carbon source is depicted in Figure 6.2. The growth parameters 
calculated for the experiments performed are showed in Table 6.2. The exponential phase 
occurred between 2 and 10 hours of growth, with a specific growth rate of 0.126 h-1 
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(doubling time of 5.6 hours), which is consistent with the value obtained in the previous 
chapter in the carbon source screening experiments. It is not possible to compare this 
value with other media using a sole carbon source because, to the best of our knowledge, 
experiments with only one carbon source with H. pylori have not been reported in the 
literature. Nevertheless, previous reports indicate that H. pylori 26695 is one of the H. 
pylori strains with the lowest growth rates 11.  
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Figure 6.2. Biomass concentration represented by Cell Dry Weight (CDW) and L-glutamate in the culture 
medium along time as a percentage of the initial concentration. Mean of three biological replicates. Error 
bars represent standard deviation at each time point.  
 
Table 6.2. Growth parameters for H. pylori 26695 growing in liquid medium with L-glutamate. 
Exponential phase (h) 
Specific growth rate (h-1) 
mean ± std dev 
Doubling time (h) 
mean ± std dev 
Biomass yield 
(Yx/s) (g g-1)* 
mean ± std dev 
2 – 10 0.126 ± 0.004 5.6 ± 0.2 0.60 ± 0.05 
*Calculated for glutamate. 
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6.4.2. Extracellular metabolites analysis 
Metabolites present in the supernatant represent metabolites that were present or 
were secreted into the culture medium. Extracellular metabolites analysis was performed 
in order to evaluate if carbon sources and essential amino acids were effectively being 
consumed and identify by-products excreted by H. pylori at the conditions used. Figure 
6.3. shows a heat map representing the percentages of amino and organic acids identified 
in the supernatant along the fermentation time (numeric values for those percentages and 
standard deviations for the biological replicates can be found in supplementary material 2 - 
Table 6.3). Some compounds that were completely consumed (L-alanine, L-proline, L-
aspartate and lactate) were not added to the culture medium and were present in low 
concentrations due to the 5% of FBS added, as described in detail in the previous chapter. 
The consumption occurs by the following order: L-proline, lactate, L-aspartate and L-
alanine. L-glutamate was completely consumed within the first 10 hours of growth, 
corresponding to the exponential phase (Figure 6.2). Lactate was present in the culture 
medium but was not accumulated and was completely consumed, suggesting that it is 
being used as an extra carbon source. Takahashi et al. (2007), also detected an 
improvement in the growth of H. pylori in the presence of L-lactate secreted by gastric 
mucosal cells12. 
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Figure 6.3. Heat map obtained with MeV9 representing the compounds identified in the supernatant of the 
H. pylori culture along the fermentation time as a percentage of the initial concentration (of three biological 
replicates). * Detected. 
 
Regarding the by-products that could be secreted by H. pylori, acetate was 
analyzed by an enzymatic kit, and was not detected in the supernatant of the culture, 
which is in agreement with the results obtained in the previous chapter but in contrast with 
the results reported by Mendz et al. (1995), that detected acetate as a metabolic product 
of glutamate consumption by H. pylori2. The observed differences may be due to 
differences in the H. pylori strain or the experimental conditions used. Succinate, another 
by-product detected by Mendz et al. (1995)2, was present in the culture medium due to 
FBS, was consumed during the exponential phase and secreted after this phase, with a 
consumption after 12 hours of culture (Figure 6.3). 
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6.4.3. 13C labeling analysis 
Labeling experiments using 13C L-glutamate were performed and the biomass 
hydrolisate was analyzed by GC-MS. In those 13C labeling experiments, extracellular 
metabolites were also analyzed at 0 hours and at 9 hours of culture. The metabolite 
profiles obtained were similar to the ones obtained for the non-labeled experiments 
described in the previous section. Glutamate was not completely consumed, remaining 
about 38% of its initial concentration in the culture medium when the biomass was 
collected for hydrolysis (9 hours), which confirms that the cells were in the exponential 
phase as required for the experiment. As described in the methods section, a control 
experiment (with 12C glutamate) was used to confirm that no isotopes fragments were 
observed in the mass spectra of the amino acids resulting from biomass hydrolisates, 
besides the natural isotopic abundance.  
The mass fraction calculation allows determining the contribution of the labeling in 
each carbon of the analyzed fragments. The mass fractions obtained for each fragment of 
the amino acids analyzed are shown in supplementary material 3 (Table 6.4). The 
fractional labeling calculated for the major fragments observed for each amino acid is 
depicted in Figure 6.4 and the selected fragments are shown in the supplementary 
material 4. A correction for the unlabeled biomass, which is derived from the inoculum, 
was applied. The inoculum contribution in this case is very high (about 60%), due to the 
low growth observed. The fractional labeling without unlabeled biomass correction is also 
depicted in Figure 6.4. The information obtained with the calculation of the fractional 
labeling allows to conclude about the percentage of each molecule that is labeled and to 
infer about the active metabolic pathways.  
Several amino acids did not show any labeling (isoleucine, histidine, leucine, 
methionine, phenylalanine and valine), while others are not measurable due to technical 
limitations already reported in the previous chapters (arginine). The fact that isoleucine, 
histidine, leucine, methionine phenylalanine and valine are not labeled confirms their 
status as essential amino acids, as hypothesized in Chapter .4 
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Figure 6.4. Fractional labeling (with and without unlabeled biomass correction) calculated for each amino 
acid present in the protein of biomass hydrolysates. Mean of three biological replicates. Error bars represent 
standard deviation. *asparagine and glutamine included in aspartate and glutamate, respectively. 
 
During biomass hydrolysis, asparagine and glutamine are deaminated to aspartate 
and glutamate, respectively. Tryptophan and cysteine are also partially degraded during 
protein hydrolysis. Thus, thioglycolic acid, a reduced agent, was added in order to avoid 
tryptophan degradation13. Also, in the biomass of H. pylori, tryptophan and cysteine are 
present in very low percentages, only accounting for 1% (each) of the total proteinogenic 
amino acids (estimated from the genome). Thus, the analysis of these amino acids in 
biomass hydrolysates is not accurate, explaining the high standard deviation observed for 
the fractional labeling of tryptophan. Nevertheless, both amino acids appeared labeled, 
showing that they are being produced with a contribution of carbon from L-glutamate. 
The fractional labeling of L-glutamate in biomass is around 0.7 (with unlabeled 
biomass correction), suggesting that L-glutamate is also being produced from other 
compounds. One possible source of L-glutamate is for instance L-proline, which can be 
converted into L-glutamate in two steps14. Another possibility is that lactate, that is being 
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consumed, is also contributing with carbon by conversion to pyruvate (by lactate 
dehydrogenase), and subsequent incorporation in the tricarboxylic acid (TCA) cycle, thus 
contributing probably not only for unlabeled glutamate but also for other unlabeled amino 
acids. L-glutamine, determined together with L-glutamate, is directly produced from L-
glutamate by glutamine synthetase (glnA, HP0512), with ATP consumption15, as described 
in the previous chapter. 
L-proline is the only amino acid that is not labeled, besides the known required 
amino acids. L-proline, which is present in FBS, appeared in the extracellular culture 
medium at a very low concentration (Figure 6.3). Testerman et al. (2006) determined that 
L-proline is essential for H. pylori growth16, although in silico it is not an essential nutrient17, 
as mentioned in Chapter 4. It seems that the need of L-proline could be strain specific18,19. 
As mentioned in Chapter 4, there are two possible biosynthetic routes of L-proline in H. 
pylori, the first one from L-glutamate (via L-glutamate 5-semialdehyde and L-1-pyrroline 5-
carboxylate), with the enzymes involved in that pathway identified by sequence homology20. 
The second one is from L-arginine, an absolute requirement for H. pylori growth. In that 
case, L-arginine is converted to ornithine, and subsequently to L-glutamate 5-
semialdehyde, which will be converted to L-proline via L-1-proline-carboxylase. However, 
the conversion from ornithine to L-glutamate 5-semialdehyde is not proved in H. pylori21. In 
our previous studies (Chapter 5), proline was tested as a carbon source and the observed 
growth was quite low, although H. pylori seems to have the necessary enzymatic 
capabilities to degrade it. Although some uncertainty remains, proline auxotrophy is not 
proved in our results, since as shown in Figure 6.2 and Figure 6.3, L-proline is exhausted 
from the culture medium at 4 hours of culture while the exponential phase lasts until 10 
hours of culture. Given the lack of labeling, it is likely that L-proline is synthesized in H. 
pylori from L-arginine rather than from L-glutamate, although further studies need to be 
performed to confirm this hypothesis.  
Another doubtful topic about the nutritional requirements of H. pylori is the need 
of L-alanine. Similarly to L-proline, it has been described that L-alanine is an absolute 
nutritional requirement for some strains18,19. In in silico experiments described by Thiele et 
al. (2005), L-alanine can be used as a carbon source17, although being essential. 
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Testerman et al. (2006) also described L-alanine as an essential amino acid16. In the 
present results, the fractional labeling of L-alanine is around 0.04, with a high standard 
deviation (0.04), explained by the low percentage of labeling. It is also important to 
highlight that alanine is present in FBS, and the low percentage of labeling is also due to 
that contribution. It seems that, despite the fact that there is a very high contribution of 
unlabeled carbon, L-glutamate also can contribute to L-alanine synthesis. The most 
plausible source of L-alanine is pyruvate, which could be obtained from L-lactate, as 
discussed above. In fact, H. pylori possess alanine dehydrogenase (ald; HP1398), which 
converts L-alanine into pyruvate and we have observed (results described in the previous 
chapter) that alanine can indeed be used effectively as a carbon source. However, despite 
the fact that the mentioned reaction is found to be reversible in several organisms, for 
instance in Mycobacterium tuberculosis22, there is no certainty that it is reversible in H. 
pylori. Additionally, using eQuilibrator23, a web interface created to estimate 
thermodynamic parameters, it is possible to confirm that the most favorable reaction 
direction in terms of energy is indeed the production of alanine from pyruvate. Another 
possible pathway for L-alanine production from pyruvate, which is used by E. coli, is 
through a transaminase such as valine-pyruvate transaminase or pyruvate-glutamate 
transaminase21,24, which are not proved as present in H. pylori. Other authors also identified 
alanine production from pyruvate and suggested that this conversion is due to the action of 
a transaminase25–27.  
The fractional labeling of aspartate (with asparagine included) is around 0.7, 
showing that the carbon flow is passing through the TCA cycle with conversion of L-
glutamate into alpha-ketoglutarate and further incorporation into the TCA cycle, being L-
aspartate produced from oxaloacetate by a transaminase (aspartate transaminase). The 
presence of this transaminase was inferred from homology15,20. Since L-asparagine is not an 
absolute requirement for H. pylori growth, it is thought that L-asparagine is synthesized 
from L-aspartate, via a tRNA dependent process in three steps21,28. L-lysine and L-threonine, 
which have a fractional labeling of 0.5 and 0.61, respectively, can also be derived from L-
aspartate15,29. The biosynthesis of L-lysine is achieved from L-aspartate using the  
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diaminopimelate pathway, involving succinylated intermediates21,30. Threonine, in turn, is 
synthesized from L-aspartate via homoserine21. 
The biosynthesis of L-tyrosine is known to be achieve with chorismate as 
precursor, sharing several steps with L-tryptophan biosynthesis21,31 The fractional labeling of 
tyrosine is around 0.25, showing again a high contribution of unlabeled carbon sources, 
that could be explained by the low level of pyruvate labeling, as discussed previously. 
It is described that L-serine biosynthesis occurs through 3-phospho-D-glycerate, an 
intermediary of glycolysis/gluconeogenesis, and that it can be a precursor for the 
production of L-cysteine and glycine. However, the fractional labeling of glycine is higher 
(0.36) than the one observed for serine (0.28). Given the standard deviations observed, 
this difference might not be meaningful. Nevertheless, if validated, this could mean that L-
serine is probably being produced from another pathway. The conversion of L-serine to 
glycine is achieved by a single reaction catalyzed by serine hydroxymethyltransferase (glyA, 
HP0183)21. There is no certainty about the reversibility of this reaction in H. pylori, 
although for E. coli it is described that the conversion of glycine to L-serine can also occur, 
meaning that glycine would have another biosynthetic route, such as from threonine by 
threonine aldolase with the production of acetaldehyde. In fact, this biosynthetic route has 
not been reported for H. pylori but is reported for other organisms such as E. coli21. Serine 
can also be converted to pyruvate, as it was reported by Mendz et al. (1994) that serine is 
one of the major sources of pyruvate26 in H. pylori. The fractional labeling of cysteine (0.28) 
is similar to the one observed for serine (0.28), consistent with the described biosynthesis 
of cysteine from serine in two steps through 0-acetyl-L-serine, with production of acetate21.  
The metabolic pathways proposed to be active under the conditions used are 
represented in Figure 6.5 . 
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Figure 6.5. Schematic representation of H. pylori’s metabolic pathways active under the conditions of the 
described experiments. Compounds added to the culture medium are shown in bold. Arrows in bold 
represent the hypothetical carbon flow through known pathways in H. pylori. Dashed arrows represent 
possible steps for which there is no certainty. 
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6.5. Conclusions 
The present study attempted to analyze the growth of H. pylori using L-glutamate 
as the main carbon source. An exometabolome analysis allowed determining the 
consumption pattern of the compounds present in culture medium. Under the conditions 
used, no acetate production was detected, showing that no fermentation is occurring. 
Additionally, the carbon flow was determined using 13C L-glutamate as the carbon source 
and measuring the labeling in proteinogenic amino acids, making this, to the best of our 
knowledge, the first study conducted with the goal of determining the carbon flow in H. 
pylori. Despite the use of fetal bovine serum, which contributed with lactate and 
consequently with unlabeled carbon, it was proved that glutamate is indeed the main 
carbon source under the conditions used and that it can be used as the sole carbon 
source, as suggested by other authors2.  
Overall, all amino acids suggested as non-essential in Chapter 4, except proline, 
presented a 13C labeling pattern. Although a definite proof is still needed, our results 
indicate that L-proline is not an essential amino acid and indicate that it is probably 
produced from L-arginine, which is present in the culture medium as an essential amino 
acid. Despite the controversy around the need of L-alanine as an absolute requirement, in 
the present study a low percentage of 13C labeling was detected in L-alanine, suggesting it 
can be produced by H. pylori, potentially from pyruvate. However, in order to confirm this 
result, experiments without FBS are needed. Finally, contributing to clarify the controversy 
around the existence of a complete TCA cycle in H. pylori, evidences were obtained with 
the presence of labeled aspartate.  
Finally, the fact that the amino acids isoleucine, histidine, leucine, methionine, 
phenylalanine and valine did not exhibit any labeling corroborates their essentiality.  
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6.7. Supplementary material  
6.7.1. Supplementary material 1 
A biomass calibration curve was achieved by plotting the cell dry weight (CDW) 
versus the optical density at 600 nm. The calibration curve obtained is depicted in Figure 
6.6. 
 
Figure 6.6. Biomass calibration curve.  
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6.7.2. Supplementary material 2 
Table 6.3 shows the compounds identified in the medium and the respective 
percentage of the initial concentration along the fermentation time obtained by GC-MS 
after derivatization with methylchloroformate (method described in Chapter 3). 
 
Table 6.3.  Evolution of the compounds identified in the culture medium as a percentage of the initial 
concentrations obtained by GC/MS. Mean of three biological replicates with three technical replicates. Mean 
± Standard deviation. Abbreviations: L-ala – L-alanine; L-asp – L-aspartate; L-glu – L-glutamate; L-ile – L-
isoleucine; L-leu – L-leucine; L-met – L-methionine; L-phe – L-phenylalanine; L-pro – L-proline; lac – lactate; 
succ – succinate; L-val – L-valine.  
Compounds 
identified 
Time (hours) 
4 8 10 12 24 48 72 
L-ala 
91% 
(± 22) 
50% 
(±19) 
0% 0% 0% 0% 0% 
L-asp detected 0% 0% 0% 0% 0% 0% 
L-glu 
81% 
(± 15) 
59% 
(±23) 
0% 0% 0% 0% 0% 
L-ile 
112% 
(± 26) 
96% 
(±9) 
118% 
(± 19) 
125% 
(±31) 
110% 
(± 29) 
97% 
(±14) 
94% 
(± 15) 
L-leu 
104% 
(± 12) 
104% 
(±11) 
118% 
(± 31) 
120% 
(±37) 
100% 
(± 3) 
101% 
(±15) 
95% 
(± 14) 
L-met 
101% 
(± 21) 
126% 
(±18) 
59% 
(± 32) 
33% 
(±27) 
45% 
(± 22) 
56% 
(±23) 
39% 
(± 23) 
L-phe 
99% 
(± 61) 
93% 
(±40) 
52% 
(± 29) 
43% 
(±23) 
51% 
(± 27) 
57% 
(±25) 
46% 
(± 16) 
L-pro 0% 0% 0% 0% 0% 0% 0% 
L-val 
104% 
(± 10) 
102% 
(±10) 
111% 
(± 8) 
120% 
(±18) 
112% 
(± 20) 
100% 
(±14) 
98% 
(± 13) 
lac detected 0% 0% 0% 0% 0% 0% 
succ 
80% 
(± 28) 
55% 
(±7) 
85% 
(± 29) 
101% 
(±41) 
84% 
(± 21) 
90% 
(±17) 
81% 
(± 13) 
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6.7.3. Supplementary material 3 
Table 6.4 shows the mass fractions calculated for each fragment analyzed for 
each derivatized amino acid in biomass hydrolysates. 
 
 
Table 6.4. Mass fractions calculated for mass isotopomers of each derivatized amino acid in biomass 
hydrolysates. Mean of three biological replicates (± standard deviation). m, m+1, m+2, m+3...m+n – mass 
isotopomer, n – number of carbons isotopicaly labeled. 
Amino acid (mass to 
charge ratio of the ion 
cluster) 
Mass isotopomer  
Mass fraction 
Without unlabeled 
biomass correction 
With unlabeled 
biomass correction 
Glycine (148) 
m  0.839 (± 0.035) 0.624 (± 0.081) 
m+1 0.039 (± 0.030) 0.064 (± 0.075) 
m+2 0.133 (± 0.032) 0.336 (± 0.075) 
Alanine (162) 
m  0.973 (± 0.024) 0.980 (± 0.061) 
m+1 0.001 (± 0.015) -0.046 (± 0.038) 
m+2 0.012 (± 0.003) 0.030 (± 0.008) 
m+3 0.015 (± 0.009) 0.039 (± 0.023) 
Aspartate/ 
Asparagine (220) 
m  0.624 (± 0.028) 0.108 (± 0.090) 
m+1 0.052 (± 0.008) 0.068 (± 0.022) 
m+2 0.102 (± 0.002) 0.259 (± 0.013) 
m+3 0.035 (± 0.005) 0.089 (± 0.011) 
m+4 0.209 (± 0.026) 0.531 (± 0.079) 
Cysteine (252) 
m  0.863 (± 0.025) 0.702 (± 0.068) 
m+1 0.028 (± 0.024) 0.022 (± 0.060) 
m+2 0.004 (± 0.008) 0.010 (± 0.019) 
m+3 0.104 (± 0.033) 0.266 (± 0.085) 
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Table 6.4.Mass fractions calculated for mass isotopomers of each derivatized amino acid in biomass 
hydrolysates. Mean of three biological replicates (± standard deviation). m, m+1, m+2, m+3...m+n – mass 
isotopomer, n – number of carbons isotopicaly labeled. (Continue) 
Amino acid (mass to 
charge ratio of the ion 
cluster) 
Mass isotopomer  
Mass fraction 
Without unlabeled 
biomass correction 
With unlabeled 
biomass correction 
Glutamate/ 
Glutamine (234) 
m  0.669 (± 0.027) 0.240 (± 0.071) 
m+1 0.018 (± 0.011) -0.034 (± 0.027) 
m+2 0.034 (± 0.004) 0.085 (± 0.011) 
m+3 0.061 (± 0.007) 0.155 (± 0.015) 
m+4 0.029 (± 0.007) 0.073 (± 0.017) 
m+5 0.213 (± 0.018) 0.542 (± 0.053) 
Lysine (277) 
m  0.647 (± 0.093) 0.202 (± 0.222) 
m+1 0.055 (± 0.026) 0.045 (± 0.069) 
m+2 0.055 (± 0.028) 0.136 (± 0.070) 
m+3 0.107 (± 0.022) 0.270 (± 0.052) 
m+4 0.089 (± 0.029) 0.218 (± 0.072) 
m+5 0.017 (± 0.007) 0.042 (± 0.018) 
m+6 0.040 (± 0.017) 0.101 (± 0.042) 
Proline (128) 
m  0.958 (± 0.010) 0.958 (± 0.025) 
m+1 0.042 (± 0.005) 0.043 (± 0.013) 
m+2 -0.0006 (± 0.007) -0.002 (± 0.010) 
m+3 -0.0003 (± 0.0001) -0.0007 (± 0.0004) 
m+4 0.0008 (± 0.001) 0.002 (± 0.003) 
Serine (178) 
m  0.846 (± 0.016) 0.658 (± 0.034) 
m+1 0.040 (± 0.006) 0.053 (± 0.014) 
m+2 0.039 (± 0.002) 0.099 (± 0.003) 
m+3 0.082 (± 0.015) 0.207 (± 0.033) 
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Table 6.4.Mass fractions calculated for mass isotopomers of each derivatized amino acid in biomass 
hydrolysates. Mean of three biological replicates (± standard deviation). m, m+1, m+2, m+3...m+n – mass 
isotopomer, n – number of carbons isotopicaly labeled. (Continue). 
Amino acid (mass to 
charge ratio of the ion 
cluster) 
Mass isotopomer  
Mass fraction 
Without unlabeled 
biomass correction 
With unlabeled 
biomass correction 
Threonine (192) 
m  0.676 (± 0.012) 0.241 (± 0.048) 
m+1 0.045 (± 0.003) 0.051 (± 0.008) 
m+2 0.080 (± 0.002) 0.203 (± 0.003) 
m+3 0.025 (± 0.002) 0.065 (± 0.005) 
m+4 0.190 (± 0.012) 0.484 (± 0.042) 
Tryptophan (276) 
m  0.186 (± 0.121) -0.896 (± 0.300) 
m+1 0.102 (± 0.092) 0.099 (± 0.233) 
m+2 0.064 (± 0.093) 0.151 (± 0.233) 
m+3 0.045 (± 0.046) 0.114 (± 0.122) 
m+4 0.042 (± 0.033) 0.107 (± 0.084) 
m+5 0.103 (± 0.102) 0.260 (± 0.254) 
m+6 0.097 (± 0.093) 0.246 (± 0.233) 
m+7 0.235 (± 0.341) 0.593 (± 0.856) 
m+8 0.003 (± 0.046) 0.007 (± 0.115) 
m+9 0.054 (± 0.032) 0.136 (± 0.125) 
m+10 0.018 (± 0.032) 0.047 (± 0.083) 
m+11 0.063 (± 0.055) 0.162 (± 0.141) 
Tyrosine (236) 
m  0.644 (± 0.056) 0.239 (± 0.141) 
m+1 0.131 (± 0.029) 0.196 (± 0.074) 
m+2 0.062 (± 0.011) 0.152 (± 0.029) 
m+3 0.071 (± 0.015) 0.180 (± 0.039) 
m+4 0.035 (± 0.015) 0.089 (± 0.036) 
m+5 0.027 (± 0.005) 0.068 (± 0.015) 
m+6 0.017 (± 0.007) 0.043 (± 0.018) 
m+7 0.005 (± 0.002) 0.013 (± 0.006) 
m+8 0.003 (± 0.005) 0.007 (± 0.011) 
m+9 0.005 (± 0.009) 0.013 (± 0.022) 
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6.7.4. Supplementary material 4 
Table 6.5 shows the mass of the ion fragments used to determine the fractional 
labeling for each amino acid and the respective fractional labeling with and without 
unlabeled biomass correction. 
 
Table 6.5. Fractional labeling determined for the fragments used for each amino acid. Mean of three 
biological replicates (± standard deviation). 
Amino acid 
Mass ion fragments/ 
Number of amino acid 
carbons 
Fractional labeling 
Without unlabeled 
biomass correction 
With unlabeled 
biomass 
correction 
Glycine 148/3 0.150 (± 0.030) 0.359 (± 0.067) 
Alanine 162/3 0.023 (± 0.015) 0.044 (± 0.037) 
Aspartate/ 
Asparagine 
220/4 0.293 (± 0.024) 0.705 (± 0.071) 
Cysteine 252/3 0.117 (± 0.031) 0.280 (± 0.081) 
Glutamate/ 
Glutamine 
234/5 0.283 (± 0.020) 0.679 (± 0.051) 
Lysine 277/6 0.191 (± 0.045) 0.463 (±0.102) 
Proline 128/4 0.011 (± 0.004) 0.011 (± 0.011) 
Serine 178/3 0.121 (± 0.015) 0.286 (± 0.032) 
Threonine 192/4 0.256 (± 0.012) 0.620 (± 0.043) 
Tryptophan 276/11 0.420 (± 0.142) 1.035 (± 0.362) 
Tyrosine 236/9 0.105 (± 0.024) 0.251 (± 0.057) 
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7.1  Abstract 
Helicobacter pylori is a pathogenic bacterium that colonizes the human gastric epithelia, 
causing duodenal and gastric ulcers, and gastric cancer. The genome of H. pylori 26695 has 
been previously sequenced and annotated. In addition, two genome-scale metabolic models have 
been developed. In order to maintain accurate and relevant the information on this bacterium 
and to generate new information and new approaches for its analysis, the assignment of new 
functions to H. pylori 26695’s genes was performed and a new genome-scale metabolic model 
was reconstructed. 
Model reconstruction originated the iTR370 metabolic model, a compartmentalized 
model containing 370 genes and composed by 666 different reactions and 432 metabolites. 
Gene essentiality analysis was performed to assess the predictive capabilities of the model, and 
growth simulations were performed using experimental data to adjust the nutrients uptake rates. 
Finally, the flux distributions predicted by the model using L-glutamate as the sole carbon source 
were analyzed. 
It is shown that the iTR370 metabolic model is useful for predicting H. pylori’s 
phenotypic responses to gene deletions, and allows a very good agreement with experimental 
results obtained for cultivation experiments using a minimal medium. This model provides 
relevant biological information for the scientific community dealing with this organism by allowing 
the elucidation of new features in H. pylori’s metabolism, assisting in the identification of new 
drug targets and the development of new approaches for enhanced treatments. 
 
Keywords: Helicobacter pylori. Genome-scale metabolic model. Genome re-annotation. 
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7.2 Introduction 
The introduction of whole-genome high-throughput sequencing techniques and the 
development of several bioinformatics tools have been generating a vast amount of new 
information, changing completely our understanding on hundreds of species1. However, in this 
post-genomic era, assigning functions to genes in a sequenced genome is still a complex and 
difficult task, involving several steps2. 
H. pylori 26695, which presents a small size genome of around 1.67 Mbp with an 
average C+G content of 39%, was the first H. pylori strain to have its genome sequenced in 
19973. The last re-annotation of this organism was published in 2003 and generated a specific 
on-line database for H. pylori (PyloriGene)4. It also reduced the percentage of hypothetical 
proteins from approximately 40% to 33%, allowing the reassignment of functions to 108 CDS 
(coding sequences)4 
The reconstruction of metabolic networks allows the development of a genome-scale 
metabolic model based on the well-known stoichiometry of biochemical reactions catalyzed by 
the enzymes encoded in the annotated genes of an organism5,6. These models can then be used 
for simulating in silico the phenotypic behavior of a microorganism under different environmental 
and genetic conditions, thus representing an important tool in metabolic engineering and drug 
design5. Numerous drugs used for the treatment of pathogenic bacteria target metabolic 
enzymes, and therefore genome-scale modeling of bacterial metabolism provides a powerful tool 
to identify and analyze pathways required for infection7. 
Two genome-scale metabolic models have been published for H. pylori 266958,9. The first 
model was published in 2002 (iCS291) with 291 genes and 388 reactions8 and, in 2005, an 
updated version was published, which accounts for 341 genes and 476 reactions, also including 
355 gene-protein-reaction (GPR) associations. These models were constructed with information 
mainly taken from the genome, as very scarce biochemical knowledge was available for H. pylori. 
However, in the last years, a vast amount of data have been published that can be used to 
upgrade and refine the published metabolic models. A new genome re-anotation was also 
recently published by the authors of this chapter10. As such, the aim of this work was to 
reconstruct a new genome-scale metabolic model using the updated re-annotation. Also, the 
physiological data collected in previous chapters was used to validate the model. 
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7.3 Methods 
Before the development of a metabolic model, the metabolic network has to be 
reconstructed. This network is defined as the set of biological reactions catalyzed by enzymes 
encoded in the genome. After the reconstruction of the metabolic network, more information is 
added, in order to develop a metabolic model5,11. 
The applied methodology in reconstructing the genome-scale metabolic model of H. 
pylori 26695 is shown in Figure 7.1. Several steps were performed including the metabolic 
network assembly and subsequent conversion to the metabolic model after the implementation 
of a biomass equation. 
The Model Reconstruction Tool, a module within the in-house merlin software (Metabolic 
Models Reconstruction using Genome-Scale Information)12 (available for download at 
http://sysbio.uminho.pt/merlin/), was used throughout this work. Briefly, this tool allows the 
researcher to load generic and organism-specific reaction and metabolite information from 
KEGG13, predict transport reactions, define pathways and integrate all the information with data 
from annotation. Afterwards, the draft metabolic model can be generated and stored in the 
Systems Biology Markup Language (SBML) format12. 
 
Figure 7.1.  Genome-scale metabolic model reconstruction workflow. 
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7.3.1 Metabolic network assembly 
Making use of the updated annotation10 the reactions promoted by each complete EC 
number identified were retrieved from KEGG by merlin, and their metabolic information was used 
to assemble the draft network. In order to prevent an overload of futile reactions, gaps and dead 
ends in the network, due to the inclusion of every reaction associated to each EC number, merlin 
uses KEGG pathways. Thus, only reactions for which the corresponding EC number is present in 
the same pathways were included in the model. From KEGG, reactions classified as spontaneous 
were also included. 
After the assembly of all enzymatic reactions encoded in the annotated genome and 
spontaneous reactions, transport reactions also need to be included, in order to allow the input 
and output of metabolites in the model. From the re-annotation10, a list of all the transporter 
proteins identified from the genome was made available. From those, the elaboration of the 
transport reactions can be made automatically in merlin. However, as the number of metabolites 
that can be possibly transported by a transport protein is very large, only those which were 
already present in the reactions within the network were assigned with a transport reaction and 
included in the model, preventing the introduction of gaps.  
 
7.3.2 Reactions compartmentation 
Being H. pylori a prokaryote and despite its cell compartmentation being limited to the 
cytosol and the periplasmic space, information on protein location and reaction 
compartmentation is very important when reconstructing the metabolic model. 
The prediction of the location and consequent assignment to compartments of enzymes 
and transport proteins was also performed using merlin. After the prediction of proteins 
localization, this information was integrated in the metabolic network.  
 
7.3.3 Assignment of reversibility to reactions 
The attribution of the correct reversibility to model reactions is very important. Models 
with an excess of reversible reactions are not sufficiently constrained, and futile cycles may 
occur, making the model unrealistic and causing problems during optimization11. In the KEGG 
database, all reactions are set to be reversible. To overcome this problem, in the reconstruction 
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of H. pylori’s model, a database developed by Stelzer et al. (2011)14 was used to perform the 
initial assignment of reversibility to reactions. This database includes the assignment of 
reversibility to KEGG reactions, therefore facilitating its implementation in our work. Additionally, 
the estimation of the standard Gibbs free energy of formation (ΔfGo) and of reaction (ΔrGo) was 
also utilized to determine reaction reversibility. Those thermodynamic parameters can be used to 
determine how much energy is required for a particular biochemical reaction to occur and in 
which direction the reaction will flow under given cellular conditions. Standard Gibbs free energy 
values can be obtained for most KEGG reactions using eQuilibrator 
(http://equilibrator.weizmann.ac.il/), a web interface that enables thermodynamic analysis of 
biochemical reactions15. Because it cannot be automatically propagated to every reaction in the 
model, this approach was only used when information on reaction reversibility was scarce or 
when doubts occurred. Since the assignment of the wrong direction to a reaction has a 
significant impact in the model, if no information could be gathered, the reaction was left to be 
reversible. 
 
7.3.4 Reactions stoichiometry 
The stoichiometry of the metabolic reactions can be determined by balancing the 
elements on the substrate and product sides of the reaction. The KEGG database contains the 
charged formula for a large amount of metabolites within reactions; however, for some 
metabolites included in the model reconstruction, the charged formula lacked, resulting in 
unbalanced reactions. Another reason for the detected unbalanced reactions is the lack of 
protons and water molecules that many biochemical databases and textbooks omit in order to 
simplify the reactions11. Unbalanced reactions might spontaneously produce protons or ATP and 
therefore every metabolite must be in the correct amounts and correctly charged to balance both 
sides of the reaction. In most cases, unbalanced reactions were balanced by simply adding the 
missing proton or water molecule. 
 
7.3.5 Gene-protein-reaction associations 
In order to accurately determine gene essentiality and to improve the assignment of 
reactions to specific genes, gene-protein-reaction (GPR) associations are required features in a 
genome-scale metabolic model. In GPR associations, a single gene can be associated with a 
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single reaction, multiple reactions, or even be integrated among other genes in a reaction 
catalyzed by a protein complex. In these cases, the association of gene(s) to reaction(s) can be 
made by applying a Boolean rule, which can be “AND” or “OR, depending on if the presence of 
all genes is absolutely required or not for the reaction to occur, respectively. 
The KEGG Brite database13 was used within merlin to retrieve information from 
orthologues and a hierarchical classification and to create GPR associations in the metabolic 
network. 
 
7.3.6 Biomass formation 
The biomass equation is the most important reaction in the model. In this equation, all 
components considered essential to the overall cellular growth, with the corresponding fractional 
contributions are included. This reaction represents the biomass composition and is composed of 
several substrates that are originated in metabolic reactions of the model, and that can be 
divided in different categories: Protein, Nucleotides (DNA and RNA), Peptidoglycan, 
Lipopolysaccharide, Lipids, Cofactors and Energy. The same reaction has, as its products, 
besides biomass itself, orthophosphate, diphosphate and hydrogen. 
As for the majority of bacteria, information on detailed biomass composition for H. pylori 
is not available. In the present work, the relative fractional contribution of biomass components 
was estimated either from the genome, experimentally, or retrieved from literature. 
The first step was the estimation of the macromolecular composition of the biomass of 
H. pylori. Total protein and DNA content were experimentally determined from cultures of H. 
pylori in the exponential phase using Ham’s F-12 (supplemented with 5% FBS) as growth 
medium (described in Chapter 4) using the Biuret16 and fluorescence with DAPI17 methods, 
respectively (detailed in Santos and Rocha (2013)18. Total content of RNA, lipids, peptidoglycan, 
lipopolysaccharide (LPS), and cofactors were retrieved from a genome-scale model of E. coli 
(iAF1260)19 and their contribution was adjusted taking into account the content of the 
macromolecules experimentally determined (protein and DNA). 
The RNA and DNA building-blocks, nucleoside triphosphates (NTPs) and deoxynucleoside 
triphosphates (dNTPs), respectively, were computationally predicted from the H. pylori’s genome 
sequence according to a published protocol11 using a Java Tool (detailed in Santos and Rocha 
(2013)18. Monomers of proteins (amino acids) were also determined computationally using the 
genome sequence. In addition, amino acids were also confirmed experimentally by HPLC after 
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protein hydrolysis. The method used was the OPA and FMOC derivatives, with minor 
modifications20. 
The lipid building-blocks (fatty acids) composition was estimated according to the 
protocols described by Thiele and Palsson (2010)11 and Bautista et al., (2013)21 . Data from specific H. 
pylori lipid composition were obtained from Hirai et al. (1995)22 and Geis et al. (1991)23. 
The composition of cell wall components, peptidoglycan and lipopolysaccharide, was retrieved 
from the E. coli model (iAF1260) and from a previous H. pylori model (iIT341), respectively. 
The cofactors and their coefficients in the biomass equation were retrieved either from 
the list of universal biomass components developed by Henry, et al. (2010)24 from an E. coli 
model (iJO1366)25 and from the previous H. pylori model (iIT341)9. 
The inclusion of the biomass equation allowed converting the genome-scale metabolic 
network into a draft genome-scale metabolic model. The units of the flux through the biomass 
reaction are h-1, since its precursor fractions are given in mmol/gDW. Thus, the biomass equation 
accounts for the number of moles of each precursor necessary to produce 1 g of dry weight of 
cells. 
 
7.3.7 Growth medium requirements 
Information on growth-enabling media is of great importance in the development of an 
accurate metabolic model. The starting point in H. pylori’s metabolic model growth medium 
requirements was the Ham's F12 defined medium26, which has been used to grow H. pylori. The 
minimal medium experimentally obtained in previous chapters for H. pylori growth was also used 
for simulations and the in silico results were compared with experimental data in order to assess 
model accuracy. 
 
7.3.8 Model curation 
After the complete assembly of the metabolic network, and posterior addition of GPR 
associations, the biomass reaction, and the establishment of growth medium requirements, the 
metabolic network was finally converted to a draft model, capable of being simulated and 
optimized. However, a manual curation of the model was still required, as, although very useful, 
these automatic methods are fallible. The manual curation was performed with a revision of the 
literature, and by consulting organism-specific databases, and tried to solve inconsistencies on 
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protein-reaction identifiers, ambiguous data, duplicated information, and propagated errors from 
annotation. After the first curation, a tool within merlin was applied in order to automatically 
eliminate reactions with dead-end metabolites from the model, being either biochemical or 
transport reactions. If a given metabolite is not consumed nor transported by another reaction, 
such reaction was deleted from the model. This was a recursive process because the removed 
reactions can sometimes originate dead-ends to other metabolites, and therefore, such process 
was performed with great care, in order to prevent the loss of valuable information from the 
model. Once curated, the genome-scale metabolic model of H. pylori was ready for simulation 
and optimization.  
 
7.3.9 Simulation and model optimization 
Metabolic model simulations were performed with parsimonious Flux Balance Analysis 
(pFBA)5. For the H. pylori's genome-scale metabolic model, the linear programming problem of 
pFBA was solved using OptFlux, an in-house developed and user-friendly software tool, open-
source and compatible with SBML. OptFlux accommodates several tools and algorithms 
developed for the manipulation and optimization of metabolic models27. 
 
7.3.10 Model validation 
In this step, the genome-scale metabolic model was evaluated and its overall 
performance validated. For the validation of the model, the analysis of strategic fluxes was 
performed. The evaluation parameters were focused on specific growth rates, by-products 
formation and corresponding yields, for different growth conditions. These results were then 
compared with the experimental data collected in previous chapters. 
Reactions with existing fluxes were analyzed and when inconsistencies between model 
and experimental data arose, the model was revised and corrected. 
Another evaluation approach consisted in the assessment of essential genes and its 
comparison with experimental data, published in the OGEE database28. When the gene 
essentiality simulations did not match with experimental data, the genome annotation was 
reviewed. 
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7.4 Results and Discussion 
7.4.1 Genome re-annotation and network assembly 
As mentioned before, a re-annotation of the genome has been performed by the authors 
of this chapter and the detailed procedure and results can be found in Resende et al. (2013)10. 
Briefly, the developed annotation pipeline successfully reviewed all the 1573 coding sequences 
(CDS) from H. pylori 26695’s genome, finding functions to 1212 of its genes and assigning EC 
numbers to 581 of them. Also, 155 CDS were classified as transporter-encoding genes. As 
depicted in Figure 7.2., the total number of coding sequences can be divided into 712 genes 
(45%) with a metabolic function and 500 (32%) with non-metabolic functions. The number of 
hypothetical CDS was 361, representing a total of 23% of the CDS in the genome, a lower 
number than the previous annotation which contained 510 hypothetical proteins (32%).  
 
Figure 7.2. H. pylori 26695 re-annotation results and statistics (detailed results can be found in Resende et al. 
(2013)10. 
 
After the genome-wide re-annotation of this bacterium and subsequent attribution of 
metabolic and transport functions to its genes, the metabolic network was assembled by 
integrating KEGG reactions information, transport reactions and enzyme localization data. This 
automatic process originated a draft network containing approximately 1800 reactions, though a 
large number of which were unconnected or erroneously integrated and, therefore, were removed 
once the model was curated, lowering the final number of reactions in the model. 
 
H. pylori 26695 genome
1573 genes
100%
Metabolic function
712 genes
45.26%
Total E.C. numbers
581 genes
36.94%
E.C. numbers only
557 genes
35.41%
E.C. & TC(s) nº
24 genes
1.53%
TC(s) nº only
131 genes
8.33%
Non-metabolic
500 genes
31.79%
Hypothetical
361 genes
22.95% 
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7.4.2 Biomass formation 
In order to convert the metabolic network into a metabolic model, a biomass equation 
was formulated to represent the biomass composition of H. pylori. Each category and the 
corresponding metabolites are concisely described next. More information about biomass 
estimation can be found in supplementary material E1 (electronic version). The macromolecular 
composition and their coefficients are showed in Table 7.1. 
 
Table 7.1. Macromolecular composition of the biomass of H. pylori and respective contribution to the overall 
biomass. 
Biomass contribution (g/g) 
Protein 0.500 
DNA 0.070 
RNA 0.224 
Lipids 0.099 
Peptidoglycan 0.027 
Lipopolisaccharides 0.037 
Cofactors and other 0.043 
 
7.4.2.1 Protein entity 
Biomass protein composition was estimated from genome information (with the referred 
Java tool), by inspecting the composition of the protein-encoding genes, and determined 
experimentally. Results are displayed in Table 7.2. All amino acids were experimentally 
determined, exception made for cysteine and tryptophan, that were not detected with the method 
used. In this case, the assumed coefficient was the one obtained by estimation from genome 
information. Also, during hydrolysis glutamine and asparagine were deaminated to glutamate and 
aspartate, respectively, and thus the coefficient for each of those four amino acids was adjusted 
using the values obtained from genome information. In the cases of glycine and threonine, as 
well as isoleucine and phenylalanine, the same correction was applied since they are being 
analyzed together in HPLC. All the remaining coefficients are taken directly for experimental data. 
The amount of each amino acid in biomass is presented in mmol of amino acid per gram of cell 
dry weight (mmol.gDW-1). 
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Table 7.2 Total amount of amino acids in biomass composition. All components are located in the cytoplasm 
Amino Acid KEGG id Coefficient (mmol.gDW-1) 
Glycine C00037 0.111850 
L-Alanine C00041 0.274183 
L-Arginine C00062 0.151668 
L-Asparagine C00152 0.185275 
L-Aspartate C00049 0.185275 
L-Cysteine C00097 0.400096 
L-Glutamine C00064 0.153044 
L-Glutamate C00025 0.282238 
L-Histidine C00135 0.103177 
L-Isoleucine C00407 0.093398 
L-Leucine C00123 0.400877 
L-Lysine C00047 0.237732 
L-Methionine C00073 0.109041 
L-Phenylalanine C00079 0.070296 
L-Proline C00148 0.048062 
L-Serine C00065 0.152764 
L-Threonine C00188 0.085215 
L-Tryptophan C00078 0.257262 
L-Tyrosine C00082 0.149287 
L-Valine C00183 0.280943 
 
7.4.2.2 Nucleotide content 
The estimation of each dNTP (i.e., dATP, dCTP, dGTP and dTTP) is shown in Table 7.3. 
Their prediction was performed using the same in-house developed Java tool referred previously, 
but this time, by calculating the frequency of each nucleobase in the whole genome. 
 
Table 7.3. Total amount of dNTPs in the biomass composition. All components are located in the cytoplasm 
dNTP KEEG id Coefficient (mmol.gDW-1) 
dATP C00131 0.043574 
dGTP C00286 0.027699 
dTTP C00459 0.044322 
dCTP C00458 0.028200 
 
The determination of the nucleotides (NTP) ATP, CTP, GTP and UTP, was performed with 
some changes in the referred protocol to account for the three main different types of RNA, 
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namely rRNA, tRNA and mRNA, existing in the cells. Biomass nucleotides composition is 
displayed in Table 7.4. 
 
Table 7.4. Total amount of NTPs in the biomass composition. All components are located in the cytoplasm 
NTP KEEG id Coefficient (mmol.gDW-1) 
ATP C00002 0.117241 
CTP C00063 0.095900 
GTP C00044 0.113151 
UTP C00075 0.125639 
 
7.4.2.3 Peptidoglycans and Lipopolysaccharides 
Peptidoglycan biosynthesis is a complex process involving several steps. Due to the lack 
of experimental data, the reaction originating peptidoglycan was adapted from the previous H. 
pylori model (iIT341 GSM/GPR)29. This metabolite was then inserted in the biomass equation with 
the coefficient calculated as previously explained. 
The lipopolysaccharide biosynthesis is also a very complex process, encompassing 
several reactions. The total amount of lipopolysaccharide in the biomass was adapted from the 
last H. pylori model (iIT341 GSM/GPR)9. Both metabolites are shown in Table 7.5 with the 
respective biomass coefficient. 
 
Table 7.5. Total amount of cell wall metabolites in the biomass composition. 
Metabolite KEEG id Compartment Coefficient (mmol.gDW-1) 
Peptidoglycan C00889 periplasmic 0.015001 
Lipopolysaccharide C00338 periplasmic 0.008404 
 
In Table 7.5, all cell wall metabolites are located in the periplasm. Although this did not 
occur in the previous model due to the lack of compartments, once produced, peptidoglycans, 
lipopolysaccharides and other cell wall compounds are transported to the periplasm. 
 
7.4.2.4 Lipids 
In order to produce lipids, a fatty acid entity was inserted in the model to represent the 
average fatty acid composition of the cell. Then, the reaction R_fattyacid was also included to 
represent the aggregation of the fatty acids experimentally identified in H. pylori (Geis, et al. 
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(1990)23 and Hirai et al. (1995))22 The substrates of this reaction are six fatty acids: myristic acid 
(tetradecanoic acid), palmitic acid (hexadecanoic acid), stearic acid (octadecanoic acid), oleic 
acid ((9z)-octadecenoic acid), linoleic acid (linoleate), and phospholipid cyclopropane fatty acid. 
The substrate coefficients needed to produce 1 entity of fatty acid are: 0.4995 (myristic acid), 
0.0511 (palmitic acid), 0.0594 (stearic acid) and 0.0998 (oleic acid), 0.0220 (linoleate) and 
0.2680 (phospholipid cyclopropane). The fatty acid entity allows the drainage of lipids for 
biomass, because it requires the production of Acyl-coA (reaction R00389) which is a precursor 
of all lipids present in the biomass equation. Such lipids are displayed in Table 7.6. 
The coefficients were determined as detailed in supplementary material E1 (electronic 
version). 
 
 
Table 7.6. Total amount of different lipids in the biomass composition. 
Lipid KEEG id Compartment Coefficient (mmol.gDW-1) 
Cardiolipin C05980 periplasmic 0.026586 
Phosphatidylethanolamine C00350 cytoplasmic 0.071349 
Phosphatidylglycerol C00344 cytoplasmic 0.015580 
Phosphatidylserine C02737 cytoplasmic 0.002473 
 
 
7.4.2.5 Cofactors 
In our model, cofactor metabolites classified by Henry, et al. (2010)24as universal 
components of biomass were added to the biomass equation (Table 7.7.). Cofactors coefficients 
were retrieved from the iJO1366 model25 and their contribution was adjusted considering the 
other biomass components. 
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Table 7.7. Different cofactors in the biomass composition with the respective coefficient. All components are 
located in the cytoplasm. 
Cofactor 
KEEG 
id 
Coefficient 
(mmol.gDW-1) 
10-Formyltetrahydrofolate C00234 0.001042 
2-Demethylmenaquinone 6 C05818 0.001042 
5-Methyltetrahydrofolate C00440 0.001042 
5,10-Methylenetetrahydrofolate C00143 0.001042 
Acetyl-CoA C00024 0.001303 
Acyl-carrier protein C00229 0.001042 
Ammonia C00014 0.057827 
Biotin C00120 0.000009 
Chorismate C00251 0.001042 
Coenzyme A C00010 0.000785 
Flavin adenine dinucleotide oxidized (FAD) C00016 0.001042 
Heme C00032 0.001042 
Malonyl-CoA C00083 0.000145 
Menquinone 6 C00828 0.001042 
Nicotinamide adenine dinucleotide (NAD) C00003 0.008348 
Nicotinamide adenine dinucleotide - reduced (NADH) C00004 0.000210 
Nicotinamide adenine dinucleotide phosphate 
(NADP) 
C00006 0.000523 
Nicotinamide adenine dinucleotide phosphate - 
reduced (NADPH) 
C00005 0.001565 
Putrescine C00134 0.155416 
Pyridoxal phosphate C00018 0.001042 
Riboflavin C00255 0.001042 
S-Adenosyl-L-methionine C00019 0.001042 
Spermidine C00315 0.031504 
Succinyl-CoA C00091 0.000458 
Tetrahydrofolate C00101 0.001042 
Thiamine C00378 0.001042 
UDP-glucose C00029 0.014014 
di-trans,poly-cis-Undecaprenyl diphosphate C04574 0.000257 
 
7.4.2.6 Energy requirements 
Growth–associated energy requirements in terms of ATP molecules needed per gram of 
biomass synthesized are also needed to be included in the biomass equation. 
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The growth ATP requirements adopted in this model were retrieved from the E. coli 
(iJO1366) metabolic model25.The coefficient representing ATP consumption requirements for cell 
growth was set to 53.95 mmol.gDW-1. 
The depletion of ATP by processes other than growth was represented in the model by an 
equation that forces ATP consumption throughout a specific flux. The boundaries of this flux were 
also retrieved and adapted from the E. coli model iJO136625. 
 
7.4.3 Model curation 
The first step in model curation was to look for reactions with wrong compartmentation 
information. After the first curation step, the size of the model was decreased by automatically 
removing reactions, either biochemical or transport, with dead end metabolites from the model. 
This process reduced the total number of reactions from about 1800 to approximately 700 
reactions. As it is a recursive method, some reactions of the model were erroneously removed, 
disabling the model's simulating capability. After this process, the origin of each biomass 
precursor was verified to identify unconnected reactions. For that purpose the model was 
exported into the SBML format, and imported into OptFlux27, so that simulations could be 
performed. Initially, the boundaries of all uptake drains of the model were unrestricted to 
determine whether the model was able to produce, or not, biomass. 
Having, finally, a model capable of simulating the production of biomass (although with 
all entries unconstrained), the model was checked for unbalanced reactions. 
Once the metabolic model was properly curated, it was ready for evaluation and 
characterization. 
 
7.4.4 Model Evaluation 
The outcome of the previous tasks allowed obtaining a genome-scale metabolic model of 
H. pylori 26695 based in its most recent genome re-annotation. The metabolic model is 
available, in the SBML format, in the supplementary material E2 (electronic version). 
 
7.4.4.1 Model characterization 
When reconstructing the metabolic model, 370 metabolic genes from the performed 
annotation were used. Though still available for the continuous improvement of the metabolic 
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model, the remaining annotated metabolic genes were not included in this version of the model. 
This happened either because the metabolites on their catalyzed reactions were unconnected 
from the metabolic network, or due to a decision taken during the manual curation of the model. 
Another reason lies on the fact that some of these excluded metabolic genes encode enzymes 
only identified with a partial EC number, thus disabling any reaction integration possibility. 
Table 7.8 displays the characteristics of the generated metabolic model. The 370 
metabolic genes included in the model encode 254 different enzymes and 61 transport proteins, 
promoting a total of 666 different reactions, when combined with the spontaneous and manually 
added reactions. 
 
Table 7.8. Metabolic model characteristics. 
Genes Enzymes Transporters 
Enzymatic 
reactions 
Transport 
reactions 
Metabolites Compartments 
370 254 61 450 216 432 2 
 
There are 176 manually inserted reactions in the model (reactions not inferred directly 
from the annotation), being 91 of which transport reactions located in the periplasmic 
membrane, allowing for the exchange of metabolites between the internal compartments and the 
environment. The remaining manually inserted reactions correspond to metabolic reactions used 
in the gap filling, during the curation process of the model and also to reactions added from 
literature evidence. All reactions included in the model are available in supplementary material 
E3 (electronic version). 
The implementation of GPR associations allowed the aggregation of enzymatic subunits 
into protein complexes in the model, which is very important when simulating the impact of 
deleting a subunit on a protein complex. If a subunit on a protein complex with a GPR association 
is deleted, the entire complex is disabled, enhancing the accuracy of model simulation and 
allowing for a better understanding of the metabolic fluxes. It also enhances the performance of 
the prediction of essential genes. In our model there are 505 reactions with gene associations, 
being 117 of which associated with 2 or more genes. GPR associations and the respective 
reactions are available in supplementary material E3 (electronic version). 
A comparison between our model (iTR370) and the last H. pylori model, the iIT341 
GSM/GPR from Thiele, et al. (2005)30 is depicted in Table 7.9. 
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Table 7.9. Comparison between the iIT341 GSM/GPR9 model and the metabolic model developed in this work 
(iTR370). 
Parameter iIT341 GSM/GPR9 iTR370 
No. of genes included 339 370 
No. of Gene-Protein-Reaction associations 355 505 
N. of GPRs with 2 or more genes 44 117 
Total no. of reactions 477 666 
No. of metabolites (internal/external) 408/77 432/76 
No. of exchange fluxes 77 76 
 
In this table we can see that our model has more genes included (31 more genes) and 
significantly more GPR association (150) than the previous model, especially when considering 
GPRs with more than one gene, where our model has nearly 3 times more associations. Over all, 
this model has more information included which translates into a greater number of total 
reactions (666 against 477 from the previous model). The number of internal metabolites is also 
higher; however, the number of external metabolites is almost the same. 
 
7.4.4.2 Gene essentiality 
In this section, in silico gene essentiality was assessed. For that purpose, the method for 
determining critical genes embedded in OptFlux was used, using loose environmental conditions, 
as gene essentiality in vivo has been performed in complex media. Thus, all reactions where 
metabolite exchange between the cell and the environment occurred were left unconstrained. 
From the total amount of 370 genes included in the model, 147 were classified as 
essential genes when the simulations were performed. The results on gene essentiality were 
afterwards compared with the data available in the OGEE database28, an online gene essentiality 
database with results from large-scale essentiality experiments. Gene essentiality information on 
H. pylori 26695 is related to the entire genome; however, only information on the genes present 
in the metabolic model was retrieved. Table 7.10. presents the results from the comparison 
between the essential genes predicted using our metabolic model, and the data from the OGEE 
database.  
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Table 7.10. Comparison between essential genes verified experimentally and retrieved from the OGEE database 
and model predictions. 
 
Ogee database28 
Essential Non-essential 
Our model 
Essential 51 96 
Non-essential 53 170 
 
By observing the information in the table we can see that the results obtained in the 
comparison between models predictions and the OGEE database have a percentage of 
agreement of 59.7%, being the genes considered non-essential in a larger number than the 
essential ones. A few reasons for the mismatch in some of the genes might be related with the 
fact that the metabolic model is not able to simulate and incorporate all the components of the 
complex medium used in the OGEE experiments, mainly because some of these components are 
not fully characterized in the literature, such as serum and protein extracts. Gene essentiality 
results and a detailed comparison are depicted in the supplementary material E3 (electronic 
version). 
 
7.4.4.3 Prediction of physiological data 
In this section the results of growth simulations performed with the metabolic model are 
shown and analyzed. The environmental conditions used in the simulations are based on the 
results achieved in the previous chapters in defining the essential amino acids for H. pylori and 
also on identifying a suitable carbon source. The final minimal medium used to perform the 
simulations had in its composition 20 metabolites: 7 essential amino acids (L-Arginine, L-
Histidine, L-Isoleucine, L-Leucine, L-Methionine, L-Phenylalanine and L-Valine), L-Glutamate as 
carbon source, 4 measured FBS compounds (L-Alanine, L-Proline, Lactate and Succinate), 2 
vitamins (Biotin and Thiamine), hypoxanthine, water, oxygen, iron and inorganic compounds, 
such as, phosphate and sulfate.  
For the simulations, the Optflux wild type simulation method was used (pFBA). After 
selecting the model and the reaction to maximize (biomass reaction, in this case) the 
environmental conditions were chosen and the model simulated. 
Results of the simulations are depicted in Table 7.11, where the set of environmental 
conditions used, the specific growth rate, the consumed metabolites and the products originated 
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can be observed. The coefficients defined in the environmental conditions represent, in the 
model, the maximum uptake rate allowed for each compound, and correspond to values 
obtained experimentally for the amino-acids and FBS components during the exponential phase. 
All the remaining metabolites were set at a maximum uptake rate of 10, except for oxygen, that 
was limited to 5 mmol.gDW-1h-1. Due to the lack of experimental data, the reaction representing 
the ATP depletion by processes other than growth (ATPMaint) was also varied and served as a 
degree of freedom for model fitting. 
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Table 7.11. Metabolic model simulations performed using experimental data on uptake rates as environmental conditions and varying the flux of the ATP Maintenance reaction in the model. 
Simulation Environmental conditions (mmol.gDW-1h-1) ATPMaint Consumption Production Biomass (h-1) 
1 
L-alanine 0,1097 Hypoxanthine 10 
1 
Oxygen H2O H+ 
0,1085 L-arginine  6,9444 Thiamine 10 Hypoxanthine L-Proline Carbonic acid 
L-glutamate 1,3917 Fe2+ 10 L-Methionine L-Histidine Xanthine 
2 
L-histidine  0,6944 Sulfate 10 
2 
L-Glutamate L-Isoleucine NH3 
0,1021 L-isoleucine 0,0444 Phosphate 10 Phosphate Succinate Biomass 
L-leucine 0,1389 H2O 10 L-Leucine Thiamine AI-2 
3 
L-methionine 0,1681 Biotin 10 
3 
Sulfate Fe2+ 5-Methylthio-D-ribose 
0,0957 
L-phenylalanine 0,2000 Oxygen 5 L-Arginine Biotin  
L-proline 0,0167 Lactate 1,2292 L-Valine   
L-valine 0,1417 Succinate 0,0013 L-Phenylalanine   
4 
L-arginine  6,9444 Hypoxanthine 10 
1 
L-Phenylalanine L-Valine H+ 
0,1070 L-glutamate 1,3917 Thiamine 10 L-Methionine Oxygen Carbonic acid 
L-histidine  0,6944 Fe2+ 10 Hypoxanthine L-Histidine Xanthine 
5 
L-isoleucine 0,0444 Sulfate 10 
2 
L-Glutamate L-Isoleucine NH3 
0,1006 L-leucine 0,1389 Phosphate 10 Phosphate H2O Biomass 
L-methionine 0,1681 H2O 10 L-Leucine Thiamine AI-2 
6 
L-phenylalanine 0,2000 Biotin 10 
3 
Sulfate Fe2+ 5-Methylthio-D-ribose 
0,0942 
L-valine 0,1417 Oxygen 5 L-Arginine Biotin  
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Table 7.11 displays the results of 6 simulations of the metabolic model under 
different environmental conditions. The simulations were divided into 2 groups, where 
each group shared the same environmental conditions, varying only the flux of the ATP 
maintenance reaction between 1, 2 and 3 mmol.gDW-1h-1 (chosen based on the described 
range of ATP-maintenance consumption for E. coli 31. In the first group (simulations 1, 2 
and 3), the set of environmental conditions correspond to the uptake rates measured for 
all the compounds consumed, whereas in the second group (simulations 4, 5 and 6) the 
compounds corresponding to the FBS were removed in order to analyze their possible role 
in biomass growth. A detailed description of the simulation results is displayed in the 
supplemental material 4 (electronic version). 
In simulations 1, 2 and 3 it is possible to observe that all metabolites had some 
consumption, with the exception of L-Alanine and Lactate. Our results also show that the 
limiting factor for the in silico growth of H. pylori is the amino acid L-glutamate, once this 
metabolite is the only compound that achieved the maximum uptake rate when the model 
was simulated (shown in supplementary material 4). These occurred in all simulations. 
The variation of the maintenance ATP flux changed the biomass growth rate, as 
expected, being the growth rate inversely proportional to the flux of the maintenance ATP 
reaction. 
Simulation 1, with an ATPMaint of 1 and the consumption of the FBS compounds 
L-proline and succinate, originated the growth rate most similar to the experimental data, 
with an in silico specific growth rate of 0.1085 h-1, compared with the in vivo specific 
growth rate of 0.126 h-1. 
In simulations 4, 5 and 6, where the FBS compounds where excluded, the 
simulated growth rate was slightly lower than in the previous simulations. These results 
show that succinate and L-proline contribute to biomass production, although they are not 
essential. Also, their overall influence is small, due to the fact that FBS concentration in 
the minimal medium in also low. 
It should be emphasized that previous models of H. pylori have failed in making 
quantitative predictions due to, on one hand, the usage of a non-specific biomass equation 
and, on the other, to the lack of experimental data available. Thus, the fact that there is a 
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remarkable match between in silico and in vivo physiological data indicates that the model 
here presented can, in the future, be used to make quantitative predictions for H. pylori. 
In the metabolite production column we can observe that there are 5 metabolites 
that are always produced independently of the environmental conditions, when simulating 
in silico the growth of H. pylori. The proton H+ is the metabolite excreted from the model 
with the higher fluxes in all conditions. As expected, Ammonium is produced as a 
byproduct of the decomposition of urea. Carbonic acid, generated in a reaction involving 
water and carbon dioxide is excreted from the model instead of carbon dioxide. Among the 
remaining metabolites produced, 5-Methylthio-D-Ribose and Autoinducer-2 are possibly the 
most peculiar in Table 7.11. 5-Methylthio-D-Ribose is part of the cysteine and methionine 
metabolism, but it originates in another pathway, the arginine and proline metabolism. In 
order to produce spermidine from putrescine, the reaction R01920 encoded by SpeE 
(HP0832) also produces 5'-methylthioadenosine that by its turn is catalyzed in reaction 
R01401 by HP0089, resulting in the formation of 5-methylthio-D-ribose. At this point, the 
only destination for this metabolite would be to continue ahead through a cascade of un-
annotated reactions until the formation of L-methionine. As this solution is not viable, once 
it is well established that H. pylori is auxotrophic for L-methionine, the only solution was to 
excrete in silico the metabolite for the environment. If this excretion has any association 
with in vivo reality remains to be checked. 
The Autoinducer-2 is regarded as a quorum sensing signaling molecule. Studies 
from32 show that this molecule is formed in the cysteine methionime pathway, through a 
cascade of reactions that starts on S-adenosyl-l-methionine, a product of L-methionine 
metabolism, and ends on S-Ribosyl-L-homocysteine33.also showed this cascade as a way to 
producing L-homocysteine. As it is a known quorum sensing molecule, reactions were 
added to the model in order to excrete this signaling molecule. 
Besides these metabolites, Xanthine is also excreted, probably due to an overflow 
in the purine metabolism. Overall, no fermentation by-products were observed in silico, 
again matching the in vivo data from the previous chapter. 
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7.4.5 Flux distribution analysis  
In this section, the analysis of the flux distribution predicted by the model is 
performed. The main pathways of the central carbon metabolism, important precursors 
and their fluxes were analyzed. Flux distribution and metabolite conversions were retrieved 
from simulation 4, where consumption of FBS components is not considered, for 
simplification purposes. Figure 7.3. depicts the most important metabolite conversions, 
and the respective reaction fluxes on 3 important pathways: Glycolysis/Gluconeogenesis, 
Pentose phosphate pathway, and the Citrate cycle (TCA cycle). Reactions occurring in 
alanine, aspartate, glutamate and proline metabolism are also presented.  
When analyzing flux distributions, it is possible to observe that H. pylori is capable 
of performing Gluconeogenesis when not supplemented with carbohydrates. 
Phosphoenolpyruvate is originated from Pyruvate and flows through a reaction cascade in 
order to produce Glycerone phosphate (Glycerone-P). Glycerone phosphate is routed to the 
lipids biosynthesis where some biomass precursors are formed. 
Fructose-6-phosphate (β-D-fructose-6P), also originated from Glycerone phosphate 
through a cascade of reactions in other pathways, is converted into glucose-6-phosphate 
(α-D-glucose-6P) which, in its turn, flows exclusively to the production of 
Lipopolysaccharides. 
In the Pentose Phosphate pathway, fructose 6-phosphate and D-Erythrose 4-
phosphate (D-Erythrose-4P) are converted in Sedoheptulose 7-phosphate (D-
Sedoheptulose-7P) and D-Glyceraldehyde 3-phosphate (D-Glyceraldehyde-3P), which are 
directed into reactions generating 5-Phospho-alpha-D-ribose 1-diphosphate (PRPP). This 
metabolite is then part of the metabolism of Purines and Pyrimidines. 
The TCA cycle is only partially completed. It begins with the conversion of 2-
Oxoglutarate into Succinyl-CoA, followed by Succinate. After being converted from 
Succinate, Fumarate originates (S)-malate, which in its turn is converted to Oxaloacetate. 
(S)-malate also originates Pyruvate, at a rate of 2.287 mmol.gDW -1h-1. All reactions in the 
TCA cycle have high flux rates, going from 1.310 to 1.360 mmol.gDW -1h-1. This is due to 
the use of L-glutamate as the sole carbon source. 
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Pyruvate produces Acetyl-coA, a precursor of many essential reactions. In fact, the 
biosynthesis of peptidoglycan, fatty acids, phospholipids and cofactors is derived from 
Acetyl-CoA34 which enhances the importance of this metabolite. 
When analyzing the amino acids metabolism we can see that L-Alanine is derived 
from Pyruvate. Despite some controversy around this amino acid, with some authors 
claiming that it is an essential nutrient for H. pylori 9 experimental data generated in our 
group suggest otherwise. Reaction directionality analysis performed in eQuilibrator15 for 
reaction R00396 (L-Alanine + NAD+ + H2O = Pyruvate + NH3 + NADH + H+) also supports 
this theory. 
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Figure 7.3. Metabolites and flux distribution in the central carbon pathways when simulating iTR370 in 
minimal medium. 
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The metabolism of L-glutamate, the limiting carbon source of the model when 
simulating with minimal medium, is also depicted. By following the fluxes in the model we 
can see that L-Glutamate is in the origin of several products, including several amino 
acids. 
L-glutamate is directly converted to L-glutamine, which in its turn is converted in D-
glucosamine 6-phosphate (D-glucosamine-6P) and directed to the aminosugars 
metabolism and to Carbamoyl phosphate which is routed to the pyrimidine metabolism. 
From its conversion to (S)-1-Pyrroline-5-carboxylate (L-1-Pyrroline-5-carboxylate), L-
glutamate also originates L-proline, although our results with 13C labeled glutamic acid did 
not prove this conversion. With the set of environmental conditions of this simulation, L-
proline is not being directed to any other metabolite, apart from the biomass, and the fact 
that in silico it is being excreted to the environment in not yet totally clear. L-Aspartate, 
originated from Oxaloacetate, can also be traced back to L-glutamate, passing through the 
TCA cycle. After its conversion, L-Aspartate originates L-Asparagine. L-glutamate can also 
be converted to L-tyrosine (data not shown) and enters the peptidoglycan biosynthesis. 
These results allow a glimpse of the routes taken by L-glutamate in the model in 
order to produce other metabolites. They also allow us to verify how reactions flow in some 
of the major pathways, as in the case of the TCA cycle, which is only partially used. The 
results obtained with the model largely agreed with the obtained experimental ones. 
 
 
7.5 Conclusions 
In this work, the reconstruction of a genome-scale metabolic model of H. pylori 
26695 is presented. 
After genome annotation, the metabolic conversions and transport systems 
identified were retrieved and assembled in a metabolic network. The resulting network was 
complemented with protein subcellular localization and reaction reversibility information. A 
Biomass equation representing the cellular composition of H. pylori was formulated and 
the entities included were Protein, Nucleotides, Peptidoglycans, Lipopolysaccharides, 
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Lipids, Cofactors and Energy requirements. After the complete assembly of the metabolic 
network and the formulation of the biomass reaction, the metabolic network was converted 
into a draft metabolic model that was then manually curated. 
The metabolic model contains 370 annotated genes, encoding 254 different 
enzymes and 61 transport proteins, promoting a total of 666 different reactions, being 
450 enzymatic and 216 of transport. The model comprises 2 compartments, cytoplasm 
and periplasm, and contains 432 metabolites. 
Simulations of biomass growth were performed using the model and the 
experimentally developed minimal medium, containing the essential amino-acids, L-
glutamate as a carbon source, FBS components and other essential elements to the 
metabolic model, such as water, oxygen, phosphate, sulfate and hypoxanthine. Gene 
essentiality analysis was performed with this model, which was found to have 147 
essential and 223 non-essential genes when simulated with all external metabolites 
unconstrained, which corresponds with an agreement of 60% comparing with experimental 
data available.  
Growth simulations were performed using the uptake rates for the amino acids 
obtained experimentally. From the 6 simulations performed, the simulation with the most 
complete medium (including FBS components) and with the lower flux in the ATP 
maintenance reaction showed to be the best when predicting the in vivo specific growth 
rate of H. pylori (0.1085 h-1 in silico and 0.126 h-1 in vivo). These results show that, as 
opposed to previous models, the model here presented allows to perform quantitative 
predictions, besides having a significantly higher coverage of genes and GPR associations.  
An analysis of the flux distributions obtained was performed for the central carbon 
metabolism, showing important metabolite conversions and the correspondent fluxes and 
allowing a better understanding of model predictions. 
The presented results bring new and more comprehensive information on H. pylori 
26695’s genome and metabolism, increasing and improving the existing knowledge on 
this human pathogen. It is shown that the new metabolic model is able to predict the 
phenotypic behavior of H. pylori, therefore becoming a useful tool in assisting the research 
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work being perform on unveiling metabolic routes, identifying new drug targets and 
enhancing treatment efficiency. 
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Helicobacter pylori is associated with gastric diseases, such as gastritis, peptic and 
duodenal ulcers, mucosa associated lymphoid tissue lymphoma and gastric 
adenocarcinomas. Despite more than half of the global population being infected with this 
bacterium, not all individuals will develop clinical symptoms. Nevertheless, its association 
with gastric cancer, the high infection rate, as well as the failures on eradication efforts 
and vaccine development lead to an important health concern. In order to better 
understand the mechanisms leading to disease and also to develop effective ways to fight 
H. pylori infection, it is important to understand its physiological and metabolic behavior.  
H. pylori is a microaerophilic, gram negative, fastidious organism, for which no 
effective defined medium has been developed. Furthermore, current cultivation procedures 
use media that, even when semi-defined, have a variety of nutrients that can be used as 
carbon and energy sources. Under those conditions, the metabolic and physiological 
characterization of H. pylori is very difficult.  
The aim of this work was thus to study the physiology and metabolism of H. pylori 
to allow a better understanding of the behavior and pathogenicity of this organism. For that 
aim, a systems biology approach was used where metabolomics data were used to 
characterize the nutritional requirements, and the potential and preferred carbon sources. 
These data, collected from experiments performed with semi-defined media, together with 
genomics and other information available, were used to build the first genome-scale 
metabolic model of H. pylori that is able to make quantitative predictions. This model can 
be used, in the future, to investigate novel drug targets and elucidate the metabolic basis 
of infection. Furthermore, a comparative study was performed that analyzed different 
methods for assessing growth, viability, culturability and morphology, as these are 
important physiological parameters. 
During this work, important conclusions were taken that can be summarized as 
follows: 
- For assessing H. pylori growth, different methods can be used that originate 
different results that often need to be interpreted with care. From the methods 
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evaluated, DAPI yielded the highest number of total cell counts when 
compared with the PNA FISH probe applied. Optical density measurements 
can also be used to assess growth with reliability. Nevertheless, before the 
application of any of those methods, it is important to perform disaggregation 
procedures, especially in samples taken after the exponential growth phase. In 
fact, cell-to-cell aggregation was visible and had a great impact in all 
measurements. 
- Culturable cell counts were in general less than total cell counts performed 
with DAPI, especially after the exponential phase, showing the presence of 
nonculturable cells. The viable but non-culturable state was mostly observed at 
the end of the culture, after 60 hours.  
- The evaluation of cell viability using Syto9/propidium iodide was not effective 
in analyzing cells during morphological changes, giving exaggerated numbers 
of nonviable cells, which is explained by the entrance of propidium iodide 
through the permeable cytoplasmatic membrane. Under the referred 
conditions, another method to estimate cell viability must be used, such as the 
measurement of membrane potential.  
- The culturable cell counts in some samples were higher compared with the 
spiral cells observed at these time points, thus indicating the potential 
presence of culturable coccoid cells, previously reported by other authors, but 
still under controversy.  
- At the end of the culture, mainly coccoid cells were observed. Taking into 
account that coccoid forms represent a cell adaptation to less favorable 
conditions, the present results suggest that some stressing factors are present 
that cause morphological changes, probably the unavailability of an essential 
nutrient. The presence of an increasing number and size of cell clusters also 
supports this hypothesis. 
- The first report on the measurement of the exometabolome of H. pylori 
indicated that, as suggested by other authors, this organism has not a 
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preference for glucose as a carbon source in the presence of amino acids in 
the culture medium.  
- In agreement with in silico and in vitro published data, some amino acids were 
confirmed to be essential under the conditions used: L-arginine, L-histidine, L-
leucine, L-methionine and L-valine. Additionally, L-isoleucine and L-
phenylalanine, for which there was no consensus, were identified to be 
essential for the growth of H. pylori 26695, under the conditions used in this 
study.  
- Nevertheless, some doubts persisted for the essentiality of L-proline and L-
alanine, as they have been detected in the fetal bovine serum added to the 
culture. Our attempts to grow H. pylori without FBS and without strain 
adaptation failed, indicating that some components are missing in the culture 
medium used or that FBS has another unknown function. Thus, further 
investigation is needed in this direction. 
- Some essential amino acids were found to be completely consumed from the 
culture medium, such as L-methionine, emphasizing the need of adjusting the 
amino acids concentration.  
- Regarding preferences and possible carbon sources, our exometabolome 
experiments have indicated that aspartate, glutamate, proline and alanine 
could be potentially preferred by H. pylori, since they were completely 
consumed in the mentioned order. Compared with amino acids, organic acids 
were not the preferred carbon sources, and, among the identified compounds, 
pyruvate seems to be the preferred one.  
- When the potential carbon sources identified were used individually for 
growing H. pylori, glutamine was identified as the carbon source that yielded a 
higher growth. However, glutamine easily suffers degradation in aqueous 
medium and is converted to glutamate and ammonium by an enzymatic 
reaction in H. pylori’s periplasm. In addition, the use of glutamate as the main 
carbon source had a higher yield in biomass regarding substrate consumption 
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and also allowed to achieve a high specific growth rate. As such, we suggest 
glutamate as the carbon source of choice for H. pylori’s growth. 
- When controlled experiments were performed with glutamate as the main 
carbon source, the specific growth rate was determined to be 0.126 h-1 and a 
biomass yield of 0.6 g/g was obtained.  
- A strategy of 13C labeling was applied to determine the carbon flow, using [U-
13C]-glutamic acid as the main carbon source. The determination of 13C labeling 
patterns of proteinogenic amino acids in biomass hydrolysates provided 
important clues about carbon flow, allowing to confirm the set of essential 
amino acids. 
- Proline is probably not essential and could be synthesized from L-arginine, 
rather than the described possible biosynthesis from L-glutamate, as it was not 
labeled during labeling experiments, although its exhaustion from the medium 
did not arrest growth.  
- L-alanine is probably also not essential and could be obtained from pyruvate 
by alanine dehydrogenase, which would be reversible in H. pylori. This 
conclusion is based on the fact that a low percentage of 13C labeling was 
detected in L-alanine, although with a high error associated. 
-  Another controversial point about the metabolism of H. pylori is the presence 
of a complete TCA cycle. In the present work, evidences of an almost 
complete TCA cycle were provided by the presence of labeled aspartate in 13C-
glutamate labeling experiments.  
- A metabolic model was developed that represents 370 annotated genes, 
encoding 254 different enzymes and 61 transport proteins, that promote a 
total of 666 different reactions, being 450 enzymatic and 216 of transport. 
The model comprises 2 compartments, cytoplasm and periplasm, and 
contains 432 metabolites.  
- Gene essentiality analysis was performed with this model, which was found to 
have 147 essential and 223 non-essential genes when simulated with all 
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external metabolites unconstrained, which corresponds with an agreement of 
60% comparing with the experimental data available.  
- A very good agreement of predictions with experimental data was obtained 
when the uptake rates for the amino acids obtained experimentally were used 
in the simulations (0.109 h-1 in silico and 0.126 h-1 in vivo). The estimated ATP 
maintenance consumption was set to 1 mmol.gDW.h-1. Moreover, the flux 
distributions obtained are consistent with the know carbon flow. 
